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AĶňŉŇĵķŉ
ĉemalaria parasite, Plasmodium falciparum, has a demonstrated history of
adaptation to antimalarials and host immune pressure. ĉis ability unraveled
global eradication programs ėěy years ago and seriously threatens renewed
eﬀorts today. Despite the magnitude of the global health problem, liĨle is known
about the genetic mechanisms by which the parasite evades control eﬀorts.
Population genomic methods provide a new way to identify the mutations and
genes responsible for drug resistance and other clinically important traits.
In this thesis, I set out to develop and apply novel approaches to studying
parasite adaptation in three parts. First, I carry out a global, genomic survey of P.
falciparum diversity and perform a genome-wide association study (GWAS) to
identify a number of candidate markers of drug resistance. Subsequent validation
shows a causal relationship between one of these candidates and parasite drug
response.
Second, I further pursue the GWAS approach by sampling a single population
more deeply andmoving from array-based genotypes to whole-genome sequence
data. I demonstrate the deėciences of array-based GWAS in low linkage
disequilibrium (LD) populations and argue for a complete transition to
sequence-based GWAS for small, low-LD genomes like P. falciparum. I
additionally develop the use of a long-haplotype natural selection test to detect
associations with adaptive traits.
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Finally, I exploit the parasite’s short generation time to detect temporal
signatures of selection in progress from samples collected over several years. I
develop and evaluate new genome-wide statistics for this test and ėnd that it
identiėes coding variants, oěen in surface proteins subject to balancing selection.
ĉis approach is complementary to existing selection tests and is a timely
addition to the genomic toolkit available to malaria eradication eﬀorts.
ĉis research contributes numerous novel approaches to the problem of the
rapidly evolving P. falciparum parasite and signiėcantly advances the ėeld’s ability
to provide the tools and knowledge required for current global eradication
campaigns.
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UsingGenomics to InformMalaria
Control and Eradication Eﬀorts
GŀŃĶĵŀ ļĹĵŀŉļ ŃŇĻĵłĽŐĵŉĽŃłň are in the midst of a renewed push to-wards the eradication and eventual extinction of the malaria parasites,themost lethal ofwhich isPlasmodium falciparum. ĉese eﬀorts rely on
a number of approaches applied in parallel, from indoor spraying and bed nets to
improved local health infrastructure. Ultimately, one of themost vital tools in this
arsenal remains the eﬀective use of antimalarial drugs [ǆǁ]. P. falciparum, how-
ever, has demonstrated an adaptability to numerous drugs (Table ƾ.ƾ). For exam-
ple, widespread chloroquine resistance was a major factor in the abandonment of
the Global Malaria Eradication Programme in ƾǆǃǆ [ƾƾƾ].
ĉeeventual emergence of resistance tomoremoderndrugs is a signiėcant con-
cern, as the current global eradication eﬀorts rely heavily on a single class of drugs:
ƾ
artemisinin and its derivatives. Although fully artemisinin-resistant formshavenot
yet been described, recent work has shown that the alarming trend of slower par-
asite clearance rates in artemisinin-treated patients is increasing over time and ap-
pears to be a genetically heritable trait of the parasite [ƾƽ, ƾƿƾ]. ĉis underscores
an urgent need for the research community to be able to detect and understand
newly emerging resistance adaptations.
Among themajor diseases of greatest human impact, malaria is unique in that it
is caused by a sexual eukaryote, allowing it to adopt beneėcial combinations of
mutations more quickly than asexual pathogens [ǃǃ]. While this ampliėes the
challenges for global disease control, it is actually a favorable feature for genomic
inquiry, as it allows us to apply many of the modern tools developed in human
genomics that require meiotic recombination such as association studies and se-
lection scans. ĉis allows for the realistic expectation that understanding emerg-
ing drug resistance in P. falciparum is feasible in the time frame required for global
eradication.
ĉis introductory chapter describes the genomic tools now available to tackle
these questions, the many challenges involved, the current state of the ėeld in
applying these approaches to the P. falciparum malaria parasite, and the lessons
learned so far about parasite evolution.
Table 1.1: Speed of drug resistance evolution in P. falciparum
Drug Introduction In vivo resistance Origin
Chloroquine ƾǆǁǂ Early ƾǆǃƽs [ƾǀƾ] SE Asia,
S America
Sulfadoxine ƾǆǃǄ Late ƾǆǃƽs [ǃƾ] SE Asia,
+ Pyrimethamine S America
MeĚoquine ƾǆǅǂ Early ƾǆǆƽs [ƾǀǄ] SE Asia
Atovaquone ƿƽƽƽ ƿƽƽƿ [ǂǂ] Africa
+ Proguanil
Artemether ƿƽƽƾ ƿƽƽǅ [ǁǄ, ƾƿǁ] SE Asia
+ Lumefantrine
ƿ
ƾ.ƾ BĵķĿĻŇŃŊłĸ
ĉeWHOestimates that close to onemillion children die frommalaria every year
[ƾƿǃ], with the highest mortality among African children. Increased control ef-
forts have reduced the malaria burden in some areas, but evidence of rebounding
malaria [ƾǃǃ] brings these general trends into question and conėrms that we have
much to learn to defeat this important human pathogen. It is now more critical
than ever to understand key aspects of malaria biology and transmission, iden-
tify targets vulnerable to intervention strategies, and create tools to interpret the
changing landscape of infection. One powerful approach uses population biology-
based investigations to provide critical insight about the causes and spread of dis-
ease. ĉis strategy aids biological discovery by using population structure and ge-
netic diversity to identify loci under selection or associated with clinical pheno-
types, and for developing tools to monitor and evaluate interventions.
P. falciparum is a eukaryotic pathogen with a complex lifecycle, spending part
of its lifespan in its deėnitive host, the anopheles mosquito, as mostly a diploid or-
ganism, and the remainder in its human host as a haploid organism where it gives
rise to numerous clinical manifestations frommild to life-threatening illness. ĉe
ƿǁ Mb genome of the parasite is distributed among ƾǁ linear chromosomes and
the parasite contains two extra-nuclear circular chromosomes that comprise the
apicoplast and mitochondrial genomes. ĉe full P. falciparum genome sequence
was published in ƿƽƽƿ [ǂǄ] and was followed by publication of other Plasmod-
ium genome sequences, including that of Plasmodium vivax [ƿǀ], which causes
signiėcant human malaria. ĉese data have allowed elucidation of basic genome
architecture and identiėcation of key structural elements, commonmetabolic and
biosynthesis pathways and unique aspects shared among several Plasmodium par-
asites [ƿƿ, ƿǀ, ǂǄ, ǃǁ].
ĉe P. falciparum genome is evolving in response to natural selection pressures
of the human host immune system, themosquito vector and various environmen-
tal factors including drug treatment and changes in transmission intensity due to
speciėc interventions [ƾƿ, ǂƽ, ƾǄǅ]. ĉe data imply that parasites can escape both
natural and artiėcial selection pressures through evolution. Understanding these
ǀ
adaptations in the P. falciparum population can allow us to identify and circum-
vent survival strategies used by the parasite, guiding the development of newdrugs
and vaccines. Indeed, similar approaches have been applied to much simpler viral
genomes for tracking inĚuenza outbreaks and for developing eﬀective inĚuenza
vaccines [ǂǆ].
ƾ.ƿ TĹķļłŃŀŃĻĽķĵŀ AĸŋĵłķĹŁĹłŉň
New genomic technologies are what drive the recent advances in our understand-
ing of the history and evolution of the malaria parasite. Population genomic stud-
ies inmalaria started with the low-coverage sequencing of a few dozen global para-
sites [Ǆǁ, ƾƽǃ, ƾǄǁ] andacceleratedwith thedevelopmentof variouswhole genome
genotyping arrays that allowed researchers to cheaply genotype ahundreds tohun-
dreds of thousands of markers across a large population of parasites. Depend-
ing on the technology, these methods can be used to characterize genomic vari-
ation at diﬀerent levels, including SNPs, microsatellite variation (MSVs), inser-
tions or deletions (indels), and copy number variants (CNVs). However, array-
basedmethods need to be custom-built for each organism, requiring speciėc tools
for P. falciparum [ǀƽ, ǁǂ, Ǆǂ, ǅǀ, ƾƽǃ, ƾƾǀ, ƾǃƾ, ƾǄƽ] and P. vivax [ƾǅƽ] to be con-
structed.
More recently, dramatic decreases in the per base-pair cost of next-generation
sequencing technologies has led to a shiě in the economics of studying the
Single Nucleotide Polymorphism (SNP)—A single base pair in the genome where the allele varies
within a population. This is the most common form of genetic variation in populations and provides the
data for most modern genomic studies.
Microsatellite—A class of repetitive DNA sequence that is made up of repeats that are 2–8 nucleotides
in length. They can be highly polymorphic and are frequently used as molecular markers in population
genetics studies.
Indel—A position in the genome that varies in the population where the alleles are not all of the same
length. Microsatellites are a type of indel.
Copy number variant (CNV)—This is a segment of DNA (e.g. a gene or a chunk of chromosome) that is
duplicated elsewhere in the genome, and individuals in the population vary as to how many copies they
have.
ǁ
modestly-sized parasite genome. Although some arrays remain valuable, for
example to identify CNVs, whole-genome sequencing is now similar in cost to
array-based genotyping, while providing information about a signiėcantly larger
number of genomic markers without the species-speciėc customization required
of arrays. Consequently, additional P. falciparum genomes have been sequenced
at greater depth to identify essentially all genetic variation in those genomes, thus
allowing delineation of the composition and relative proportions of parasite types
within a human infection [Ǆ, ƾǀ, ƿǅ, ǆǂ, ǆǅ, ƾƽƿ, ƾƿǄ–ƾƿǆ].
ĉese practical advancements are enhanced by several key bioinformatics anal-
ysis improvements, many of which were developed for the analysis of other organ-
isms and driven by international collaborative eﬀorts such as theHumanGenome
Project [ǅǃ]. Newcomputational strategies to identify SNPs andother variants in-
cludingMSVs, indels andCNVs fromsequencingdata are beingdeveloped and ap-
plied to P. falciparum, providing additional markers that are potentially associated
with drug resistance. Availability of genome sequences for closely related species,
including Plasmodium reichenowi [Ǆǁ] (which infects non-human primates [ǆƾ]),
will greatly advance our ability to make population genomic inferences by identi-
fying derived alleles for selection analysis.
Once obtained, this rich genomic information can yield important insights
about the biology of the malaria parasite, as described in the following sections.
Applications include gaining insights into parasite population structure and in-
terventions, and identifying important regions of the genomeãeither those that
show evidence of evolutionary selection or speciėc loci identiėed by genome-
wide association studies (GWASs) or mutant screensãthat are responsible for
particular parasite phenotypes.
ƾ.ǀ PŃńŊŀĵŉĽŃł SŉŇŊķŉŊŇĹ ĵłĸ LĽłĿĵĻĹDĽňĹŅŊĽŀĽĶŇĽŊŁ
Genetic variation in the parasite reveals the exposure history of a given parasite
or parasite population to selective pressures. Central to our understanding of ge-
netic variation in P. falciparum is determining its current population structure,
including how allele frequencies vary between diﬀerent populations within the
ǂ
species, and the degree to which alleles at neighboring variant sites are correlated
by linkage disequilibrium (LD). Data used to inform our current understanding
of population structure and LD is derived from genome-wide array-based meth-
ods [ǃ, ǀƾ, ǁǂ, ƾƽǄ, ƾƾǀ, ƾǃƽ, ƾǃƾ, ƾǄƽ], from SNP information provided by older
sequencing data from a few dozen published genomes [Ǆǁ, ƾƽǃ, ƾǄǁ], and from re-
cent next-generation sequencing studies [ƿǅ, ǆǂ, ƾƽƿ]. Genomic structure among
isolates has been delineated using principal components analysis (PCA), from
which one can infer the relatedness of samples.
ƾ.ǀ.ƾ GŀŃĶĵŀ GĹłŃŁĽķ DĽŋĹŇňĽŉŏ
Advances in genomic technologies have enabled analysis of many diﬀerent para-
sites derived from distinct geographic locations. Large-scale population structure
inP. falciparum follows continental lines, withmajor branches in Africa, South and
Central America, andSouth andEastAsia (extending toPapuaNewGuinea) [ƾƽǂ,
ƾƾǀ]. ĉe picture within each group depends on the region. Within Africa, popu-
lation diﬀerences between countries have ranged from undetectable (Uganda vs.
Congo [ǅ], Cameroon vs. Congo [ƾǁƾ]) or very small (Zimbabwe vs. Uganda and
Congo [ǅ]), to modest over the longest distances (Nigeria vs. Sudan vs. South
Africa [ǀǂ]). By contrast, in Southeast Asia and the western hemisphere, local
population structure is pronounced even within a single country [ƾƽǂ, ƾǄǁ]. ĉe
overall picture is consistent with a recent geographic spread from a source pop-
ulation in Africa, which has remained by far the largest population. Estimates of
genetic diversity measurements present the same picture, with the highest values
consistently occurring within Africa and the lowest in the Americas. From these
types of analyses, we can identify mutations that are ėxed in one parasite popula-
tionbut aredistinct fromother populations, and thusmaybeuseful to identify spe-
Linkage Disequilibrium (LD)—In population genetics, linkage disequilibrium is the nonrandom
association of alleles. For example, alleles of SNPs that reside near one another on a chromosome often
occur in nonrandom combinations owing to infrequent recombination.
Principal components analysis (PCA)—A statistical method used to simplify data sets by transforming
a series of correlated variables into a smaller number of uncorrelated factors. It is commonly used to
correct for stratiﬁcation in genome-wide association studies.
ǃ
ciėc parasites. Knowledge of the genetic characteristics of geographically distinct
populations is important for controlling for population stratiėcation in GWASs,
tracking persistent parasite types as interventions are applied and localizing new
sources of infection to maximize the eﬀectiveness of control measures.
ƾ.ǀ.ƿ EŎńŀĵłĵŉĽŃłň ĺŃŇ OĶňĹŇŋĹĸ LD SŉŇŊķŉŊŇĹ
Levels of genomic diversity in diﬀerent populations are reĚected in the observed
paĨerns of LD. Very liĨle LD is seen in Africa, and what is seen extends less than ƾ
kb [ǀǁ, ƾƽǂ, ƾƿǆ, ƾǄǁ]. LD is slightly higher in Southeast Asia (mean rƿ = ƽ:ǀ for
markers less than ƾ kb apart) and more so in South America (mean rƿ = ƽ:ǂ,
for markers less than ƾ kb apart), where it spans about ƾƽ kb. ĉis diﬀerence
could stem fromdemographic history. For example, population boĨlenecks in the
non-African populations could have eliminatedmany allele combinations, leaving
strong correlations, thus high LD, in the remaining parasites. It could also stem
from a smaller eﬀective population size outside of Africa, limiting these popula-
tions to fewer allele combinations, which contributes to higher levels of LD. De-
tailed understanding of recombination andof the demographic history of diﬀerent
populations is needed to distinguish the two causes.
LD paĨerns also reĚect the transmission history of strains within that popula-
tion. ĉe sexual phase of the P. falciparum life cycle occurs in themidgut of female
Anopheles mosquitoes, following consumption of a blood meal containing male
and femaleP. falciparum gametocytes. Because female Anophelesmosquitoes typ-
ically bite only a single human host during each egg-brooding cycle, the gameto-
cyte pool available for sexual union in the midgut matches the gametocyte com-
position in individual infected human hosts. In geographical regions with high
levels of malaria transmission, a high complexity of infection (COI) is thought to
Population stratiﬁcation—The presence of multiple population subgroups that show limited
interbreeding. When such subgroups differ in both allele frequency and disease prevalence, this can
lead to erroneous results in association studies.
Effective population size (Ne)—The number of individuals in a population genetic model that most
closely matches the allele frequency distributions in the data. This can differ from actual population size
owing to historical demographic events, such as population bottlenecks, migration and other factors.
Ǆ
be produced through ‘super-infection’ (multiple bites from distinct, P. falciparum-
infected mosquitoes), although new evidence supports a model of co-infection
of mixed infections [ƾƿƿ]. ĉis makes recombination (outcrossing) possible be-
tween genetically distinct P. falciparum gametocytes during the sexual phase (pro-
vided genetic diversity is high enough to ensure genetically distinct parasites), and
results in short blocks of LD. By contrast, if only a single P. falciparum strain is
present, the gametocytes will be identical, and the lack of recombination will re-
sult in longer blocks of LD.
Ultimately, as parasite population sizes get extremely small, one would antici-
pate that LD should become extended and theoretically approach a value of one.
ĉus, tools to measure changes in parasite population structure have the poten-
tial to inform reductions in malaria transmission as outcrossing rates are reduced
to the point where selėng among parasites occurs in a given population, such as
might be expected during a successful intervention strategy [ǁƽ].
ƾ.ǁ SĽĻłĵŉŊŇĹň Ńĺ SĹŀĹķŉĽŃł
In the course of its life cycle, the parasite faces numerous and intense selective pres-
sures. ĉese include exposure to antimalarial drugs and immune challenges from
both the human host andmosquito vector. Evidence abounds from recent studies
of parasite diversity for two broad classes of strong natural selection in the parasite
genome.
ƾ.ǁ.ƾ BĵŀĵłķĽłĻ SĹŀĹķŉĽŃł
Genotyping and sequence analysis indicate that an unusually large fraction of
the P. falciparum genome exhibits the polymorphism proėle of immune-mediated
balancing selection: a high density of high frequency polymorphisms is seen in
hundreds of antigenic genes [Ǆ, ǂƽ, ƾǄǅ]. Balancing selection maintains polymor-
phisms with the potential to encode alternate immunological identities and keeps
Balancing selection—Selection that favors the maintenance of more than one polymorphic allele in a
population by mechanisms such as frequency-dependent selection or heterozygote advantage.
ǅ
them at an intermediate population frequency indeėnitely (Figure ƾ.ƾA)
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Figure 1.1: Signatures of balancing selection. (A) In a given population (large grey cir-
cle) there are numerous individuals (square matrix of circles) each containing alleles (red
or yellow circles) across their genomes. Diversity refers to the amount of allelic variation
among individuals in a population, whereas divergence refers to the amount of allelic vari-
ation between different populations. Under balancing selection, one would expect to ﬁnd
high diversity at a locus under selection, but low divergence between populations. (B) Dis-
tribution of loci based upon both within population differences (diversity, as measured by π)
and between population differences (divergence, as measured by FST between parasites
from Senegal and Thailand) is shown. Loci classiﬁed as transporters or enzymes including
the acyl-CoA-synthetase (ACS) genes are shown as blue diamonds; loci classiﬁed as anti-
gens including var, riﬁn, stevor, and surﬁn molecules are shown as red diamonds; and all
other loci are shown as grey diamonds. Molecules along the x-axis (high diversity and low
divergence) are under diversifying selection and these include a number of known antigens.
In contrast, molecules along the y-axis (low diversity and high divergence) are more likely
under directional selection and these include a number of known drug resistant molecules.
Panel (B) was previously published in Van Tyne et al. [170].
When parasite populations are geographically separated, genes subject to bal-
ancing selection are unlikely to diverge as rapidly as other genes, because the se-
lection prevents diﬀerences fromdiﬀerentially ėxing in the populations. Genome-
wide comparisons of diversity (within a population, measured by π) and diver-
gence (between populations, measured by FST) identify genetic loci that aremore
likely to be aﬀected by this diversifying selection [ƾǄƽ] in that they exhibit elevated
diversity with relatively low divergence. (Figure ƾ.ƾB shows an example diver-
ǆ
sity and divergence analysis between parasites from Senegal andĉailand [ƾǄƽ].)
From these analyses known antigens and vaccine candidates are identiėed, as well
as novel genetic loci that encode putative antigens that trigger the human immune
response. ĉis prediction was validated when several highly polymorphic genes
were expressed and recognized by human immune sera, including seven previ-
ously unknown antigens [ƾƽǃ]. ĉis result suggests that diverse genomic regions
may encode antigenic loci useful for vaccine approaches. However, a number of
vaccine studies suggest that the ability to successfully target a polymorphic locus
such as merozoite surface protein ƾ (MSPƾ) [ƾǂǆ] or apical membrane antigen ƾ
(AMAƾ) [ƾǃǀ] may be undermined by the parasite’s ability to survive the elicita-
tion of a locus-speciėc immune response. ĉus, strategies to use a combination of
non-variant yet immunogenic vaccine targets may be warranted.
Diversity and divergence analyses can identify loci that, conversely, diverge
between parasite populations (FST > ƽ:ǁ). Divergent loci between popula-
tions from Senegal and ĉailand [ƾǄƽ] encode proteins that are proposed to
have various cellular functions including DNA replication (e.g. PFȊȉ_ȉȊȏȎ;
PFȊȍ_ȉȋȐȑ; PFȊȍ_ȉȌȊȏ), lipid metabolism (e.g. PFBȉȏȒȎc; PFEȊȋȎȉw;
PFBȉȏȑȎc; PFCȉȉȎȉc); gametocytogenesis or sexual development molecules
(e.g. PFȊȌ_ȉȋȍȑ; PFCȉȏȍȉw) and transporters (e.g. PFLȊȊȋȎw; PFȊȍ_ȉȌȍȋ;
PFȊȍ_ȉȍȎȎ) (Figure ƾ.ƾB). ĉe reasons for the divergence are currently unclear
and require further investigation, but may be a consequence of diﬀerences in
vector populations or other distinct selective pressures between Senegal and
ĉailand.
ƾƽ
ƾ.ǁ.ƿ DĽŇĹķŉĽŃłĵŀ SĹŀĹķŉĽŃł
Directional selection in the context of a traditional ‘selective sweep’ [ƾǂǂ] leaves a
distinctive genomic imprint consisting of depleted polymorphism and enhanced
LD (Figure ƾ.ƿAB). ĉis genomic signature is detectable via ‘haplotype-based’
tests of natural selection, such as the long-rangehaplotype (LRH) test. In response
to strong selective pressures, long haplotype signals resulting from the rapid rise of
variants linked to Ěankingmutations are easily detected as they stand out from the
normally short LD of the genomic background [ƾǂƽ] (Figure ƾ.ƿB). It is impor-
tant to note that these signals may be absent if directional selection began on com-
mon or standing variation [ƾǂƽ]. Equally important is the diﬃculty in identify-
ing a clear demarcation between selective sweeps and neutral processes without a
detailed understanding of demographic history and recombination rate variation,
knowledge that is lacking for P. falciparum. Nevertheless, in genome-wide scans
for selective sweeps a number of loci show strong evidence for recent directional
selection, and they all point to a single, recent evolutionary pressure: drugs. Loci
known to confer resistance to formerly eﬀective anti-malarial drugs, including the
chloroquine resistance transporter (pfcrt) for chloroquine [ƾǅǁ] and bifunctional
dihydrofolate reductase–thymidylate synthase (dhě-ts) for pyrimethamine [ƾƽǆ]
show all the signs: a local desert of diversity and strong LD between those SNPs
found in the swept region (Figure ƾ.ƿA). Other key modiėer genes, including the
P. falciparum multiple drug resistance gene (pfmdrȊ) [ǂǃ, ƾǅǀ] and the GTP cy-
clohydrolase gene (gchȊ) [ǅǀ, ƾƾƽ], have been implicated in some drug responses,
generally through adaptive changes in their copy number.
A plethora of additional genes show weaker evidence for recent positive selec-
Directional selection—Selection that favors one allele over all other alleles of a gene. The frequency of
this beneﬁcial allele can rise or can be held in check by recurrent mutation.
Selective sweep—Describes the reduced levels of genetic diversity observed around a selected locus.
A selective sweep (also referred to as genetic hitch-hiking) arises because positive selection for an
advantageous allele increases the frequency of not only that allele but also other alleles contained within
the same haplotypes.
Long-range haplotype (LRH) test —A test for haplotypes with signiﬁcantly longer than expected
ranges of linkage disequilibrium; this indicates a lack of recombination between genetic markers caused
by natural selection.
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Figure 1.2: Signatures of directional selection. (A) Selective sweep as a consequence of
selection for drug resistant parasites results in the reduction of diversity (red line) from av-
erage genome values (blue line) as a consequence of selection for an allele (red box) that
confers survival under drug pressure. Neighboring alleles are maintained along with the
advantageous allele, resulting in a relatively large area of the genome with reduced diver-
sity. Identiﬁcation of genomic regions with reduced diversity in drug resistant parasites
as a consequence of directional selection reveals candidate drug resistant genes. (B) A
haplotype bifurcation diagram [150] visualizes long-range associations for a given SNP.
The thickness of the line represents the relative frequency of each allele in the population
under study. Although the long-range associations between the ancestral (A) allele have
been whittled away by recombination, the derived (T) allele maintains long-range associ-
ations with other SNPs, suggesting it arose recently and that insufﬁcient time has passed
for recombination to substantially break down these associations. Panel (B) was previously
published in Volkman et al. [174].
ƾƿ
tion [ǃ, ƿǅ, ǀƾ, ǆǂ, ƾƽƿ, ƾƽǄ, ƾǃƽ, ƾǄƽ, ƾǅǂ], raising thepossibility they are also asso-
ciated with drug responses. ĉeir products have various putative functional roles
[ƾǄƽ], including cell-surface adhesion, membrane transporters, genome mainte-
nance, transcriptional regulation, metabolism and post-translational modiėcation
such as ubiquitination. Evidence for sweeps at multiple genes in a single path-
way suggest that selection has been involved. For example, several genes in the
ubiquitination pathway [ƾǀǀ] are under positive selection both in worldwide pop-
ulations and in a deep population analysis of parasites isolated recently in Sene-
gal. Similarly, proteins in the faĨy acid and lipid metabolism pathway have among
the highest signals of selection, implicating the human or mosquito physiological
state as strong selective forces on parasite survival and propagation. Key to the
success of these approaches is functional characterization of candidate loci and
demonstrating their involvement in conferring important clinical phenotypes such
as drug resistance [ƾǄƽ]. Preliminary functional data suggests thatmembers of the
cytoadherence-linked asexual protein or clag family can modulate parasite drug
responses [ƾƾǃ], consistent with the observation that some surface molecules are
under positive selection [ƾƽǄ, ƾǄƽ].
ƾ.ǂ FĽłĸĽłĻ ŉļĹGĹłĹŉĽķ BĵňĽň ĺŃŇ SńĹķĽĺĽķ PļĹłŃŉŏńĹň
ƾ.ǂ.ƾ PĵŇĵňĽŉĹ PļĹłŃŉŏńĹň
A key challenge for identifying causal loci from genomic or functional studies is
classiėcation and quantiėcation of robust and reliable phenotypes. Clinical phe-
notypes related to pathogenesis (anemia or severe disease), immunity or parasite
clearance rates (associated with drug resistance) are most informative and reliable
when they are assessed in parasites that are taken directly from the patient during
a natural infection. However, the human host unavoidably complicates interpre-
tation of these traits, and their assessment can oěen only be obtained once. A
thorough phenotypic assessment would therefore necessitate large sample num-
bers and thoughtful study design to account for variation both within the hu-
man and parasite populations. ĉus far, phenotyping has been mainly carried out
ƾǀ
on culture-adapted [ƾǃǂ] parasites that have been isolated from patients. ĉese
can then be tested for various in vitro phenotypes including drug response, inva-
sion types, cytoadherence properties, the ability to produce gametocytes, or their
metabolic proėles.
ĉis section focuses on the use of genomics to identify mutations associated
with altered drug responses, but these approaches could be applied to other bio-
logically important phenotypes.
ƾ.ǂ.ƿ LĽłĿĵĻĹ AłĵŀŏňĽň Ľł P. ļķłĹĿņķŉŌŃ
Linkage mapping in P. falciparum has been accomplished using laboratory genetic
crosses to correlate segregation paĨerns in the progeny associated with speciėc
phenotypes, including drug response [ǂƾ, ǃǂ, ƾƿǀ, ƾǁǅ, ƾǂƿ, ƾǄǆ], pathogenesis
[ǃǂ], or mosquito infectivity [ƾǃǅ]. OriginallyMSVs were used as genomicmark-
ers [ƾǂǄ], but these have now been augmented with variants determined using
whole-genome methods (array- or sequencing-based). Linkage studies leverage
the reasonably high level of recombination inP. falciparum [Ǆǃ] tomap the genetic
determinants for speciėc traits: one round of recombination between parents and
progeny results in large haplotype blocks that require fewer markers to identify
[ƾƿ]. In some geographic regions, where low diversity means that recombination
rarely results in the reassortment of haplotype blocks, it may even be possible to
carry out similar analyses using ėeld isolates [ǁǃ, ǃƿ]. Combining linkage analysis
with other independent tests, such as association mapping, provides a potentially
powerfulmeans of prioritizing candidate genes responsible for a given phenotype.
ƾ.ǂ.ǀ CļĵŀŀĹłĻĹň Ńĺ GWASň Ľł P. ļķłĹĿņķŉŌŃ
ĉe molecular and genetic mechanisms of many phenotypic traits that are most
relevant to elimination and eradication, such as variability in parasite responsive-
ness to drugs, are poorly understood. BecauseGWASs donot require prior knowl-
edge of gene functions or trait mechanisms, they are useful for identifying impor-
tant genetic variants in organisms such as P. falciparum that have many genetic
loci with no known functional homologues. Although these candidate variants
ƾǁ
require functional validation, the use of GWAS as a hypothesis-generating experi-
ment provides a powerful starting point for identifying traits and is one of themost
eﬀective approaches available in our modern genomic toolkit.
Undertaking GWASs in P. falciparum requires overcoming various challenges
including: identifying heritable traits, copingwith lowLD, using appropriate sam-
ple collection or other methods to deal with population stratiėcation, and func-
tionally validating associations. ĉese challenges are described below, followed
by examples of successful GWASs.
When surveying the P. falciparum genome for genotype-phenotype associa-
tions, only phenotypes with a strong genetic basis (those with high heritability)
will be detected by a GWAS. Heritability of P. falciparum traits, such as drug resis-
tance, can be variable: recent studies of parasite clearance rates in Southeast Asia
found that the heritability of this phenotype depends onwhen andwhere samples
are collected [ƾƽ, ƾƾ]. Confounding this complication, anti-malarial responses can
be quantiėed in variousways, including in vitro basedmetrics, such as ICǂƽ, or clin-
ically derived metrics, such as in vivo parasite clearance rates.
ĉe short blocks of LD inP. falciparum, particularly inAfrican populations [ƾƾǀ,
ƾǄƽ], are an important consideration for study design. Traditional GWASs rely
on the genotyped markers being correlated to causal mutations through high LD
[ǁƿ]. In a population with low LD, an array-based GWASmay not have suﬃcient
detectionpower unless the causalmutation is present on the array. However, when
a signal is found, short LDmakes localizing the signal to a single genemuch easier
[ƾǁƽ]. Loss of detection power due to limited LD can therefore be circumvented
by utilizing whole-genome sequencing to identify all variants in the genome. Use
of sequence data for GWASs reveals stronger association signals, provides more
supporting markers in areas of high LD and can detect candidate loci in areas of
low LD that were previously missed by array-based GWASs. Sequencing-based
Heritability—The proportion of the total phenotypic variation in a trait that can be attributed to genetic
effects.
IC50—Also known as the half maximal inhibitory concentration, this is the concentration of a small
molecule that results in 50% inhibition of a molecular target or cellular process. In the case of drug
resistance studies, this is the concentration of drug that kills half of the parasites.
ƾǂ
approaches are thus a promising avenue for future GWASs in malaria.
Populationdemographyãparticularly in the formofpopulation stratiėcationã
can hinder GWAS analyses if not appropriately controlled for. ĉe presence of
closely related individuals in the dataset or, conversely, broad genetic diﬀerences
between groups of samples due to diﬀering population histories can erroneously
inĚate associations and produce false positives [ǂ]. ĉe ideal GWAS would elim-
inate such confounders by choosing samples with a broad range of values for
each strongly heritable phenotype while sampling entirely from a single, non-
stratiėed population. However, this is not always possible and many approaches
have been developed to eliminate false positives [ǁǁ, ƾǀǂ, ƾǀǆ] while analysing
stratiėed data sets. In particular, mixed-model approaches [Ǆǆ, ǅƽ, ƾǀǃ, ƾǃǁ] have
been used successfully to control for population stratiėcation in malaria studies
[ƾƿǆ, ƾǃƽ, ƾǄƽ].
For studies with relatively small sample sizes, which include all malaria-based
GWASs to date, gains in study power can be achieved by using multi-marker or
haplotype-based association approaches [ǀƾ, ǁƿ, ƾƿǆ, ƾǃƽ, ƾǄƽ] insteadof standard
single-marker tests. Positively selected variants typically lie on long haplotypes
[ƾǂƽ] that are more easily detectable by multi-marker tests, such as the LRH test.
ƾ.ǂ.ǁ GWAS AńńŇŃĵķļĹň ŉŃ IĸĹłŉĽĺŏ DŇŊĻ RĹňĽňŉĵłķĹ LŃķĽ
Although the GWAS approach is promising, we are still in the early days of ap-
plying this methodology for loci discovery in the malaria parasite, with the few
GWASs primarily investigating novel variants associated with drug resistance.
ĉese studies [ǀƾ, ƾƽǄ, ƾƿǆ, ƾǃƽ, ƾǄƽ, ƾǅǂ] generate long lists of loci hypothesized
to be associated with speciėc phenotypes, and a current challenge is winnowing
the list to the most likely candidates. One strategy involves combining results
of independent tests to identify the most likely candidate genes for functional
follow-up (Figure ƾ.ǀ).
Mixed-model approaches—A class of linear model in which quantitative phenotypes are modelled
using both ﬁxed, genetic effects (including SNP genotypes and the principal components of population
structure) and random effects (which explicitly models both the heritable and non-heritable components
of phenotypic variation).
ƾǃ
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Figure 1.3: Identifying drug resistance loci using GWASs and functional studies. (A)
Schematic representing data from a drug assay, measured as an inhibitory concentration
of 50 percent (ICǂƽ) that represents the drug concentration at which parasite viability is de-
creased by half. Such assays can be used to classify parasite responses to anti-malarial
compounds, thus distinguishing a drug-resistant parasite (green line) from a drug-sensitive
parasite (grey line). (B)Genome-wide association study (GWAS) analysis results shown as a
Manhattan plot where P-values for variants across the fourteen chromosomes (represented
by different colors across the x-axis) are shown. The Bonferroni level for genome-wide sig-
niﬁcance is shown as a dotted line, and genetic variants that rise above this level are as-
sociated with the drug phenotype observed in panel A. (C) Multiple independent analysis
approaches can be combined to improve the power of locus identiﬁcation for functional
follow up. For example, alleles identiﬁed by GWASs, long-range haplotype (LRH) tests, or
diversity and divergence analyses are identiﬁed, and a gene expression construct is cre-
ated comprising the genetic variant that is associated with drug resistance. To test whether
each gene variant is necessary and sufﬁcient to confer the observed drug resistant pheno-
type, each putative drug-resistance variant is introduced into a drug sensitive parasite by
transfection, followed by testing for drug resistance.
ƾǄ
Several previously known drug targets and one novel GWAS result have now
been functionally validated, lending support to the idea of using GWAS to ėnd re-
sistance loci. ĉeGWAS by Van Tyne et al. [ƾǄƽ] identiėed a highly polymorphic
locus,PFȊȉ_ȉȌȎȎ, as being associatedwith halofantrine resistance based on a rela-
tively small set of globally diverse parasites. PFȊȉ_ȉȌȎȎwas classiėed as amember
of themspȌ gene family [ƾƿǂ]. When a variant ofPFȊȉ_ȉȌȎȎ from a drug resistant
parasitewas introduced into a drug sensitive parasite through transfection, the par-
asite was rendered resistant not only to halofantrine but also to chemically similar
drugs (meĚoquine and lumefantrine), but not to chemically distinct compounds
(chloroquine, artemisinin, atovaquone). ĉis is the ėrst functional demonstration
that a potential drug resistance locus identiėed by a GWAS confers a drug resis-
tance phenotype.
ĉis study employed a modest number of parasites sampled from many popu-
lations using a limited marker set. More recent studies now assay larger parasite
numbers from single populations using sequencing data to capture essentially all
genetic variation and demonstrating signiėcant increases in power [ƾƿǆ].
ƾ.ǃ CŃłķŀŊňĽŃłň ĵłĸDĽňňĹŇŉĵŉĽŃłOŋĹŇŋĽĹŌ
Genomic analysis is providing rich and unique insight into the biology and pop-
ulation history of P. falciparum. ĉe strongest selective forces that leave visible
imprints on the parasite genome are the signals of balancing selection on surface
proteins due to human immune pressure, as well as the signals of directional selec-
tion due to anti-malarial drugs. ĉe goal of contemporary disease elimination ef-
forts should be to prevent selective sweeps from occurring in response to current
treatment strategies. ĉis can be achieved through careful genomic surveillance
and Ěexible, combinatorial application of drug treatments.
In the decade since the publication of the P. falciparum genome sequence [ǂǄ],
modern genomics has advanced our understanding of the parasite. However, we
are just beginning to leverage population genetic information to discover the vari-
ants responsible for clinically important phenotypes. ĉework in this dissertation
plays an important role in the development of these tools and methods.
ƾǅ
In Chapter ƿ, I perform one of the ėrst GWASs for antimalarial drug resistance.
As the only such study todate that includes a functional validation, it demonstrates
the utility of the GWAS approach to ėnd causal markers for poorly understood
phenotypes. It also inĚuenced the methodologies used by others in the malaria
genomics ėeld, with later drug studies adopting the linear model [ǀƾ] and mixed
model [ƾǃƽ] association methods ėrst successfully demonstrated here.
In Chapter ǀ, I demonstrate the use of whole-genome sequence data for asso-
ciation studies and the clear deėciencies of array-based association studies. Other
groups in the ėeld are now moving from array to next generation sequence data
as well [Ǆ, ǆǂ, ƾƽƿ]. Importantly, I also demonstrate the novel use of the cross-
population extended haplotype homozygosity selection test (XP-EHH, a type of
LRH test, [ƾǂƾ]) in the context of a GWAS. Similar approaches that combine XP-
EHH and association tests can be seen soon aěerwards in work by others [ƾǃƽ].
InChapter ǁ, I explore theuseof timecoursedata todirectly infer the strengthof
directional selection throughout the genome. Such approaches have not yet been
shown on a genome-wide scale, nor have they been applied in the malaria para-
site previously. ĉe results provide an additional source of insight into the evolu-
tionary forces shaping the P. falciparum genome. Here I demonstrate a proof of
concept study, and outline the parameters for properly designing and conducting
a whole-genome time-course selection study.
ĉe research described in this dissertation has the potential to provide substan-
tial new insights into the recent evolution of the malaria parasite, particularly as
it relates to drug resistance. ĉe results highlight a number of candidate genes
andmutations that can lead to biological insights and epidemiological surveillance
tools. Butmore importantly, this thesis develops andprovides newgenomicmeth-
ods that can be used by others in conducting similar types of research. As such, it
makes signiėcant advancements to the ėeld of malaria genomics by improving the
way research is conducted globally.
ƾǆ
ĉis chapter was originally published as Van Tyne, Park,
et al., Identiėcation and functional validation of the novel
antimalarial resistance locus PFȊȉ_ȉȌȎȎ in Plasmodium
falciparum, PLoS Genetics (Ȑ), ȋȉȊȊ [ȊȐȉ]. ĉis work was
also presented at the American Society of Tropical Medicine
and Hygiene (Nov ȋȉȊȉ, Atlanta, GA). See page xiv for de-
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Genome-wide Association Studies
Identify the Antimalarial Resiﬆance Locus
PFȊȉ_ȉȌȎȎ
ĉĹ PłķŊŃŅĺĿŌŃ ļķłĹĿņķŉŌŃ ńĵŇĵňĽŉĹ’ň ability to adapt to environ-mental pressures, such as the human immune system and anti-malarial drugs,makesmalaria anenduringburden topublic health.
Understanding the genetic basis of these adaptations is critical to intervening suc-
cessfully against malaria. To that end, we created a high-density genotyping ar-
ray that assays over ƾǄ,ƽƽƽ single nucleotide polymorphisms (~ƾ SNP/kb), and
applied it to ǂǄ culture-adapted parasites from three continents. We character-
ized genome-wide genetic diversity within and between populations and identi-
ėed numerous loci with signals of natural selection, suggesting their role in recent
ƿƽ
adaptation. In addition, weperformed a genome-wide association study (GWAS),
searching for loci correlated with resistance to thirteen antimalarials; we detected
both known and novel resistance loci, including a new halofantrine resistance lo-
cus, PFȊȉ_ȉȌȎȎ. ĉrough functional testing we demonstrated that PFȊȉ_ȉȌȎȎ
overexpression decreases sensitivity to halofantrine, meĚoquine and lumefantrine
but not to structurally unrelated antimalarials, and that increased gene copy num-
ber mediates resistance. Our GWAS and follow-on functional validation demon-
strate the potential of genome-wide studies to elucidate functionally important
loci in the malaria parasite genome.
ƿ.ƾ IłŉŇŃĸŊķŉĽŃł
Plasmodium falciparummalaria is a major public health challenge that contributes
signiėcantly to global morbidity and mortality. Eﬀorts to control and eliminate
malaria combine antimalarial drugs, bed nets and indoor residual spraying, with
vaccine development a longer-term goal. Genetic variation in the parasite popula-
tion threatens to undermine these eﬀorts, as the parasite evolves rapidly to evade
host immune systems, drugs and vaccines. Studying genetic variation in parasite
populations will expand our understanding of basic parasite biology and its ability
to adapt, andwill allowus to track parasites as they respond to intervention eﬀorts.
Such understanding is increasingly important as countriesmove towards reducing
disease burden and the ultimate elimination of malaria.
Given the potential impact of rapid evolution of P. falciparum in response to
control and eradication strategies, discovery and characterization of P. falciparum
genetic diversity has accelerated in recent years. Since the ėrst malaria genome
was sequenced in ƿƽƽƿ [ǂǄ], over ǃƽ,ƽƽƽ unique SNPs have been identiėed by
concerted sequencing eﬀorts [Ǆǁ, ƾƽǃ, ƾǄǁ], and several genomic tiling arrays [ƿǁ,
ǁǂ, Ǆǂ, ǅǀ, ƾǃƾ] and low-density SNP arrays [ƾƽǄ, ƾƾǀ] have been developed to
query this genetic variation. Recently theėrstmalariaGWASwaspublished [ƾƽǄ],
in which ƾǅǆ drug-phenotyped parasites from Asia, Africa and the Americas were
genotyped using a low-density array (ǀ,ƿǂǄ SNPs); that study identiėed loci under
positive selection and found several novel drug resistance candidates.
ƿƾ
For our study, we adopted two strategies for identifying genes involved in the
malaria parasite’s adaptive response: searching for signals of recent or ongoing
natural selection, and searching for loci associated with one important clinical
adaptationãresistance to antimalarial drugs. Tomake these searches possible, we
began by sequencing ǆ geographically diverse strains of P. falciparum to identify
novel variation, thereby doubling the number of publicly available SNPs to ƾƾƾ,ǂǀǃ
(all accessible at http://plasmodb.org/), and used these SNPs to develop a high-
density genotyping array assaying ƾǄ,ǂǅƿ validated markers. Aěer characterizing
linkage disequilibrium and population structure in our samples, we used the ar-
rays to search for evidence of both ongoing balancing selection and recent positive
selection, and to carry out a GWAS that sought loci associated with resistance to
thirteen antimalarial agents. We then followed up one of the novel loci associated
with drug resistance in order to verify that variation therewas biologically involved
in modulating drug response.
ƿ.ƿ RĹňŊŀŉň
ƿ.ƿ.ƾ GĹłĹŉĽķ DĽŋĹŇňĽŉŏ
We identiėed global population structure among malaria parasites using princi-
pal components analysis (PCA) of ǂǄ genotyped culture-adapted parasite sam-
ples (Figure ƿ.ƾA, Table C.ƾ, Figure C.ƾ). African, American and Asian samples
form three distinct clusters, reĚecting the likely independent introduction of P.
falciparum from Africa into Asia and the Americas. ĉere was liĨle evidence for
structure within Africa, suggesting high gene Ěow throughout the region (Figure
C.ƾ). Asian and American parasites however both show substantial internal struc-
ture.
ĉere are also dramatic diﬀerences in linkage disequilibrium (LD) between
populations, with substantial LDextending less than ƾ kb in Senegal, ƾƽ kb inĉai-
land, and ƾƽƽ kb in Brazil (Figure C.ƿ). ĉese observations are consistent with
previous ėndings, which showed that LDdecaysmore rapidly in Africa, due either
to founder eﬀects in other continents [ǅ] or to elevated outcrossing frequencies in
ƿƿ
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Figure 2.1: Parasite global population structure and genetic diversity vs. divergence. (A)
Population structure is visualized using the ﬁrst two principal components of genetic vari-
ation for 57 parasites. Solid circles represent individual parasites, with colors assigned by
reported origin: Africa in red, America in blue, and Asia in green. The nine strains used for
ascertainment sequencing are indicated with (*). (B) Genetic diversity (SNP π) in Senegal
versus divergence (FST) between Senegal and Thailand is reported for 688 genes contain-
ing > ǀ successfully genotyped SNPs. Blue diamonds: enzymes, acyl-CoA synthetases
(ACS) or transporters; red diamonds: antigens, vars, riﬁns, stevors or surﬁns; gray dia-
monds: all other genes. Gene IDs (http://plasmodb.org/) for highlighted genes are
listed in Table C.7. A gene with unknown function is ﬂagged with (*) to indicate that SNP π
is off-scale (0.014).
ƿǀ
Africa [ǅ, ƾƽǂ], where higher transmission intensity leads to a greater likelihood of
sexual outcrossing rather than selėng within the mid-gut of vector mosquitoes.
ĉe short LD in malaria, driven by high levels of recombination, means that a
high density ofmarkers is required to identify candidate loci in association studies,
since causal variants not on the array can seldom be tagged by neighboring alleles
(Table C.ƿ). On the other hand, short LD can aid in ėne-mapping candidate asso-
ciations and greatly accelerates the search for causal genes. Short LD also aids in
identifying genomic regions under recent positive selection with recombination-
basedmethods, since the increasedLD in selected regions should standout against
the short-LD background.
ƿ.ƿ.ƿ DĹŉĹķŉĽłĻ SĽĻłĵŀň Ńĺ NĵŉŊŇĵŀ SĹŀĹķŉĽŃł
We expect that many parasite proteins that interact with the host immune system
will be under balancing selection, because they will be under selective pressure
to maintain high levels of diversity. Indeed, previous studies have shown that re-
gions of the P. falciparum genome that are highly polymorphic and appear to be
under balancing selection encode antigens that are recognized by the human im-
mune system [ƾƽǃ]. We examined evidence for balancing selection in our data by
searching for regions with high nucleotide diversity (as measured by SNP π) and
low population divergence (as measured by FST) (Figure ƿ.ƾB). When we exam-
ined the loci lying in this region of the graph (Figure C.ǀ), we found a number of
known antigens and vaccine candidates. Loci in the same region with unknown
function are thus potential novel antigens that trigger human immune response to
malaria, and may prove useful as biomarkers or as candidate vaccine molecules.
We carried out a similar search for loci under positive selection by identifying
regions with both low nucleotide diversity within Senegal andĉailand and high
population divergence between the two populations (Figure ƿ.ƾB). We observed
throughout the genome that nucleotide diversity was lower for nonsynonymous
SNPs than for intergenic SNPs (Figure C.ǁ), a characteristic result of widespread
purifying selection. At the same time, nonsynonymous SNPs exhibited signiė-
cantly greater divergence than intergenic SNPs in all pairwise population com-
ƿǁ
parisons, suggesting the eﬀect of positive selection in local P. falciparum popu-
lations. Nonsynonymous SNPs with low diversity within a population and high
divergence between the two populations studied may represent polymorphisms
responsible for adaptive evolution.
We also carried out a genome-wide scan for recent positive selection using the
long-range haplotype (LRH) test [ƾǂƽ], which identiėes common variants that
have recently spread to high prevalence using recombination as a clock. Approx-
imately ƾǂ genes were identiėed as having undergone recent positive selection by
this approach, including known drug resistance loci (pfcrt and dhě) as well as
multiple members of the acyl-CoA synthetase (ACS) and ubiquitin protein lig-
ase families (Figure C.ǂ and C.ǃ); these laĨer genes also exhibit high divergence
between Senegal andĉailand (Figure ƿ.ƾB), evidence for selection that is recent
and population-speciėc. Taken as a group, the genes identiėed by the LRH test
show a signiėcant enrichment for higher than average population divergence (as
measured by FST, Mann-WhitneyU = ƾǂǅǀ, P = ƽ:ƽƽǄƾ). All of these loci (Ta-
ble C.ǀ, Dataset ƾ), which include genes in the folatemetabolism, lipid biosynthe-
sis and ubiquitin pathways, should be viewed as candidates for functional follow-
up and further characterization.
ƿ.ƿ.ǀ GĹłŃŁĹ-ŌĽĸĹ AňňŃķĽĵŉĽŃłň ŌĽŉļ DŇŊĻ RĹňĽňŉĵłķĹ
In order to directly assess the genetic basis for one important response to anti-
malarial intervention, we carried out aGWAS to identify loci associatedwith drug
resistance in parasites. ĉis same approach can potentially be applied to many
other clinically relevant malaria phenotypes, e.g. host response, invasion, and ga-
metocyte formation. Our ėrst step was to measure drug resistance (ICǂƽ values)
to ƾǀ antimalarial drugs (amodiaquine, artemether, artesunate, artemisinin, ato-
vaquone, chloroquine, dihydroartemisinin, halofuginone, halofantrine, lumefan-
trine, meĚoquine, piperaquine and quinine) in ǂƽ culture-adapted parasites using
a high-throughput assay (Tables C.ǁ and C.ǂ, Appendix C, Dataset ƾ).
We performed the genome-wide association analysis using two statistical tests:
eﬃcient mixed-model association (EMMA) and a haplotype likelihood ratio
ƿǂ
(HLR) test (Figures C.Ǆ, C.ǅ, C.ǆ, C.ƾƽ, Appendix C). EMMA identiėes quan-
titative trait associations in individuals with complex population structure and
hidden relatedness; it has previously been shown to outperform both PCA-based
and λGC-based correction approaches in highly inbred and structured mouse,
maize, and Arabidopsis populations [Ǆǆ]. EMMA is particularly applicable for
small and structured sample sets: one of its ėrst applications was in a study of
ƿǁ diploid mouse strains [Ǆǆ], essentially the same sample size as in our study
(ǂƽ haploid strains). ĉe HLR test is a multi-marker test designed to detect the
association of a single haplotype with a phenotype, and is particularly powerful
when the associated haplotype experienced recent strong selection (and is there-
fore long) and occurs on a low-LD background [ǆƽ]; it is therefore particularly
appropriate for this study. We addressed the eﬀect of population structure in
the HLR test using population-speciėc permutation (Section ƿ.ǁ). When used
together, these two complementary approaches provide a highly sensitive screen
for association signals within the P. falciparum genome.
ĉe well-characterized chloroquine resistance locus, pfcrt, served as a positive
control for our GWASmethods (Figure ƿ.ƿA and ƿ.ƿC, Table C.ƿ), an important
test given our small sample size and the limited LD present in P. falciparum. As
expected, we found evidence for association with resistance to chloroquine using
both tests, consistent with previous studies [ƾƽǄ]; EMMA yielded evidence for
association with genome-wide signėcance, while the signal from the HLR test fell
just short of genome-wide signiėcance (Figure ƿ.ƿC).
Applying the same tests to the other drug phenotypes, we detected numerous
novel loci showing signiėcant associations with drug resistance (Figure ƿ.ƿA and
ƿ.ƿD, Table ƿ.ƾ). Quantile quantile plots for each test demonstrate that we were
able to eﬀectively control for population structure (Figure ƿ.ƿB).Despite our small
sample size and the low LD in P. falciparum, in total eleven loci achieved genome-
wide signiėcance for association with resistance to ėve diﬀerent drugs: amodia-
quine, artemisinin, atovaquone, chloroquine and halofantrine. In most cases, the
short extent of LD allowed localization to individual genes. Among the loci iden-
tiėed were various transporters and membrane proteins, as well as ėve conserved
genes with unknown function (Table ƿ.ƾ, Dataset ƾ).
ƿǃ
Figure 2.2: Genome-wide association study (GWAS) results. (A) Genome-wide signiﬁ-
cant associations were found for ﬁve antimalarials (out of thirteen tested) using EMMA and
HLR tests. They include pfcrt (chromosome 7) associated with chloroquine resistance and
eleven novel associations with resistance to several drugs, listed in Table 2.1. (B) Quantile-
quantile plots for the P-value distributions in (A) show no signiﬁcant confounding from pop-
ulation structure. Bonferroni-corrected genome-wide signiﬁcance is marked with a dashed
line; Benjamini-Hochberg signiﬁcance is marked with a dotted line. (C-D) Close-ups are
shown of the GWAS signal (top) and haplotypes (bottom) for resistance to (C) chloroquine
(CQ) around the gene pfcrt and (D) halofantrine (HFN) around the gene PF10_0355. Yellow:
sensitive allele; red: resistant allele; Blue: no data. Isolates are ordered by ICǂƽ, with the
highest ICǂƽ on the bottom.
ƿǄ
Table 2.1: Eleven genome-wide signiﬁcant associations with antimalarial drug resistance.
Positions are given with respect to the PlasmoDB 5.0 reference assembly of 3D7. Drug ab-
breviations are ATV: atovaquone; CQ: chloroquine; HFN: halofantrine; ADQ: amodiaquine;
ARTS: artemisinin. The HLR test for CQ-pfcrt association is just below the genome-wide
signiﬁcance threshold and is omitted here, but is shown in Figure 2.2C.
chr SNPs test drug P-value genes PlasmoDB de-
scription
ǃ ǃǄǁ,ƾǂǁ EMMA ATV ƿ:ǀǃ ƾƽ Ǆ PFFƽǄǅǂw Ndcǅƽ homologue,
putative
Ǆ ǁǂǆ,ǄǅǄ EMMA CQ ǁ:Ǆƿ ƾƽ Ǆ MALǄPƾ_ƿǄ chloroquine resis-
tance transporter
ƾƽ ƾ,ǁǀǂ,ƿƿǃ,
ƾ,ǁǀǂ,ƿǅǃ,
ƾ,ǁǀǂ,ǀǄƽ,
ƾ,ǁǀǄ,ǃǆǂ,
ƾ,ǁǀǄ,Ǆƾǅ,
ƾ,ǁǁƾ,ǂǆƽ,
ƾ,ǁǁǁ,ǅǃǅ
HLR-
risk-ǃ
(ƿ over-
lapping
hits)
HFN ǁ:Ǆƾ  ƾƽ ǃ,
ǁ:ƿǂ ƾƽ ǃ
PFƾƽ_ƽǀǂǂ,
PFƾƽ_ƽǀǂǃ
erythrocyte mem-
brane protein
putative, liver stage
antigen ƾ
ƾƾ ǃǂǄ,ǀǁǆ EMMA ATV ǁ:ƽƾ ƾƽ ǃ PFƾƾ_ƽƾǄǅ conserved unknown
ƾƾ Ǆǀǅ,ǁƽǄ EMMA HFN Ǆ:ƿƽ ƾƽ Ǆ PFƾƾ_ƽƿƽǀ peptidase, putative
ƾƾ ƾ,ƾƿǀ,ƽƿǅ,
ƾ,ƾƿǁ,ƽǀƽ
HLR-risk-
ƿ
ADQ ǂ:ƿǃ ƾƽ ǃ PFƾƾ_ƽǀƽƿ conserved unknown
ƾƿ ƾ,ǆǃǁ,ǆǀǂ EMMA HFN ǃ:ƾǂ ƾƽ ǅ PFLƿƿǅǂc conserved unknown
ƾǀ ǄǂǄ,ǃǅǆ EMMA HFN ƾ:ƿǅ ƾƽ Ǆ PFƾǀ_ƽƾƽƾ conserved unknown
ƾǁ ƾ,ƿǀǀ,ǁǄƽ EMMA HFN ǂ:ǀƿ ƾƽ Ǆ PFƾǁ_ƽƿǆǀ conserved unknown
ƾǁ ƿ,ǅƾǁ,Ǆǆǀ,
ƿ,ǅƾǂ,Ǆƾǁ
HLR-risk-
ƿ
ARTS ǁ:ǆƽ ƾƽ ǃ PFƾǁ_ƽǃǂǁ aminophospholipid
transporter, puta-
tive
ƾǁ ǀ,ƾǀƽ,ǁǁǆ EMMA ATV ƾ:ƽǀ ƾƽ ǃ PFƾǁ_ƽǄƿǆ early transcribed
membrane protein
ƾǁ.ƿ
ƿǅ
ƿ.ƿ.ǁ FŊłķŉĽŃłĵŀ VĵŀĽĸĵŉĽŃł Ńĺ ĵ NŃŋĹŀ RĹňĽňŉĵłķĹ CĵłĸĽĸĵŉĹ
Demonstrating that a signal of association actually reĚects a causal molecular pro-
cess requires functional testing and validation of the candidate locus, both be-
cause of concerns about power and reproducibility of genetic association tests,
and because even a robust statistical correlation need not imply biological cau-
sation. To conėrm the ability of GWAS to identify functionally relevant can-
didates, we investigated one of our association ėndings, PFȊȉ_ȉȌȎȎ, in greater
depth. ĉis gene contains multiple SNPs associated with halofantrine resistance
(Figure ƿ.ƿD), and encodes a putative erythrocyte membrane protein (http://
plasmodb.org/) characterized by high genetic diversity.
We set out to determine the role of PFȊȉ_ȉȌȎȎ in halofantrine resistance by
transfecting halofantrine-sensitive Ddƿ parasites with episomal plasmids con-
taining the PFȊȉ_ȉȌȎȎ gene from a halofantrine-resistant parasite (SenPƽǅ.ƽǁ),
a technique that is used routinely for stable transgene expression [ǀǃ]. Two in-
dependent transfectants overexpressing the PFȊȉ_ȉȌȎȎ gene from SenPƽǅ.ƽǁ
both showed reduced susceptibility to halofantrine when compared with the Ddƿ
parent or a transfection control (Figure ƿ.ǀA), suggesting that this gene is indeed
involved in modulating parasite drug response.
Two independent transfectants overexpressing the endogenous PFȊȉ_ȉȌȎȎ
gene from halofantrine-sensitive Ddƿ also showed reduced susceptibility to hal-
ofantrine (Figure ƿ.ǀA), however, pointing to a role of overexpression in the
observed resistance. Because PFȊȉ_ȉȌȎȎ is annotated as a putative erythrocyte
membrane protein and belongs to the merozoite surface protein ǀ/ǃ family, we
tested the hypothesis that the observed eﬀect was the by product of a growth or
invasion-related process, rather than resistance due to a direct interaction with the
antimalarial itself. To that end, we expanded our drug testing in the transfectant
lines to include other antimalarials, some structurally related and some unrelated
to halofantrine.
Overexpression of PFȊȉ_ȉȌȎȎ from either the Ddƿ or the SenPƽǅ.ƽǁ parent
caused increased resistance to the structurally related antimalarials meĚoquine
and lumefantrine (Figure ƿ.ǀB and ƿ.ǀC), but had no eﬀect on parasite sus-
ƿǆ
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Figure 2.3: Overexpression of PF10_0355 decreases parasite susceptibility to halofantrine
(HFN) and related antimalarials. Parasite susceptibility to six antimalarials was measured
by 3H-hypoxanthine incorporation. Comparisons were made between Dd2 (HFN-sensitive
strain) and SenP08.04 (HFN-resistant strain), as well as 4 transfected lines. “Dd2+Dd2”:
Dd2 parasites overexpressing PF10_0355 from Dd2; “Dd2+P08”: Dd2 parasites overex-
pressing PF10_0355 from SenP08.04. Overexpression of PF10_0355 decreases parasite
susceptibility to (A) HFN and structurally related (B)meﬂoquine (MFQ) and (C) lumefantrine
(LUM). Overexpression of PF10_0355 does not alter parasite susceptibility to (D) chloro-
quine (CQ), (E) artemisinin (ARTS) or (F) atovaquone (ATV). Mean ICǂƽ standard error is
shown. Signiﬁcance levels: *: p < ƽ:ƽǂ, **: p < ƽ:ƽƾ, ***: p < ƽ:ƽƽƾ.
ǀƽ
ceptibility to the structurally unrelated antimalarials chloroquine, artemisinin
or atovaquone (Figure ƿ.ǀD and ƿ.ǀE). Indeed, we found evidence of cross-
resistance between halofantrine and both meĚoquine and lumefantrine (Figure
ƿ.ǁ). We also observed cross-resistance between halofantrine and artemisinin,
which is expected as cross-resistance between aminoquinolines and artemisinin
compounds has been previously demonstrated [ƾƽǄ, ƾǀǁ] and resistance to all
these drugs has been shown to be mediated by changes in pfmdrȊ copy number
[ƿǆ, ƾǂǀ]. Overexpression of PFȊȉ_ȉȌȎȎ, however, alters parasite susceptibility
to the aminoquinolines but not to artemisinin, suggesting that this eﬀect is spe-
ciėc for that set of structurally related compounds and distinct from the eﬀect of
pfmdrȊ, which seems to exert a global eﬀect of resistance to unrelated compounds
(i.e. both aminoquinolines and artemisinins). Using the Ddƿ parasite line, which
has ampliėed pfmdrȊ copy number, as a background for PFȊȉ_ȉȌȎȎ overexpres-
sion allowed us to distinguish between cross-resistance to a structurally related
class of compounds (mediated by PFȊȉ_ȉȌȎȎ overexpression) and pan-resistance
to multiple classes of drugs.
Given that overexpression of the PFȊȉ_ȉȌȎȎ gene both from a halofantrine-
resistant and from a sensitive parasite conferred resistance to halofantrine-related
drugs, we investigated whether gene ampliėcation might be driving the observed
resistance, as it oěen does for antimalarial drugs [ǆ, ǂǃ, ƾƾƽ, ƾǀǄ, ƾǁǃ, ƾǅǀ]. We
quantiėed PFȊȉ_ȉȌȎȎ copy number in our transfectants and found that the trans-
fectant with the highest ICǂƽ for all three drugs (Ddƿ+PƽǅB) also had the high-
est PFȊȉ_ȉȌȎȎ copy number, as measured by quantitative PCR (qPCR) (Figure
ƿ.ǂA). Furthermore, when we examined the PFȊȉ_ȉȌȎȎ gene on our SNP array,
we detected a substantial increase in hybridization intensity at the PFȊȉ_ȉȌȎȎ
locus compared to the genome average, suggesting that this gene is ampliėed in
some parasites (Figure ƿ.ǂB). ĉe ampliėed region appears only to contain the
PFȊȉ_ȉȌȎȎ gene itself and not surrounding loci. We observed a similar paĨern at
pfmdrȊ on chromosome ǂ, where copy number variation is well established (Fig-
ure C.ƾƾ). Follow-up qPCR analysis of ǀǅ parasite lines conėrmed that parasites
with ampliėed PFȊȉ_ȉȌȎȎ have a greater mean halofantrine ICǂƽ. (Figure ƿ.ǂC,
Table C.ƾƾ, Dataset ƾ). Copy number variation was further conėrmed in a num-
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Figure 2.4: Correlations between antimalarial drugs tested. (A) Pearson correlation values
(r) between logƾƽ(ICǂƽ) values are rendered as a color in a symmetric correlation matrix
(red: correlated; white-uncorrelated, blue: inversely correlated). Thirteen antimalarials are
measured: artemether (ARTM), artesunate (ARTN), artemisinin (ARTS), dihydroartemisinin
(DHA), halofantrine (HFN), lumefantrine (LUM), meﬂoquine (MFQ), quinine (QN), chloroquine
(CQ), amodiaquine (ADQ), atovaquone (ATV), piperaquine (PIP), and halofuginone (HFG).
Drugs are grouped by structural relatedness. (B-F) Correlation plots are given with a linear
regression line for HFN compared to the 5 other drugs tested for antimalarial resistance
with PF10_0355 overexpression: (B) LUM, (C) MFQ, (D) ATV, (E) CQ, and (F) ARTS.
ǀƿ
ber of parasites by quantitative Southern bloĨing (Figure C.ƾƿ).
ƿ.ǀ DĽňķŊňňĽŃł
In this study we used natural selection and genome-wide association methods
to probe the genetic basis of adaptation in P. falciparum. ĉese approaches are
complementary: scanning for selected loci permits an unbiased search for un-
known adaptive changes, but provides liĨle information about the processes at
work, whileGWAS gives a focused look at one easily identiėed (and clinically crit-
ical) adaptive phenotype. Results from both approaches open up new avenues for
study, as we seek to understand the biological signiėcance of the ėndings.
ĉe speciėcs of our strategy were designed to cope with two potential limita-
tions in applying genome-wide population genetic approaches to malaria: small
sample sizes, due to the diﬃculty in adapting parasites to culture and assessing
drug and other phenotypes; and a lack of correlation (LD) between nearby vari-
ants in the parasite genome, which limits our ability to infer untyped SNPs from
genotyped markers. ĉe second limitation we addressed by developing a high-
density genotyping array (based on new sequencing), to increase the fraction of
genetic variation that we could directly interrogate, while the eﬀect of the ėrst was
mitigated by the phenotype we targeted in our GWAS.
Drug resistance is a phenotype well-suited for GWAS because it is expected to
be caused by common alleles of large eﬀect at few genomic loci [ǃǂ]. If this is the
case, associations will be much easier to detect than in a typical human GWAS,
in which the phenotype is caused by alleles at many loci that are either rare or of
small eﬀect. Additionally, the haploid nature of the intra-erythrocytic stage of P.
falciparum further heightens GWAS power by eliminating the issue of allelic dom-
inance. Finally, the increased LD caused by recent selection for drug resistance
counteracts the loss of power that comes from short LD, small sample size, and
the temporal and geographic stratiėcation of the parasite population that we ex-
amined. ĉus, despite the potential limitations, we were able to detect a known
drug resistance locus (pfcrt), observed liĨle P-value inĚation in our GWAS data
(Figures C.ǅ, C.ǆ, C.ƾƽ), and identiėed a number of genome-wide signiėcant loci
ǀǀ
20
15
10
5
0
25
Position on Chromosome 10 (Mb)
Parasite Isolate
PF
10
_0
35
5 
C
op
y 
N
um
be
r
A
B
C
 Dd2 WT Dd2+Dd2A Dd2+Dd2B Dd2+P08A Dd2+P08B
20
15
10
5
0
-5
H
yb
 In
te
ns
ity
 (z
 s
co
re
)
1.425 1.430 1.435 1.440 1.445
PF10_0355
H
FN
 IC
50
 (n
M
) ●
Single Copy Amplified
20
15
10
5
Figure 2.5: Copy number variation at PF10_0355 is associated with HFN resistance. (A)
Mean PF10_0355 copy number ( standard deviation for three replicates) in the par-
ent Dd2 and transfected lines from qPCR analysis. Dd2+Dd2: Dd2 parasites overex-
pressing PF10_0355 from HFN-sensitive Dd2; Dd2+P08: Dd2 parasites overexpressing
PF10_0355 from HFN-resistant SenP08.04. Copy number was compared to the reference
locus PF07_0076. (B) Increased hybridization intensity at PF10_0355 on the high-density
SNP array, measured by Z-scores for normalized and background-corrected data, for the
HFN-resistant isolate SenP19.04. (C) Strains with increased copy number of PF10_0355 (as
measured by qPCR> ƾ:ƿ 3D7) show a signiﬁcantly higher resistance to HFN (p = ƽ:ƽƿ,
Student t-test).
ǀǁ
associated with drug resistance. Part of this success was likely due to speciėc tests
we used to account for population structure.
Going beyond these statistical tests, we went on to functionally validate one
of these loci, demonstrating that increased PFȊȉ_ȉȌȎȎ copy number confer resis-
tance to three structurally related antimalarial drugs. ĉis demonstrates the feasi-
bility of coupling GWAS and functional testing in the malaria parasite for identi-
fying and validating novel drug resistance loci and illustrates the power of GWAS
to ėnd functionally important alleles.
Comparing our results to the recentGWASdescribed byMu et al. [ƾƽǄ], which
was also directed at ėnding drug-resistance loci, we see that, beyond the well-
known pfcrt locus, there was no overlap between the associations identiėed by
each study. Diﬀering sets of drugs tested and analytical methods explain much
of the disagreement. Of the eleven candidate associations in Table ƿ.ƾ, one (that
with pfcrt) was found by both studies, eight were associations with drugs not as-
sayed in Mu et al. (atovaquone and halofantrine), and two were found only with
a haplotype-based test, an approach not used byMu et al.. Our candidate locus at
PFȊȉ_ȉȌȎȎ, in fact, would not have been detectable in theMu et al. study because
it was identiėed only by the multi-marker HLR test, because it involved an associ-
ationwith halofantrine, and because theMu et al. genotyping array lackedmarkers
within ǁ kb of the gene (http://plasmodb.org/).
Diﬀerent parasite populations andmarker sets probably explainmany of the di-
hydroartemisinin, meĚoquine and quinine associations identiėed byMu et al. but
not seen in our data set. ĉe studies useddiﬀerent parasite population setsãtheirs
was weighted toward southeast Asian strains, and ours toward African strainsã
and selection pressures and selected alleles can both vary between populations.
Our smaller sample size also means that we might lack power to identify some as-
sociations accessible to Mu et al.. ĉese diﬃculties are reĚected in human GWAS
studies as well, where the ability to replicate associations using multiple tests and
in diﬀerent sample sets has also been challenging to achieve [ǆƿ].
Ultimately, the disparities in loci identiėed point to the role of population anal-
ysis as a tool for candidate gene discovery and not as a deėnitive study. Even
ǀǂ
within each study, there is liĨle overlap between the signals observed with dif-
ferent methodsãour study detects only one gene (pfcrt) by both GWAS tests
(EMMA and HLR), while Mu et al. detected only two genes (unknowns, not
pfcrt) by both of their GWAS tests (Eigensoě and PLINK). Even a well-designed
GWAS serves only as a hypothesis-generating experiment, and it is vital to em-
pirically validate candidate loci associated with a phenotype of interest. Espe-
cially given the small sample sizes and relatively sparsemarker density used in both
malaria GWAS studies to date, functional validation of candidates is necessary to
address concerns about false positive results.
Our functional result, that increased PFȊȉ_ȉȌȎȎ copy number confers de-
creased susceptibility to halofantrine, meĚoquine and lumefantrine, raises addi-
tional questions for study. Further work will be needed to determine the precise
contributions of copy number variation and gene mutation to the parasite’s re-
sponse to these drugs. ĉe biological function of this gene’s product is unknown,
but previous work indicates putative localization to the parasite surface [ƾǂǁ],
as well as it being a potential target of host immunity and balancing selection
[ƾƿǂ]. While the protein itself does not appear to be a transporter, it is possible
that it directly binds drug or perhaps couples with transport proteins to modulate
drug susceptibility; interaction betweenmembrane transporters and non-channel
proteins has been demonstrated in cancer, plant and yeast systems [ƾǄ, ǂǅ, ƾƽƽ].
Additional experiments are certainly required to determine the precise role of
PFȊȉ_ȉȌȎȎ in modulating parasite response to this class of compounds, includ-
ing assessing its relevance to resistance in natural populations, but it is clear that
alteration of this locus can mediate drug resistance in P. falciparum.
Although halofantrine,meĚoquine and lumefantrine are not commonly used as
primary interventions, widespreadhalofantrineusehas recently beendocumented
in West Africa. Notably, halofantrine was used to treat nearly ƾǅ million patients
between ƾǆǅǅ and ƿƽƽǂ [ƿƽ, ǃƽ], and it remains in production and use today.
Use of halofantrine, meĚoquine or lumefantrine as monotherapy may further ex-
plain how mutations and copy number variation in the PFȊȉ_ȉȌȎȎ gene were se-
lected. Lumefantrine is also currently used as a partner drug in the artemisinin-
based combination therapy (ACT) Coartem. ĉe shorter half-life of artemether
ǀǃ
allows lumefantrine to be present as monotherapy, making it vulnerable to selec-
tion of drug resistant mutants. As genetic loci associated with drug responses are
identiėed and validated, these provide newmolecular biomarkers to evaluate drug
use and response in malaria endemic seĨings. ĉus, our ėndings have implica-
tions for deėning molecular biomarkers for monitoring partner drug responses as
intervention strategies, such as ACTs, are applied.
Beyond identifying a novel drug resistance locus, this study illustrates the gen-
eral utility of aGWAS approach for the discovery of gene function inP. falciparum.
Even with a small and geographically heterogeneous sample of parasites, we iden-
tiėed a number of new loci associated with drug response and validated one of
them. Larger samples from a single population will have much greater power to
detect additional loci, including those where multiple and low frequency alleles
contribute to resistance. Future GWAS have the potential both to provide greater
insights into basic parasite biology and to identify biomarkers for drug resistance
and other clinically relevant phenotypes like acquired protection, pathogenesis,
and placental malaria.
Future GWAS will be able to counteract the loss of power caused by low LD,
either by focusing on parasite populations with reduced outcrossing rates, or by
studying cases of very strong selective pressure. ĉis issuewill soon becomemoot,
however, as the declining cost of whole genome sequencing makes it practical to
assay every nucleotide in the genome on a routine basis. Culture-adapted para-
sites are amenable to robust and reproducible phenotypic characterization, but
their limitationsãthepotential for artifactualmutationsduring adaptation and for
a biased selection of clones within a given infectionãmean that genetic changes
identiėed using them require both functional validation and demonstration that
the changes are important during natural infection. As direct sequencing of clini-
cal isolates with demonstrable clinical phenotypes such as ex vivo drug response
or invasion properties becomes increasingly feasible, sequencing will enable us to
directly identify genetic changes in the parasite associated with clinically relevant
phenotypes. In the years ahead, genome analysis of P. falciparum has the poten-
tial to identify genetic loci associated with many phenotypes, enhance our under-
standing of the biology of this important human pathogen, and inform the devel-
ǀǄ
opment of diagnostic and surveillance tools for malaria eradication.
ƿ.ǁ MĹŉļŃĸň
ƿ.ǁ.ƾ PĵŇĵňĽŉĹň, DŇŊĻ TĹňŉĽłĻ, ĵłĸ DNA IňŃŀĵŉĽŃł
Parasite samples and origins are detailed in Appendix C and Table C.ƾ. Parasites
were maintained by standard methods [ƾǃǂ] and were tested for their response to
amodiaquine, artemether, artesunate, artemisinin, atovaquone, chloroquine, di-
hydroartemisinin, halofuginone, halofantrine, lumefantrine, meĚoquine, pipera-
quine and quinine according to the methods outlined by Baniecki et al. [ƾǃ] (Ta-
ble C.ǁ, Figure C.ƾǀ, Appendix C). Follow-up drug testing was done bymeasuring
uptake of ǀH-hypoxanthine [ƾǄǄ]. Nucleic acids were obtained from parasite cul-
tures usingQiagen genomic-tips (Qiagen, USA). All DNA sampleswere evaluated
by molecular barcode [ǀǆ].
ƿ.ǁ.ƿ AŇŇĵŏ GĹłŃŉŏńĽłĻ
We sequenced nine geographically diverse parasite isolates to ƾ:ƿǂ coverage,
nearly doubling the number of publicly available SNPs to ƾƾƾ,ǂǀǃ (Appendix C).
ĉese parasites had been previously sequenced to ƽ:ƿǂ coverage [ƾǄǁ] and the
deeper sequencing allowed for more thorough SNP discovery. Using this com-
bined marker set, we created a high-density Aﬀymetrix-based SNP array for P. fal-
ciparum containing Ǆǁ,ǃǂǃ markers. Arrays were hybridized to ǂǄ independent
parasite samples (Table C.ƾ), including ƾǄ previously sequenced strains used as
a validation set. Genotype calls were produced using the BRLMM-P algorithm
[ƾ]. Markers that didnotdemonstrateperfect concordancebetween sequence and
array data for the ƾǄ strains were removed (Appendix C). ĉe remaining ƾǄ,ǂǅƿ
SNPs constituted the high-conėdencemarker set used throughout this study (me-
dian marker spacing ǁǁǁ bp, mean spacing ƾ,ǀƾǃ bp). All genomic positions and
translation consequences are listedwith respect to thePlasmoDBǂ.ƽ assembly and
annotation. SNP genotype data are publicly available on http://plasmodb.org/
ǀǅ
(release ǃ.ƽ, July ƿƽƽǆ) and dbSNP (Build Bƾǀǁ,May ƿƽƾƾ), accessible by search-
ing for submission batches Pf_ƽƽƽƿ (sequencing of nine isolates) and Pf_ƽƽƽǀ
(genotyping of ǂǄ isolates) from submiĨer BROAD-GENOMEBIO. Genotype
data is also available as Dataset ƿ.
ƿ.ǁ.ǀ PŇĽłķĽńĵŀ CŃŁńŃłĹłŉ AłĵŀŏňĹň
Principal components analysis (PCA) was performed using the program Smart-
PCA [ƾǀƽ]. All single-infection samples were used for the analysis in Figure
ƿ.ƾ. Samples that tightly clustered with the wrong continental population (Aǁ,
Malayan Camp and Tƿ_Cǃ) represented likely cases of contamination and were
thus omiĨed from all other analyses.
ƿ.ǁ.ǁ DĽŋĹŇňĽŉŏ/DĽŋĹŇĻĹłķĹ AłĵŀŏňĽň
Wemeasured diversity using a statistic we term ‘SNP π,’ which quantiėes the aver-
age number of pair-wise diﬀerences among samples from a given population at as-
sayed SNPs. Population divergence was measured using FST, calculated using the
method of Hudson et al. [ǃǆ]. Statistical evaluation of the signiėcance of diﬀer-
ences in SNP π and FST among populations was performed using a bootstrapping
approach, where the SNP set was re-sampled with replacement and each statistic
recomputed ƾƽƽƽ times.
ƿ.ǁ.ǂ LĽłĿĵĻĹ DĽňĹŅŊĽŀĽĶŇĽŊŁ (LD) AłĵŀŏňĽň
ĉe statistic rƿ was calculated within each population for all pairs of SNPs sharing
the same chromosome [ǃǄ]; pairs were binned by distance and averaged within
each bin. ĉe level of LD between unlinked markers was estimated by calculat-
ing rƿ between all pairs of SNPs on diﬀerent chromosomes. To determine the
bias caused by small sample size, the unlinked calculation was repeated, with the
change that for each pair of SNPs, the genotype for one was taken from one strain
while the genotype for the secondwas taken fromanother strain. ĉis background
value of rƿ was calculated separately for the possible pairs of diﬀerent strains and
ǀǆ
then averaged. Only single infections, as assessed by molecular barcode, were
used.
ƿ.ǁ.ǃ LŃłĻ RĵłĻĹ HĵńŀŃŉŏńĹ (LRH) AłĵŀŏňĽň
Because of the small number of samples, LRH results for individual continental
populations had a high level of variance. ĉus, we pooled together samples from
Africa (n = ƿǃ) and Asia (n = ƾǅ, excluding India), as suggested by our PCA
analysis. SNPs included in the analysis had a minor allele frequency of at least
ƽ.ƽǂ and a call rate of at least ƽ.ǅ; missing genotypes were imputed using PHASE.
LRH analysis was performed using Sweep. Each SNP deėned two core alleles,
one base pair in length. We calculated relative extended haplotype homozygosity
(REHH) for each core allele, to its leě and right [ƾǂƽ], yielding up to four REHH
scores per SNP locus. We standardized the REHH scores as a function of core
allele frequency, deėned on a discrete grid from ƽ.ƽǂ to ƽ.ǆǂ with even spaces of
ƽ.ƽƿǂ. ĉis yielded a normally-distributed set of Z-scores for which we calculated
corresponding P-values and Q-values.
ƿ.ǁ.Ǆ GĹłŃŁĹWĽĸĹ AňňŃķĽĵŉĽŃł SŉŊĸŏ (GWAS)
We performed a GWAS for drug resistance to thirteen antimalarials across ǂƽ of
our genotyped samples. Ǆ,ǁǀǄ SNPs that had aminor allele count of ėve samples as
well as an ǅƽ% call rate under every phenotype condition were used for GWAS. A
Bonferroni signiėcance threshold of logƾƽ(P-value) > ǂ:ƾǄ was used for all tests.
See Appendix C for more details on GWASmethods.
ĉe Eﬃcient Mixed-Model Association (EMMA) test [Ǆǆ] models quantita-
tive trait associations to a data set with complex population structure and hidden
relatedness. It calculates a genotype similaritymatrix instead of discrete categories
and does not require a priori speciėcation of populations. ĉe resulting P-value
distributions demonstrate liĨle remaining eﬀect from population structure (Fig-
ure C.ǅ) while retaining power to ėnd a number of associations at genome-wide
signiėcance (Figures C.ǅ, ƿ.ƿA, Table ƿ.ƾ).
ǁƽ
ĉeHaplotype Likelihood Ratio (HLR) test [ǆƽ] models the likelihood that a
single, resistant haplotype rose to dominance while all other haplotypes propor-
tionally decreased. PLINK [ƾǁƿ] is used to produce sliding window haplotypes
across the genome and calculate haplotype frequencies for input to the HLR test.
We produced input for all ƿ-, ǁ- and ǃ-marker windows. ĉe LOD scores gener-
ated by the HLR test were converted to empirical pointwise P-values by perform-
ing approximately ǀǄƽ,ƽƽƽ permutations of the nullmodel for each test condition,
allowing us to calculate empirical P-values up to a signiėcance of ƾƽ ǂ:ǃ. We pre-
served population-speciėc phenotype frequencies by permuting only within each
of three populations deėned by our PCA analysis (Table C.ƾ). Resulting P-value
distributions ėt expectations well for the vast majority of test conditions (Figures
C.ǆ, C.ƾƽ) and the test demonstrates power to detect a number of loci at genome-
wide signiėcance (Figure ƿ.ƿA, Table ƿ.ƾ).
ƿ.ǁ.ǅ CŃńŏ NŊŁĶĹŇ VĵŇĽĵŉĽŃł (CNV)
Copy number was assessed by evaluating the hybridization intensity at the
PFȊȉ_ȉȌȎȎ locus on the high-density SNP array (Appendix C). Follow-up anal-
yses were done by quantitative real-time PCR (qPCR) of the PFȊȉ_ȉȌȎȎ locus
using the Delta Delta Ct method [ǂƿ] PFȊȉ_ȉȌȎȎ was compared to the refer-
ence locus PFȉȐ_ȉȉȐȏ and ǀDǄ was used as a reference strain. A summary of
PFȊȉ_ȉȌȎȎ copy number for all parasite strains tested is provided in Table C.ǃ.
Select resistant strains that were found to havemultiple copies of PFȊȉ_ȉȌȎȎwere
further analyzed by quantitative Southern bloĨing and PFȊȉ_ȉȌȎȎ copy number
was compared to the dhps gene from the ǀDǄ strain [ƾǃǄ].
ƿ.ǁ.ǆ PFȊȉ_ȉȌȎȎOŋĹŇĹŎńŇĹňňĽŃł
ĉe full lengthORFofPFȊȉ_ȉȌȎȎwas ampliėed fromeither theDdƿ(HFNsensi-
tive) or SenPƽǅ.ƽǁ (HFN resistant) parasite isolate and cloned into the pBICƽƽǆ
plasmid under the expression of theHspȑȏ promoter. Plasmid DNAwas isolated,
tranfected into the Ddƿ parasite strain and stable transfectants were selected with
ƿ.ǂnMWRǆǆƿƾƽ [ǂǀ]. Parasites from two independent experiments for each vec-
ǁƾ
tor type (Ddƿ+Ddƿ and Ddƿ+SenPƽǅ.ƽǁ) were isolated and successful transfec-
tion was conėrmed by plasmid rescue as well as episome-speciėc PCR and se-
quencing. Additionally, a vector control strain was made by transfecting Ddƿ
parasites with the pBICƽƽǆ plasmid containing the ėreĚy luciferase gene (EC
ƾ.ƾǀ.ƾƿ.Ǆ).
ƿ.ǂ AķĿłŃŌŀĹĸĻĹŁĹłŉň
We gratefully acknowledge B. Coleman, J. Dvorin, M.T. Duraisingh, U. Ribacke
and C. Valim for help with overexpression vectors and useful discussions. T.
Burke, N. Mahesh, G. Ramirez, and N. Senaratne provided technical help. Para-
sites lines or samples were provided by: J. Barnwell, A.P. Dash, C.E. Chitnis, K.
Day, A. Djimde, C. Plowe, A.M. Katzin, D. Kyle, S. ĉaithong, S.d.L. Moraes,
J. Smith; and X. Su. Malaria Research and Reagent Resource Repository pro-
vided parasites deposited by: W. E. Collins, D.E. Kyle, L. H. Miller, D. Baruch, W.
Trager, D.Walliker, U. Certa, R. Reber-Liske, T.E. Wellems, and Y.Wu (Appendix
C).
ǁƿ
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Sequence-based Association and
SeleČion-association Scans
ĉŇŃŊĻļ ŇĵńĽĸ ĻĹłĹŉĽķ ĵĸĵńŉĵŉĽŃł and natural selection, thePlasmodium falciparum parasiteãthe deadliest of those thatcause malariaãis able to develop resistance to antimalarial drugs,
thwarting present eﬀorts to control it. Genome-wide association studies (GWAS)
provide a critical hypothesis-generating tool for understanding how this occurs.
However, in P. falciparum, the limited amount of linkage disequilibrium (LD)
hinders the power of traditional, array-based GWAS. Here, we demonstrate the
feasibility and power improvements gained by utilizing whole-genome sequenc-
ing for association studies. We analyze data from ǁǂ Senegalese parasites and
identify genetic changes associated with the parasites’ in vitro response to twelve
diﬀerent antimalarials. To further increase statistical power, we adapt a common
test for natural selection, XP-EHH, and utilize it to identify genomic regions
ǁǀ
associated with resistance to drugs. Using this sequence-based approach and the
combination of association and selection-based tests, we detect several loci asso-
ciated with drug resistance. ĉese include the previously known signals at pfcrt,
dhě, and pfmdrȊ, as well as many genes not previously implicated in drug resis-
tance roles, including genes in the ubiquitination pathway. Based on the success
of the analysis presented in this study, and on the demonstrated shortcomings
of array-based approaches, we argue for a complete transition to sequence-based
GWAS for small, low-LD genomes like that of P. falciparum.
ǀ.ƾ IłŉŇŃĸŊķŉĽŃł
ĉemalaria parasitePlasmodium falciparum imposes a tremendous disease burden
on human societies and is responsible for ƾ.ƿ million deaths annually [ƾƽǅ]. Cur-
rent eﬀorts to eradicate malaria depend on the continued success of antimalarial
drugs [ǆǁ]; however, the emergence of drug resistant parasites threatens to ham-
per global health eﬀorts to control and eliminate the disease. Understanding the
genetic basis of these adaptations will be necessary to maintain eﬀective global
health policies in the face of an ever-changing pathogen.
A key to elucidating the genetic basis of drug resistance is identifying the spe-
ciėc genes associated with the phenotype. In human studies of this kind, the
genome-wide association study (GWAS) has overtaken the classic candidate gene
approach, made aﬀordable by the use of genotyping arrays (or SNP arrays) that
measure only a subset of variants in the genome [ǂ]. ĉis optimization is only pos-
sible because of the extensive correlation between geneticmarkers (called “linkage
disequilibrium” or LD) in the human genome, which allows the subset of SNPs on
an array to act as proxies for other markers not present; this process is known as
“tagging” [ǁƿ].
InP. falciparum, however, array-basedGWAS is severely limited by the relatively
short extent of LD [ƾƽǄ, ƾǄƽ, ƾǄǃ, ƾǅǂ]. Lacking that correlation between genetic
markers, genotyping arrays usually cannot detect associationswith untypedmark-
ers, eﬀectively limiting inferences tomarkers actually presenton the array; even the
highest density P. falciparum array reported to date found that LD between adja-
ǁǁ
cent markers on the array was too weak for tagging in African populations [ƾǄƽ].
Consequently, current P. falciparum arrays cannot conėdently capture all causal
variants for important phenotypes.
ĉe rapidly decreasing cost of whole-genome sequencing oﬀers a promising so-
lution. In principle, working with whole genome sequence allows one to directly
assay all mutations segregating in the population, obviating the detection prob-
lems associated with short LD. Discovering mutations directly also avoids the as-
certainment bias inherent to arraysãbias that is exacerbated when SNP discov-
ery and genotyping are performed in diﬀerent populations [ƿ]. Additionally, the
small size of theP. falciparum genome (ƿǀMb, roughly the size of a human exome),
makes it potentially a hundred fold cheaper thanwhole-genome sequencing in hu-
mans. As malaria sequencing projects become cost-competitive with genotyping
arrays, whole-genome sequencing has the potential to become the most eﬀective
approach to performing association studies in malaria.
Here, we test the hypothesis that whole-genome sequencing will identify SNP
associations not detected by classic array-based approaches. We apply thismethod
to identify loci in the P. falciparum genome that are associated with antimalarial
drug resistance and compare the approach to a standard array-based GWAS. We
improve the statistical power of this analysis by adapting a commonly used selec-
tion test, the cross-population extended haplotype homozygosity (XP-EHH) test
[ƾǂƾ], and utilize it as an association test for positively selected phenotypes. ĉese
approaches identify a number of candidate loci associated with anti-malarial drug
resistance, including genes in the ubiquitination pathway, suggesting that alter-
ation of the parasite’s ability to modulate stress may contribute to evasion of drug
pressure and development of resistance in P. falciparum.
ǀ.ƿ RĹňŊŀŉň
ǀ.ƿ.ƾ ǁǂ PĵŇĵňĽŉĹ GĹłŃŁĹň ĵłĸ ŉļĹ AĶňĹłķĹ Ńĺ LD
We chose a population in a West African region near Dakar, Senegal and culture-
adapted ǁǂ Plasmodium falciparum parasites recently isolated from malaria
ǁǂ
infected patients. ĉis population is particularly relevant for these studies as it has
recently been exposed to multiple, changing drug regimens as clinical resistance
to traditional drugs has emerged [ƾƽǁ]. We obtained whole-genome sequence
data and generated high-quality consensus base calls for an average of ǅǀ% of each
genome. ĉis produces ƿƿǂ,ǃƿǀ segregating single nucleotide polymorphisms
(SNPs), of which ƿǂ,ǄǂǄ met our call rate and minor allele frequency criteria for
further study (see Section ǀ.ǁ). Sequence-based SNP calling in P. falciparum is
technically challenging due to its extremely AT-rich genome [ǆǅ, ƾƿǄ]. In light of
this, we validated our sequence-based approach against array-based methods by
using a previously described SNP array [ƾǄƽ] to genotype ƿǁ of the ǁǂ isolates.
Of the Ǆǁ,ǃǂǃ SNPs assayed by the array, ǁ,ǃǂǀ meet our call rate and minor allele
frequency criteria. We observe nearly perfect concordance between Aﬀymetrix
genotypes and sequence genotypes (see Section ǀ.ǁ).
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Figure 3.1: Simulated P. falciparum arrays are unable to tag SNPs not present on the ar-
ray. (A) A histogram of LD between adjacent SNPs from sequenced P. falciparum (black).
The vast majority of markers have little to no LD with their neighbors (62% of SNPs have
rƿ  ƽ:ƽǂ, 76% have rƿ  ƽ:ƿ, and 87% have rƿ  ƽ:ǅ). This contrasts with human
studies where much more of the genome shows moderate to strong LD between neighbor-
ing SNPs (gray). (B) Simulated genotyping marker sets of various sizes are plotted against
the percentage of the entire sequenced marker set that they are able to tag (with rƿ  ƽ:ǅ).
The dashed, identity line depicts the theoretical scenario where all SNPs are in complete
linkage equilibrium and no SNP tags another. Since this is true of 87% of SNPs in the
malaria sequence data, the increase is almost linear (black dots). This contrasts with the
array tagging performance seen in human studies (gray dots), where only a small fraction of
markers are needed to tag the bulk of the genome—a principle that array-based GWAS de-
pends on. The open triangle depicts the actual performance of the Affymetrix-based Broad
Institute P. falciparum SNP array [170].
ǁǃ
Our data demonstrate that SNPs in P. falciparum have very liĨle ability to tag
neighboring SNPs due to the short LD in the African population fromwhich they
were sampled. While some portions of the genome exhibit signiėcant LD, over
ǃƿ% of the SNPs in the genome have no LD (rƿ < ƽ:ƽǂ) between adjacent SNPs,
and ǅǄ% of the SNPs have insuﬃcient LD to tag their neighbor (Figure ǀ.ƾA) us-
ing the criterion derived fromhumanGWAS(rƿ < ƽ:ǅ) [ǁƿ]. Tomeasure tagging
ability directly, we simulate genotyping arrays of various sizes by sampling ran-
dom subsets of SNPs from our sequence data. We ėnd that the simulated arrays
are not able to tag a signiėcant portion of unassayedmarkers, a result in stark con-
trast to the performance of human arrays (Figure ǀ.ƾB).ĉe tagging performance
of our own Aﬀymetrix array (tagging only ƿƿ.ǃ% of segregating SNPs in Senegal)
is even lower than simulated arrays of similar size (Figure ǀ.ƾB), most likely due to
population-based ascertainment biases [ƿ] that were notmodeled in our idealized
approach. ĉese ėndings lead us to conclude that array-based studies in P. falci-
parumwill rarely be able to detect signals resulting frommutations not present on
the array.
ǀ.ƿ.ƿ SĹŅŊĹłķĹ-ĶĵňĹĸ GĹłŃŁĹ-ŌĽĸĹ AňňŃķĽĵŉĽŃł SŉŊĸĽĹň
ĉe goal of these studies is to identify genomic changes associated with changes
in parasite response to antimalarial drugs, as measured in the set of ǁǂ indepen-
dent P. falciparum isolates. We assayed the cultured parasites for in vitro drug re-
sponses (measured by ICǂƽ) to twelve standard antimalarials: amodiaquine, arte-
misinin, atovaquone, chloroquine, dihydroartemisnin, halofantrine, lumefantrine,
meĚoquine, piperaquine, primaquine, pyrimethamine, and quinine. ĉese consti-
tute the twelve phenotypes used in our association studies (Figure D.ƾ). Not sur-
prisingly, drugs with similar chemical structures (e.g. halofantrine, lumefantrine,
andmeĚoquine) show a strong correlation in responses (FigureD.ƿ), as has previ-
ously been observed [ƾǄƽ, ƾǅǂ], and provide the opportunity for cross-validation
of SNPs identiėed in association studies.
To test associations between SNP genotypes and drug response, we use eﬃ-
cientmixed-model association (EMMA). EMMA is a quantitative association ap-
ǁǄ
proach well-suited for small sample sizes and partially inbred organisms, such as
the malaria parasite [Ǆǆ]. It is a commonly used tool amongmixed-model GWAS
approaches [ƾǀǃ] and has recently demonstrated eﬀectiveness with P. falciparum
drug studies [ƾǄƽ]. Aěer correcting for multiple testing (Bonferroni correction
for ƿǂ,ǄǂǄ SNPs, P < ƿ  ƾƽ ǃ), EMMA is able to detect a number of previ-
ously known markers of drug resistance, such as four non-synonymous SNPs in
pfcrt [ǂǁ, ƾǅǁ] associated with chloroquine response (NǄǂE/K, KǄǃT, QƿǄƾE,
RǀǄƾI), one pfmdrȊ SNP [ǁǆ, ƾƿƽ] associated with halofantrine, lumefantrine,
and meĚoquine response (NǅǃY), and three dhě SNPs [ƾƽǆ] associated with
pyrimethamine response (NǂƾI, CǂǆR, SƾƽǅN). We note here that, although mi-
tochondrial and apicoplast genomes were also sequenced, no signiėcant associa-
tions were found and the known mitochondrial mutations associated with atova-
quone resistance [ǁǅ, ǅƿ] were ėxed in all ǁǂ individuals for the drug-sensitive
alleles (cytochrome b ƿǃǅY, ƾǀǀM, ƿǅƽG). In all, EMMA detects ǀǁ signiėcant
SNPs associated with parasite response to ėve drugs (Figure D.ǀ). Most are in
or near previously known associations [ƾǄǃ], and ėve are novel associations with
pyrimethamine response (Dataset ƾ).
While these sequence-based ėndings validate the previously known relation-
ship between the pfmdrȊ gene and parasite responses to halofantrine, lumefan-
trine, and meĚoquine, it is notable that this association is not detectable by our
SNP array (Figure ǀ.ƿ, Figure D.ǂ), as the array lacks any markers in pfmdrȊ with
a suﬃciently high minor allele frequency. ĉis exempliėes the type of association
that can be missed by arrays due to limited LD. Additionally, the agreement be-
tween these three drugs at this locus provides validation of this result with respect
to structurally related drugs.
ǀ.ƿ.ǀ UňĽłĻHĵńŀŃŉŏńĹ-ĶĵňĹĸ SĹŀĹķŉĽŃł TĹňŉň ĺŃŇ AňňŃķĽĵŉĽŃł
To test thehypothesis that drug resistance is largelydrivenbypositive selection,we
searched for longhaplotypes associatedwith selection for drug resistanceusing the
XP-EHH test [ƾǂƾ]. ĉis selection test has not previously been used as a GWAS
tool, but it is well suited for this purpose when we presume that the phenotype
ǁǅ
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Figure 3.2: Meﬂoquine association signals around the known drug resistance locus pfmdr1.
EMMA results are shown for all of chromosome 5 with P-values for each SNP on a  logƾƽ
scale against physical position. The array-based study (Array 24) does not detect any asso-
ciation at the known pfmdr1 locus due to a lack of marker coverage within the gene and suf-
ﬁcient LD around the gene. The sequence-based study with the same 24 samples (Seq 24)
detects the expected hit at 0.96Mb. Including all samples from the sequence-based study
(Seq 45) increases the strength of this signal. The dashed line indicates the Bonferroni-
corrected signiﬁcance threshold (P = ƽ:ƽǂ, genome-wide SNP counts are 7,068, 17,278,
and 25,159 respectively).
we are studying is under positive selection. While this assumption is not valid for
most human-based GWAS for non-communicable diseases, it is very likely to be
the case when studying parasite genomes for resistance adaptations towidely used
drugs, which represent a strong selective pressure. Used in this way, the XP-EHH
test identiėes areas in the genomewhere resistant parasites showmuch longer hap-
lotypes than sensitive parasites, indicative of recent positive selection on the resis-
tant population. In our data, the test detects a number of signals, including pfcrt
and dhě, as well as a number of other hits spanning a total of ǀƿ genomic regions
across eleven drugs (Figure ǀ.ǀ, Figure D.ǁ, Dataset ƾ). Seventeen of these re-
gions are indicative of selection in the drug resistant population, whereas ėěeen
are consistent with selection in the drug sensitive population. With the exception
of the regions containingpfcrt anddhě, noneof these lociweredetectedbyEMMA
alone.
While this approach does not detect the known pfmdrȊ locus, this is consis-
tent with our expectations, due to the nature of the test. ĉe NǅǃY mutation in
pfmdrȊ confers increased susceptibility [ǁǆ, ƾƿƽ] to many drugs when compared
ǁǆ
Figure 3.3: Signiﬁcant signals of drug-associated selection across ﬁve antimalarial drugs.
XP-EHH results are shown using a Manhattan-inspired plot, with SNP Z-scores plotted
against genomic position, with each chromosome colored separately. Positive Z-scores
suggest selection in drug resistant parasites, negative Z-scores suggest selection in sensi-
tive parasites. The dashed lines indicate the two-sided Bonferroni signiﬁcance thresholds
(P = ƽ:ƽƿǂ and ƽ:ǆǄǂ). Only drugs with signiﬁcant hits are shown here, Z-score and
quantile-quantile plots for all drugs are shown in Figure D.4.
to the wild-type allele. As such, this SNP would not be an expected candidate for
positive natural selection on a novel variantãthe type of selection XP-EHH is de-
signed to detect. Moreover, the absence of a pfmdrȊ signal from the XP-EHH test
is consistent with the lack of ėndings in this gene from previous genomic scans for
positive selection based on the REHH, iHS, and XP-EHH tests in multiple popu-
lations [ǀƾ, ƾƽǄ, ƾǄƽ].
In searching for long haplotypes, the XP-EHH test typically identiėes a large
number of signiėcant SNPs in close proximity to each other. ĉese regions oěen
spanmany tens of kilobases and several annotated genes. ĉis is expected because
the process of positive natural selection increases the prevalence of both the se-
lected variant as well as of nearby variants, generating local regions of extended
haplotypes. ĉus, while XP-EHH strongly implicates these ǀƿ regions as areas of
phenotype-associated positive selection, by itself it is usually unable to localize the
source of this selection to a speciėc gene. WeuseP-values fromEMMAto improve
ǂƽ
signal localization by identifying the strongest signals of association within each
region. ĉis approach allows us to suggest a possible gene or mutation as a focus
of phenotype-speciėc positive selection for each identiėed region (Dataset ƾ) and
is reminiscent of earlier approaches that intersect selection and association results
[ǀƾ, ǅǁ].
A more comprehensive examination of the regions under drug-associated se-
lection reveals discrete biological pathways and processes that may be particu-
larly important as mediators of drug response in P. falciparum (Section D.ǀ). ĉe
ǂǆ genes in these ǀƿ regions can be functionally classiėed as: surface molecules
or transporters, genomemaintenance or transcriptional regulation, metabolic en-
zymes including lipidmetabolizers, andmembers of the ubiquitin proteasome sys-
tem. Most surfacemolecule associatedmutations and intergenicmutations are lo-
calized to intra-chromosomal clusters containing var, riėn and stevor genes; and
a number of genes are found among molecules modulating ubiquitination, lipid
metabolism, or folate metabolism. Members of these pathways are also repre-
sented in the large region of pyrimethamine-speciėc selection on chromosome ǃ,
where it is diﬃcult to localize the focus of selection. Collectively, these ėndings
argue that certain biological processes in general, and genes in the ubiquitination
and lipid metabolism pathways in particular, play important roles in modulating
drug responses in P. falciparum.
ǀ.ǀ DĽňķŊňňĽŃł
Complete genome sequencing provides many advantages over array-based geno-
typing for association studies. ĉese include the ability to directly type the causal
allele, the increased detection power from increased marker density, and the abil-
ity to overcome ascertainment biases that arise when studying diﬀerent popula-
tions with a ėxed marker set. In P. falciparum, the lack of tagging ability due to
the near absence of long-range LD limits the utility of arrays for association stud-
ies. Furthermore, the small genome size of P. falciparum brings the cost of whole
genome sequencing to approximate parity with traditional genotyping arrays, and
recent advances in pathogen-speciėc DNA-enrichment and host-speciėc DNA-
ǂƾ
depletion techniques for clinical samples makes the sequence-based GWAS ap-
proach more accessible and cost-eﬀective than ever before [ǆǅ, ƾǄƾ].
We introduce a selection-association approach based on the XP-EHH selection
test. While this approach may not be appropriate for many association studies,
it is sensible when the phenotype under study is under strong selection, which
is likely the case for drug resistance in pathogens. As a haplotype-based test that
takes advantage of multiple, adjacent SNPs, it has the advantage of being more
sensitive than single-marker approaches like EMMA, given the same sample size
[ǁƿ]. In addition to detecting new signals of drug-associated selection, we also
ėnd that the directional nature of the test statistic, a Z-score, provides useful in-
formation about whether the selection is associated with drug sensitivity or re-
sistance. Consequently, we also introduce an alternative visualization of the out-
put: a ManhaĨan-like plot of Z-scores, instead of   logƾƽ P-values, to illustrate
the directionality of the signals (Figure ǀ.ǀ). In our data, we observed a tendency
for many drugs (artemisnin, dihydroartemisnin, primaquine, halofantrine, lume-
fantrine, and meĚoquine) to show highly signiėcant signals of selection for drug
sensitivity at pfcrt, the gene known to be responsible for chloroquine resistance
(Figure D.ǁ). While, in principle, this type of signal may result from selection to-
wards drug sensitivity, in this particular case, it most likely results from the general
paĨern of anti-correlation between chloroquine and these six other drugs (Fig-
ure D.ƿ). Additionally, the absence of a signiėcant chloroquine sensitivity signal
at pfcrt is consistent with reports that the return of chloroquine sensitive para-
sites in Africa did not result from a classic selective sweep [ǅǄ]. In either case,
theManhaĨan-likeZ-score plots allow us to note the presence of these drug sensi-
tivity signals while keeping them visually separate from the drug resistance signals
on which we wish to focus.
Our approaches identify a signiėcant number of loci associated with changes in
drug response (Dataset ƾ). ĉe strongest of these contain previously knownmedi-
ators of resistance, such as themutations in pfcrt, pfmdrȊ, and dhě. Curation of our
remaining results using a variety of gene and protein prediction algorithms and lit-
erature searches [ƾǁ] point to several cellular processes and pathways of potential
interest, including the ubiquitin proteasome system, lipid metabolism, and folate
ǂƿ
metabolism(Dataset ƾ). We argue that these ėndings point to biological processes
used by the parasite to survive drug pressure or circumvent the action of anti-
malarial compounds. Other genes of interest include three ABC transportersãa
class of transporters known tomodulate drug responses inother organisms [ǅǆ]ã
and genes proposed to modulate chromatin [ǀǀ, ǀǄ], DNA repair [ƿǂ, ƾǃƿ], or
RNA binding [ǆǆ]ãpathways that have been shown to potentially be altered in
response to drug pressure.
Anumberof the signals of recentpositive selectionareunique topyrimethamine-
resistant parasites. While the known resistance locus, dhě, is present among these,
there are even stronger signals of pyrimethamine-associated selection on chro-
mosome ǃ and chromosome ƾƿ. ĉe region on chromosome ǃ contains two
previously uncharacterized genes proposed to participate in folate metabolism
(PFFƾǀǃƽw and PFFƾǁǆƽw), as well as six genes acting as either chaperones or in
ubiquitination (PFFƾǀǃǂc, PFFƾǁǅǂw, PFFƾǁǁǂc; PFFƾǁƾǂc; and PFFƾǂƽǂw),
and three molecules likely to modulate lipid metabolism (PFFƾǀǂƽc, PFFƾǀǄǂc-
a/b, and PFFƾǁƿƽw). In the chromosome ƾƿ region, the XP-EHH test produces
signiėcant P-values for eight SNPs over a ƾǂkb region spanning ėve adjacent
genes. ĉe extended haplotypes surrounding these SNPs continue even further,
spanning ƿǅkb and fourteen genes in total (Figure ǀ.ǁA). ĉese results present
challenges for experimental validation, as the goal of association studies is to
generate a small number of testable hypotheses about molecular mechanisms.
Fortunately, the use of EMMA P-values in this region can assist in localizing
the signal. We ėnd that the strongest EMMA SNP coincides with the strongest
XP-EHH SNP, which is a non-synonymous mutation in PFLƿƾƽƽw, a putative
ubiquitin conjugating enzyme (Eƿ) (Figure ǀ.ǁB). Additionally, a signiėcant,
pyrimethamine-speciėc selection signal on chromosome ǅ is entirely contained
within MALǅPƾ.ƿǀ (a putative HECT ubiquitin ligase Eǀ) (Dataset ƾ), another
gene in the ubiquitin-mediated pathway [ƾǀǀ]. Given the role of this pathway in
directing protein degradation and recycling, it is possible that alterations in these
genes create changes in stress responses or protein turnover of key resistance
modulators that allow the parasite to survive under drug pressure.
ĉe evolution of drug resistance in the natural seĨing is likely to be a multistep
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Figure 3.4: Localizing the pyrimethamine-associated selection signal on chromosome 12.
(A) Deﬁning the region: XP-EHH identiﬁes eight genome-wide signiﬁcant SNPs in close
proximity on chromosome 12. Each of these eight SNPs represents the center of an area
of extended haplotype homozygosity, as measured by the EHH statistic. Haplotype decay
for resistant parasites is plotted for each of these eight SNPs, which deﬁnes a larger region
from 1.807Mb to 1.835Mb in which the causal mutation may exist. This region spans 28kb
and 14 genes. (B) Localizing the signal: focusing within this region, we utilize single-
marker association signals from EMMA to localize the signal. The most signiﬁcant EMMA
SNP coincides with the most signiﬁcant XP-EHH SNP and localizes to an E398D mutation
in PFL2100w (ubiquitin conjugating enzyme E2).
ǂǁ
process and our work potentially identiėes key pathways involved in this process.
Field-based evidence has demonstrated a reduced ėtness for drug resistant para-
sites in the absence of drug pressure and laboratory-based work has demonstrated
the relative ėtness of diﬀerentmutational changes in target enzymes. Our ėndings
point to potential compensatory mutations in a pathway related to protein stabil-
ity and turnover and it is tempting to speculate that such adaptations enable the
“expression” of a resistant phenotype, such as has been observed in yeast [Ǆǀ]. Al-
though molecular approaches are required to validate the role of this pathway in
modulating drug response, these results demonstrate the potential for sequence-
basedGWASapproaches to identify pathways, in addition to individual genes, that
may be responsible for the phenotype of interest.
Ultimately, all association results require experimental validation and follow-
up work to explore possible mechanisms of action. Association studies, even in
their ideal form, simply generate hypotheses based on correlations. However, im-
proved methods for association studies can signiėcantly reduce the necessary val-
idation work by reducing false positive rates, increasing study detection power,
and improving localization ability. ĉis study successfully pilots the use of whole-
genome sequencedata for association studies inmalaria and it demonstrates signif-
icant advantages in detection power over array-based studies. We strongly recom-
mend that future association studies in low-LD, small-genome organisms adopt
the sequence-based GWAS approach as well, given the relative costs. We addi-
tionally demonstrate the eﬀectiveness of the XP-EHH selection test as an associ-
ation test for phenotypes under positive selection. Finally, we combine data from
both tests to localize long signals and reduce the number of hypotheses for follow-
up validation. ĉis combined approach identiėes more candidate loci than with
single-marker tests alone.
ǂǂ
ǀ.ǁ MĹŉļŃĸň
ǀ.ǁ.ƾ SĹŅŊĹłķĽłĻ
Parasites were obtained frompatients with uncomplicatedmildmalaria in Senegal
from ƿƽƽƾ to ƿƽƽǆ under ethical approval with informed consent for the study.
Parasites were culture adapted by standardmethods [ƾǃǂ] and genomicDNAwas
extracted from ǁǂ single-clone samples. Samples were determined to be mono-
clonal and genetically distinct by a ƿǁ SNP molecular barcode [ǀǆ]. Genomic
DNA was sequenced using Illumina Hi-Seq machines. ĉe ėrst ƾƿ parasites were
sequenced with Ǆǃbp single-end reads and the remaining ǀǀ were sequenced with
paired-end reads ranging fromǄǃbp to ƾƽƾbp in length. ĉemedian sequence cov-
erage depth was ƾǁǁ:ǅ aěer alignment (ranging from ǀƿ to ǁƽƽ).
Reads were aligned with BWA vƽ.ǂ.ǆ-rƾǃ against the ǀDǄ reference assembly
(PlasmoDB vǄ.ƾ). A consensus sequence was called for each strain using the
GATK Uniėed Genotyper vƾ.ƿ.ǀ-gǃƾbǅǆeƿ [ǆǃ] with the following parameters:
-A AlleleBalance -stand_emit_conf 0 --output_mode EMIT_ALL_SITES.
Bases were then removed if they exhibited poor quality (GQ less than ǀƽ or
QUAL less than ǃƽ) or if they called a heterozygous genotype. ĉis leě consensus
calls for ǂǃ-ǆƾ% of the genome (ǅǀ%median) for each of ǁǂ individuals. Of these
sites, ƿƿǂ,ǃƿǀ positions are polymorphic among the ǁǂ individuals. Of these
SNPs, only ƿǂ,ǄǂǄ had genotypes in at least ǀǃ individuals (ǅƽ% call rate) and
were non-singletons (i.e. minor allele count> ƾ or minor allele frequency> ǁ%).
All analyses are based on this set of ƿǂ,ǄǂǄ SNPs. SNP data is available in dbSNP
as batch Pf_ƽƽƽǁ from submiĨer BROAD-GENOMEBIO. SNPs are being pro-
cessed at PlasmoDB [ƾǁ] for release later this year. SNP data and consensus calls
for the whole genome are available as supplemental data ėles (Section D.ƿ).
Principal component analysis was conducted using the program SMARTPCA
[ƾǀƽ] in the EIGENSOFT ǀ.ƽ package. We applied a local LD correction (nsnpl-
dregress = ƿ) and found no signiėcant eigenvectors in the population.
ǂǃ
ǀ.ǁ.ƿ TĵĻĻĽłĻ AłĵŀŏňĽň
Tagging analysis in Figure ǀ.ƾB was generated by using PLINK [ƾǁƿ] to ėnd tag-
ging SNPs for each SNP that were within ƾƽkb and at least rƿ  ƽ:ǅ. We then sim-
ulated genotyping arrays by randomly sampling subsets of SNPs of varying sub-
set sizes and calculating the fraction of total SNPs that are tagged by the subset.
We ėrst reduced the sequence data to ǁƽ random individuals to simulate ascer-
tainment bias against low allele-frequencymarkers, then randomly sampledmark-
ers that were still polymorphic among the smaller population size to simulate a
genotyping array. We simulated ƾǆ diﬀerent array sizes, ranging from ǂ% of the se-
quenced SNPs (ƾ,ƿƿǄ) to ǆǂ% of the sequenced SNPs (ƿƿ,ƽǅǄ). ƿƽƽ simulations
per array size were run and the result was highly consistent: ǆǂ% conėdence inter-
vals were too small to visualize on the ėgure. Simulations for the human genome
were based on ǃƽ diploid individuals of European descent (CEU) from Hapmap
release ƿǀa. Each iteration chose ǂǁ random individuals to simulate ascertainment
bias, ėltered SNPs to an ǅƽ% call rate and to non-singletons. Our Aﬀymetrix array
was able to tag ǂ,ǂƽǅ SNPs in our sequence data using the ǁ,ǅǆǁ SNPs on the array
that overlapped with the ƿǂ,ǄǂǄ SNPs in our sequence data (open triangle in Fig-
ure ǀ.ƾB). Histograms in Figure ǀ.ƾA are binned into ƿƽ evenly spaced bins of rƿ
from ƽ to ƾ. ĉe plot is normalized such that the sum of all bars in each histogram
is equal to ƾ to show the relative proportions of SNPs in each bin. Simulation data
is provided in supplemental data ėles (Section D.ƿ).
ǀ.ǁ.ǀ DŇŊĻ Aňňĵŏň
Drug assays were performed as described [ƾǀƿ] with slight modiėcations for ǀǅǁ-
well format (Section D.ǁ). ĉe range of drug concentrations are shown in Fig-
ure D.ƾ, and the ICǂƽ data, along with raw input data for all association tests, is
provided in supplemental data ėles (Section D.ƿ).
ǂǄ
ǀ.ǁ.ǁ EMMA
Single marker association tests were run using EMMA [Ǆǆ]. Since not all drugs
have complete phenotype data for all ǁǂ individuals, SNPs are additionally ėltered
to those that met our previous call rate and minor allele criteria among the subset
of samples for which drug data exists. ĉis results in ƿǀ,ƽƽƽ to ƿǂ,ƾǅƽ SNPs for
any given drug. logƾƽ(ICǂƽ) values were used for this quantitative test. Biologi-
cal replicates of drug data were presented to EMMA as multiple individuals from
the same genetic strain. ĉis allows EMMA to use the additional data to discern
heritable phenotypic variance from non-heritable variance [ƾǀǃ], and mimics the
use of clonally identical parasites in other studies [ƾƽ, ƾƾ]. Signiėcance was de-
ėned as SNPs that exceeded a Bonferroni-corrected threshold of P < ƽ:ƽǂ while
also surviving ǃƽ% of jackknife simulations. EMMA results were jackknifed by
performing ƿƽƽ random subsets of ǀǅ samples and requiring an FDR-corrected
signiėcance ofQ < ƽ:ƾ. SNPs that passed this threshold in ǃƽ% of jackknife sim-
ulations were considered to be robust against false positives due to small sample
size eﬀects.
ǀ.ǁ.ǂ XP-EHH
Selection-association tests were run using the cross population extended haplo-
type homozygosity test (XP-EHH) [ƾǂƾ]. Each drug deėned a partitioning of
samples into two “subpopulations” (“sensitive” and “resistant”) based on cutoﬀs
shown in Figure D.ƾ and provided in supplemental data ėles (Section D.ƿ). XP-
EHH requires a recombination map as input, which we constructed with LDhat
vƿ.ƾ [ǆǄ] (Section D.ǁ). XP-EHH also requires fully imputed genotypes. Impu-
tation was performed using PHASE ƿ.ƾ.ƾ [ƾǂǃ], producing ƿǆ,ǃƽǂ non-singleton
SNPs (Section D.ǁ).
XP-EHH computes a signiėcance value for each SNP in the genome, assuming
that SNP comprises the haplotype “core” of selection. Because the test identiėes
long haplotypes, it results in a large number of genome-wide signiėcant SNPs (de-
ėned byBonferroni-correctedP < ƽ:ƽǂ) in clustered stretches of the genome. We
reduced the set of signiėcant SNPs to a set of signiėcant genomic regions by tak-
ǂǅ
ing each signiėcant core SNP, computing a window around each one where EHH
decayed to ƽ.ƽǂ, and merging overlapping windows. ĉis resulted in a smaller list
of signiėcant regions for each drug (Dataset ƾ). Regions were further ėltered by
removing those which did not contain at least one core SNP that survived ǂƽ% of
jackknife simulations. XP-EHH results were jackknifed by performing ƿƽƽ ran-
dom subsets of ǀǅ samples and requiring a Bonferroni-corrected signiėcance of
P < ƽ:ƾ.
ǀ.ǁ.ǃ GĹłŃŉŏńĽłĻ AŇŇĵŏň
A subset of ƿǂ parasites was also hybridized to an Aﬀymetrix array containing
Ǆǁ,ǃǂǃmarkers [ƾǄƽ]. SNPs were called using BRLMM-P fromAﬀy Power Tools
vƾ.ƾƽ.ƿ and ėltered according to the same methods as Van Tyne et al. [ƾǄƽ], re-
sulting in ƾǂ,ƽǄǂ validated SNPs, ǅ,ǄǄǅ of which were polymorphic among the
ƿǂ individuals from Senegal. SNP coordinates were converted from PlasmoDB
vǂ.ƽ coordinates to vǄ.ƾ coordinates using whole genome nucmer alignments
[ǅǂ]. Concordance between array and sequencing data was measured for the set
of markers in which genotype calls existed by both methods. For ƿǁ samples,
nearly perfect concordance between Aﬀymetrix genotypes and sequence geno-
types was observed for the ƿǁ samples (averaging ǆǆ.ƿ% concordance, with all
ƿǁ samples above ǆǅ.ƿ% concordance). ĉis level of concordance is similar to
what is observed with technical replicate hybridizations of the same DNA sample
[ƾǄƽ]. One sample, SenPƾǆ.ƽǁ.c, reported a ƿǅ.ƿ% mismatch rate, suggestive of a
sample identiėcation error, and was removed from the analysis. EMMA analyses
were run on the array data using the same ėlters and procedures as for sequence
data described above, utilizing ǁ,ǂƾǁ-ǁ,ǃǂǀ SNPs per drug phenotype. Results are
shown in Fig D.ǂ. Array data for these ƿǁ samples are in supplemental data ėles
(Section D.ƿ).
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Temporal Signatures of SeleČion
ĉĹ ĺĽłĵŀ ķļĵńŉĹŇ Ńĺ ŉļĽň ĸĽňňĹŇŉĵŉĽŃł explores an alternate ap-proach at studying selection in the malaria parasite by examiningtemporal signatures of selection in-progress. Here, we take advan-
tage of a fully sequenced set of ƾǂǆ Senegalese samples spread out in time over
a dozen generations. Recently developed Hidden Markov-based methods allow
us to estimate the parameters for driě (Ne) and selection (s) in this type of time-
series data. In particular, the estimation of s for every SNP in the genome allows us
to conduct highly speciėc scans for markers with extremely rapid changes in allele
frequency. ĉese markers are candidates for very strong selection in an environ-
ment where malaria is currently subject to a strong eradication program. Finally,
this new approach provides a complementary view into the selective environment
of the parasite when combined with traditional tests for selection.
ǃƾ
ǁ.ƾ IłŉŇŃĸŊķŉĽŃł
ĉestudyof natural selectionhas been a signiėcant focus ofmethods development
in population genetics. ĉese eﬀorts have produced numerous statistical tests for
identifying selection based on genetic data [ƾǁǆ]. Most of these testsãsuch as
long-haplotype tests or population diﬀerentiation testsãoperate on data sampled
from a present-day snapshot of the population andmake inferences about historic
selective events based on the telltale remnants in the genome that are produced by
historic natural selection.
Many large parasite sample sets that are currently being produced are spread out
in time over several years. As the sexual generation time of P. falciparum is thought
to be on the order of three generations per year, these data sets can easily span the
human-equivalent of several centuries in time. ĉis breaks the contemporaneous
sampling assumptionmadebymost selection tests, butmore importantly, itmisses
an opportunity to exploit time course data as evidence for selection. In this study,
we seek to use this type of data as a direct observation of the eﬀects of selection in
action.
Studying selection using time series genetic data has gained recent aĨention.
Based on previous methods for inferring eﬀective population size (Ne) from time
series data, Bollback et al. pioneered the use of a HiddenMarkovModel (HMM)
to jointly estimate bothNe and the selection coeﬃcient (s), at a single locus [ƾǆ].
Intuitively, the model treats the observed allele frequencies at each time point as
noisy estimates of a hidden state, where the emission probabilities (measurement
errors) and transition probabilities (changes in frequency over time due to driě
and selection) of the HMM are well established probability distributions in pop-
ulation genetics.
BasedonBollback et al., a number of similarmethods to estimate selection from
time series data have emerged recently [Ǆƽ–Ǆƿ, ǆǀ]. Some of these are speciėc to
asexual microbes, where the problem of clonal interference is a signiėcant con-
founder. But these approaches have largely remained tests of a single marker or
a small number of markers. Scaling this test to whole-genome data requires both
speed optimizations and modiėed statistics. In this chapter, we adapt the original
ǃƿ
Bollback et al. method into a genome-wide test for selection, create new statistics
based on it, evaluate its behavior under simulated neutral conditions, and apply it
to a set of ƾǂǆ parasites from a population where the introduction of artemisinin
drug pressure is relatively recent.
ǁ.ƿ RĹňŊŀŉň
We based our analyses on ƾǀǆ sequenced samples collected from patients in Sene-
gal from ƿƽƽǅ to ƿƽƾƾ (ƾǆ samples from ƿƽƽǅ, ǂƿ from ƿƽƽǆ, ǁǃ from ƿƽƾƽ, and
ƿƿ from ƿƽƾƾ). From these genomes, we identiėed a set of ƿǄ,ƿǂǂ variants (SNPs
and small indels) that met a number of ėltering criteria (Section ǁ.ǁ.ƾ). At each
of these variants, we estimated the selection coeﬃcient, s, using code based on the
Bollback et al. algorithm (see Section ǁ.ǁ.ƿ).
We ėxed the driě parameter, Ne, to ƾƽƽ, based on recent studies of driě in
the same population [ǁƽ]. ĉis represents extremely strong driě and, as a con-
sequence, suggests that we will only be able to detect the strongest signals of selec-
tion in this population. ĉis should also result in a more conservative test, since
the model will aĨribute more changes to the eﬀects of strong driě.
ĉe distribution of estimated selection coeﬃcients across the genome is shown
in Figure ǁ.ƾA. ĉis statistic is unimodal and centered at zero, though it does not
closely follow any standard distribution (Figure ǁ.ƾB). ĉe distribution is asym-
metric with a large leě tail, suggesting thousands of candidate variants for strong
negative selection. In order to compute signiėcance of this statistic empirically,
we modeled the behavior of s under the null hypothesis by producing forward-
simulated time course data (driě only, no selection) and ran the HMMƿǄmillion
times (methods in Section ǁ.ǁ). ĉe resulting distribution is similarly leě-tailed
(Figure ǁ.ƾC). ĉis suggests that the many variants under strong negative selec-
tion are artifacts of the HMM-based estimation (further analysis of this issue in
Section E.ǀ). Indeed, if you calculate empirical signiėcance values based on the
simulated null data, the resulting Z-scores are normally distributed with no sig-
niėcant outliers (Figure ǁ.ƾD). ĉis suggests that our data set is not suﬃciently
powered to reject the null hypothesis.
ǃǀ
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Figure 4.1: The genomic distributions of the two test statistics, s, at left, and the likelihood-
ratio test (LRT), at right, do not allow us to reject the null hypothesis of no selection. The
population size was ﬁxed at Ne = ƾƽƽ. (A) Distribution of s (calculated by HMM) over all
genomic markers. (B) QQ-plot showing the distribution of observed values of s against a
normal distribution. It shows a large left-tail of markers reporting strong negative selection.
(C) Distribution of s from null simulations. This displays a very similar distribution to the
observed values in panel (B). (D) Corrected s based on the empirical distribution in (C).
Observed values of s do not signiﬁcantly depart from the simulated null distribution. (E)
Distribution of the likelihood ratio test (LRT), which tests against the null hypothesis (s = ƽ),
over all genomic markers. (F) QQ-plot showing the distribution of observed values of LRT
against the expected χƿ distribution. This matches the neutral expectation very closely.
(G) Distribution of LRT from null simulations. This demonstrates that the neutral behavior of
this test statistic is χƿ distributed, as expected. (H) Corrected LRT based on the empirical
distribution in (G). Observed values of the LRT do not signiﬁcantly depart from the simulated
null distribution.
ǃǁ
Weadditionally evaluated an alternate test statistic based on the likelihood ratio
test (LRT), a standard approach in statistical inference [ƾǅƿ]. While estimating
the maximum-likelihood value for s, the [ƾǆ] HMM additionally emits the log-
likelihood surface for all evaluated values of s. Using this, we can compute a test
statistic that should be χƿ distributed (with one degree of freedom) under the null
hypothesis of no selection (Figure ǁ.ƾE):
LRT = ƿ [logL(s = s^MLE)  logL(s = ƽ)]
We ėnd that the resulting distribution of LRT statistics across the genome
matches the expected χƿ null quite well (Figure ǁ.ƾF). As before, we also com-
puted an empirical distribution of the LRT using ƿǄ million iterations of our
simulations of the null hypothesis and found an identical χƿ distribution (Figure
ǁ.ƾGH).
ĉis test provides a beĨer measure of statistical signiėcance than s since its dis-
tribution is well characterized. However, our data set remains underpowered aěer
correction for multiple-testing. It is likely that the overwhelming strength of ge-
netic driě in this population will mask the signal of all but the strongest selective
events, and that larger sample sizes and longer time spansof datawouldbe required
to conėdently detect weaker selection.
However, in an absolute sense, most variants in the genome exhibit what is tra-
ditionally considered to be strong selection (ƿǁ,ƽǁǃ out of ƿǄ,ƿǂǂ variants show
jNesj > ƾ, that is, the product of eﬀective population size and the selection coeﬃ-
cient are above one). Althoughwe cannot conėdently rule out neutrality for these
markers, we can look at the tails of the distribution to understand the behavior of
our method and the types of signals it is more sensitive to. Table ǁ.ƾ highlights the
top candidates for strong selection.
Additionally, long-haplotype selection tests and GWAS tests were performed
on the same data and are shown in Sections E.ǁ and E.ǂ but are not the focus of
this chapter and are not elaborated on here.
ǃǂ
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ǁ.ǀ.ƾ CĵłĸĽĸĵŉĹň Ńĺ SŉŇŃłĻ SĹŀĹķŉĽŃł
ĉe candidates described in Table ǁ.ƾ are indicative of atypically strong changes in
allele frequency over a relatively short time frame. Taken together, they describe
the types of genetic regions that our approach is most likely to detect selection in.
It is notable that all thirteen of these hits lie in coding regions of the genome (the
genome is roughly ǂƽ% genic). Roughly half of the hits lie in proteins of unknown
functionãthis is consistent with the proportion of unknown genes in the genome
as whole.
It is also notable that ėve of these thirteen hits are surface proteins (DBL,
CLAGƿ, MSPǀ, two unknown membrane proteins). ĉese loci are typically
thought to be under balancing selection due to their exposure to the host immune
system (Section ƾ.ǁ). Indeed, a number of these genes have been identiėed in
tests for balancing selection previously [Ǆ]. However, balancing selection can
behave like directional selection when observed over a relatively short time span.
Balancing selection on a gene as a whole may also look like directional selection
at individual SNPs within that gene. As such, though the HMM explicitly models
directional selection, it is sensible for our method to detect signals of balancing
selection as well. In our West African population, where many infections can be
asymptomatic, one can speculate that balancing selection due to host immune
pressure plays a stronger role than drug pressure in the short term: all parasites
must encounter the host immune system during its life cycle, but not all will
encounter drug treatment.
None of themajor loci associated with chloroquine, pyrimethamine, or amino-
quinolone resistance are observed in these results, but intriguingly, three of our
hits occur within close proximity to pfcrt. Although these positions have previ-
ously been shown to reside within a long haplotype around this gene, the move-
ments in our three markers appear to be entirely decoupled from the compara-
tively static allele frequencies in the central chloroquine resistance mutations of
pfcrt (Figure E.ƿ). ĉis may simply represent the gradual breakdown of LD over
ǃǄ
time and the reintroduction of favorable genetic diversity previously suppressed
by the selective sweep ǂƽ years ago.
ĉe absence of well-characterized drug resistance loci in our ėndings suggests
that this test is not sensitive to historic strong selective events in the way long-
haplotype and other common selection tests are. Based on how selection is mod-
eled, one would expect that even recent historic events would go undetected and
that only selection currently in progress would produce a noticable signal. For this
reason, this approach provides a very complementary set of insights to existing se-
lection tests regarding the adaptive behavior of the parasite.
ǁ.ǀ.ƿ FŊŉŊŇĹ DĽŇĹķŉĽŃłň
In this chapter, we have demonstrated the concept of scaling a temporal test for
selection up to a genome-wide scale. We have established a number of useful ge-
nomic statistics based on this method originally developed by Bollback et al. in a
single-marker seĨing. We have explored the behavior of this type of approach and
the types of selective signals to which it is sensitive. And as an initial foray into
a new type of selection test, we have also learned a number of ways in which the
methods can be expanded upon in future work. ĉese future directions are elabo-
rated upon here.
ĉedriěparameter,Ne, is currently set to a ėxed valuebasedonprevious studies
in this population [ǁƽ]. Although we did manually examine the behavior of this
statistic under several other values of this parameter (Figure E.ǁ), this approach
would beneėt if it were combined with methods that can estimate Ne genome-
wide. ĉe existing HMM is able to provide a maximum-likelihood estimate of
Ne for a single marker, but it is not able to jointly estimate the parameter across
many markers. Additionally, recent evidence shows that eﬀective population size
may be changing over time as malaria control eﬀorts take eﬀect [ǁƽ]. It would be
ideal to be able tomodel a changingNe over time, though this would require some
signiėcant changes to the underlying soěware.
Similarly, our model currently assumes a constant directional selection pres-
sure over the entire time period sampled. When studying samples from a country
ǃǅ
where the national drug treatment policies change over time (such as the introduc-
tion of a new standard of therapy in a certain year), this assumption does not hold.
For these types of studies, it would not be hard tomodel a stepwise change in s at a
given time point by spliĨing the data into two separate time intervals and running
the HMM to estimate s separately for each time interval. A likelihood ratio test
statistic can then be produced by testing against the null hypothesis of sTƾ = sTƿ.
ĉis would allow us to isolate regions of the genome where the selection coeﬃ-
cient signiėcantly changes at a given point in time.
We have previously described how this test provides a complementary view of
selection to existing long-haplotype-based selection tests. ĉe natural next step is
to compute composite statistics based on this and other tests to leverage the dis-
tinct information provided by each. ĉis can be done using a thoroughlymodeled
approach as in Grossman et al. [ǃǀ], or a more naive approach that simply com-
bines signiėcance values from each test [ƾǅƾ, ƾǅǃ].
Very recent work shows that the complex life cycle of themalaria parasite (with
multiple boĨlenecks in the asexual and sexual stages) produces some impor-
tant departures from the standard coalescent and Wright-Fisher models that our
method is based on [ƿǄ]. ĉis is particularly true with regards to the strength
of driě and selectionãthe very forces that this model tries to estimate. ĉis
complexity has oěen been overlooked in the past, but it is becoming clear that,
particularly in studies of selection, it can no longer be ignored. It would be prudent
to replace our forward simulations with the Chang et al. model while updating
the transition probabilities in the Bollback et al. HMMwith one that more closely
matches those produced by the malaria life cycle.
Ideally, an expanded studywould run forward simulations at a range of selection
coeﬃcients (here, we only simulated the null: s = ƽ), driě rates, sample sizes,
number of time points, and total time spanned. ĉiswould produce amore formal
calculation of the test’s power and sensitivity to detect a certain level of selection
and evaluate possible study designs before collecting the data.
Going forward, DanNeafsey at the Broad Institute has proposed future work to
utilize the methods developed in this chapter for a large scale study in Southeast
ǃǆ
Asiaãa population where clinical phenotypes appear to be in motion [ǁǄ, ƾƿǁ].
ĉe studywould use the hybrid-selection approach developed at theBroad [ǆǅ] to
sequence ǃƽƽ samples collected over ƾƽ years from northwestĉailand in collab-
oration with François Nosten and TimAnderson. ĉe techniques developed here
in this chapter can help inform the design of this study and provide the soěware
framework on which to build that analysis.
ĉe loci identiėed in Table ǁ.ƾ are biologically interesting and display some of
the most signiėcant movement of allele frequencies in our short time frame. Be-
cause this is based on genome-wide data fromonly a handful of time points, Diana
Miao, a Harvard undergraduate, is presently validating these loci in theWirth Lab
at the Harvard School of Public Health. Using single-marker PCR assays, she is
genotyping these top markers across a set of hundreds of unsequenced parasite
samples from the same Senegalese population, across roughly a decade of time
points. ĉis will help determine whether these loci continue to show directional
movement over a longer period of time, or whether they exhibit more driě-like
behavior in the unsequenced years.
ǁ.ǀ.ǀ CŃłķŀŊňĽŃł
In the end, our time-series based approach is important for studying selection in
malaria because of the very recent introduction of artemsinin-based selective pres-
sures. From a disease control standpoint, it is also essential to detect the parasite’s
adaptations as close to real-time as possible, before resistance mutations become
widespread. ĉis necessitates using and combining as many distinct types of se-
lection tests as possible to provide a clearer picture of the parasite’s evolutionary
responses. ĉe approach piloted in this chapter provides a signiėcant step in that
direction.
ĉis work, taken together with the chapters before it, make signiėcant contri-
butions to the ėeld of malaria genomics. Each chapter of this dissertation demon-
strates a new application of population genomic methods to the study of malaria,
oěen adapting these methods in ways not originally foreseen. Each chapter also
produces a number of candidate genes and mutations that lend insight to parasite
Ǆƽ
evolution, drug mechanisms, and point to possible genomic surveillance markers.
ĉis dissertation provides timely advances to both methods and knowledge for a
ėeld in need of innovative means to thwart the highly adaptable parasite responsi-
ble for one of the most prevalent human diseases.
ǁ.ǁ MĹŉļŃĸň
ǁ.ǁ.ƾ SĵŁńŀĹ CŃŀŀĹķŉĽŃł ĵłĸ SĹŅŊĹłķĹ AłĵŀŏňĽň
ƾǆƽ parasite samples were collected from patients in Senegal over a ten year span
from ƿƽƽƾ to ƿƽƾƾ. Parasite DNA was isolated either by culture adaptation [ƾǃǂ],
hybrid-selection enrichment [ǆǅ], or direct sequencing of patient DNA, depend-
ing on sample quality. Genomic DNA was sequenced at the Broad Institute using
Illumina Hi-Seq machines using paired-end reads ranging from Ǆǃbp to ƾƽƾbp in
length.
Reads were aligned with BWA vƽ.ǃ.ƿ against the ǀDǄ reference assembly (Plas-
moDB vǆ.ƽ). A consensus sequence was called for each sample individually using
theGATKUniėedGenotyper ƿ.ǁ-ǆ [ǆǃ] using the EMIT_ALL_SITES option. Both
SNPs and indels were allowed. Bases were then removed if they exhibited poor
quality (QUAL less than ǃƽ) or if they called a heterozygous genotype. Aěer this
ėltering, all samples were merged into a single VCF ėle.
ƿƾ samples were then discarded that had genotype consensus calls for less than
ǂƽ% of the genome (roughly ƾƾ.ǄMb). Aěer removing sites that were monomor-
phic in the remaining ƾǂǆ samples, we had ǃǀƾ,ƽǀƿ variants. Of these, ǃƿ,ǂǆǆwere
biallelic and non-singleton (at least two samples with a minor allele). Functional
consequences of these variants were annotated using snpEﬀ and PlasmoDB ǆ.ƽ.
For this analysis, we further restricted our sample set to the ƾǀǆ samples col-
lected between ƿƽƽǅ and ƿƽƾƾ, as these were the only four years with large enough
sample sizes to reduce the errors in our estimate of annual allele frequencies. We
reduced ourmarker set to those that had non-missing genotype calls for at least ƾƿ
samples in each of the four years, had a minimum minor allele frequency of ƽ.ƽƿ
Ǆƾ
across all samples, had at least one year with a minor allele frequency of at least
ƽ.ƽǂ, and had a non-missing genotype call for the P. reichenowi genotype to infer
ancestral/derived status. ĉis resulted in ƿǄ,ƿǂǂ variants, of which ƿǂ,ǅƽǄ were
SNPs and ƾ,ǁǁǅ of which were small indels.
In most selection studies (particularly with long-haplotype selection tests),
SNP and indel data cannot be jointly analyzed due to the diﬀerences in mutation
rates and, with some types of indels, recombination mechanisms. However, our
approach measures selection against genetic driě (instead of recombination)
which should aﬀet both classes of variants equally. As such, we analyzed the data
set without separating SNPs and indels while recognizing that our ability to ascer-
tain indel variation with these methods (short reads, BWA, GATK) is restricted
to only smaller and simpler indels.
ĉe derived-vs-ancestral status of each variant was determined from ge-
nomic sequence from P. reichenowi, the closest known outgroup for P. falci-
parum. Raw reads from the “Dennis” isolate sequenced by the Wellcome Trust
Sanger Institute were downloaded from the European Nucleotide Archive using
project accession ERPƽƽƽƿǆǆ (see http://www.ebi.ac.uk/ena/data/view/
ERP000299 and http://www.sanger.ac.uk/resources/downloads/protozoa/
plasmodium-reichenowi.html). Reads were aligned to ǀDǄ with BWA and
variants were genotyped with GATK’s Uniėed Genotyper in the same manner as
the P. falciparum samples described earlier. ĉe resulting derived allele frequency
distributions are shown in Figure E.ƾ.
ǁ.ǁ.ƿ EňŉĽŁĵŉĽłĻ ŉļĹ SĹŀĹķŉĽŃł CŃĹĺĺĽķĽĹłŉ
To estimate selection coeﬃcients from our time series data, we started
from the HMM implemented in Bollback et al. publicly available at http:
//www.simmap.com/bollback/software.html. ĉis package, called selƿns,
models a single marker when provided with derived and ancestal allele counts
for each time point. ĉe user must specify a range of parameter space to explore
(for Ne and s) and a resolution to explore it at (the number of intervals for each
parameter) and the program will emit log-likelihoods for each combination of
Ǆƿ
parameter values in a linearly spaced grid within the speciėed boundaries. ĉe
output can then be examined to determine which parameter values result in the
maximum likelihood.
ĉis can result inmanyCPU-days of runtime when applied to a whole genome,
but signiėcant optimizations can be made to the likelihood maximization ap-
proach. As this soěware was originally intended for single locus studies, such
optimizations were not a priority for the original authors. We wrapped the
selƿns soěware with our own script that uses well-established algorithms to op-
timize relatively well-behaved objective functions using an implementation of
Brent’s algorithm in the SciPy package (scipy.optimize.minimize_scalar).
ĉis approach eﬃciently ėnds the maximum likelihood estimate (MLE) of the
parameters with as few executions of the HMM as possible.
We used a ėxed value ofNe across the whole genome and, at each variant, esti-
mated values for s and also computed a likelihood ratio test to produce a measure
of signiėcance against the null hypothesis of no selection. Eﬀective population size
is a concept used for multiple purposes in population genetics. BecauseNe is used
here to simulate the strength of driě over a short span of time, it makes sense to
use a ėxed value over the entire genome. Other interpretations ofNe that allow for
varying values across the genome are used to describe how allele frequency spec-
tra are aﬀected by recent population history. However, since this is not howNe is
used by the HMM, it is sensible to ėx a single value, since the entire genome will
experience driě at the same rate within this period of time.
Forward simulations of the null model were producedwith a simple implemen-
tation of the Wright-Fisher driě model using an initial allele frequency sampled
randomly from thedistributionof derived allele frequencies observed in thewhole
genome. Similar to the HMM, we introduced binomial sampling errors at each
sampling time point, using annual sample sizes equal to those used in our actual
data. ĉe main diﬀerence between this model and the one described in Bollback
et al. is the use of theWright-Fisher model for driě here vs. the Kolmogorov back-
ward equation used in selƿns, but this diﬀerence should be negligible. ĉese sim-
ulations are meant to model the behavior of the selƿns output under the null hy-
pothesis. ĉe simulations can easily be adapted to incorporate directional selec-
Ǆǀ
tion by introducing a modiėcation of the allele frequency at each Wright-Fisher
generation prior to binomial sampling with the following additive model:
pnext =
p(ƿ+ s+ ps)
ƿ+ ƿps
Such a modiėcation would allow for an examination of the sensitivity of selƿns
to detect selection at various strengths.
ǁ.ǁ.ǀ OŇŉļŃĻŃłĵŀ TĹňŉň ĺŃŇ SĹŀĹķŉĽŃł
Additional analyses were also performed on this data set that are shown in Ap-
pendix E. ĉese include traditional long-haplotype based tests for positive selec-
tion (Section E.ǁ) and drug resistanceGWAS for a subset of phenotyped parasites
(Section E.ǂ).
Long haplotype tests focused on sequence data fromour Senegalese population
combinedwith twootherWestAfricanparasite populations sequencedbyManske
et al. [ǆǂ]: Burkina Faso and Mali. Raw reads from these samples were obtained
from the EuropeanNucleotideArchive using the accessions listed inManske et al..
Alignment and variant calling was performed as described previously with our
Senegalese and the P. reichenowi sample.
GWAS tests were performed exactly as in Chapter ǀ, with the exception that
parasite drug response is now assesed using an ex vivo drug assay (manuscript in
preparation) instead of the previous method relying on culture adaptation.
ǁ.ǂ AķĿłŃŌŀĹĸĻĹŁĹłŉň
Daria Van Tyne (HSPH) has been involved with project concept and strategy.
Hsiao-Han Chang (OEB), Clarissa Valim (HSPH), Hilary Finucane (MIT),
Stephen Schaﬀner (Broad), and Dan Neafsey (Broad) have provided very valu-
able insight and guidance into the statistics andmodels. Sample management was
handled by Sarah Volkman and colleagues in the Wirth Lab at HSPH. My thesis
commiĨee, comprised of Pardis Sabeti, Dan Hartl, John Wakeley, and Dyann
Ǆǁ
Wirth helped guide this project throughout.
Ǆǂ
ĉis chapter describes thirteen recent manuscripts in which
I have played an assistive role. Nine of these have reached
publication, four more are in process.
A
Secondary Publications
During my time here, I also assisted with a number of publications led by other
researchers. ĉe following manuscripts are interior-author publications of mine
from Fall ƿƽƾƽ to the present. OmiĨed from this listing is the Nature Reviews
Genetics paper that forms the basis of Chapter ƾ.
A.ƾ PŊĶŀĽňļĹĸ ŁĵłŊňķŇĽńŉň, SĹńŉ ƿƽƾƽ ŉŃ JŊŀŏ ƿƽƾǀ
[ǁƽ] Rachel F Daniels, Hsiao-Han Chang, Papa Diogoye Séne, Daniel J Park,
Daniel E Neafsey, Stephen F Schaﬀner, Elizabeth J Hamilton, Amanda K Lukens,
Daria Van Tyne, Souleymane Mboup, Pardis C Sabeti, Daouda Ndiaye, Dyann F
Wirth, Daniel L Hartl, and Sarah K Volkman. Genetic Surveillance Detects
Both Clonal and Epidemic Transmission of Malaria following Enhanced In-
tervention in Senegal. PLoS ONE, ǅ(ǁ):eǃƽǄǅƽ–eǃƽǄǅƽ, April ƿƽƾǀ. doi:
Ǆǃ
ƾƽ.ƾǀǄƾ/journal.pone.ƽƽǃƽǄǅƽ. URL http://www.plosone.org/article/
info%3Adoi%2F10.1371%2Fjournal.pone.0060780ãĉis paper describes the
use of a genetic barcode on a parasite sample set in Senegal spanning ėve years.
It ėnds an increase in parasite clonality over time, consistent with a reduction in
eﬀective population size during a period of intense malaria control eﬀorts. ĉis
eﬀort was led by Harvard graduate students Rachel Daniels (BBS) and Hsiao-
Han Chang (OEB). I played a minor role, providing some analysis for array-based
validations and was involved in some discussions around data analysis.
[ǃǀ] Sharon R Grossman, Kristian G Andersen, Ilya Shlyakhter, Shervin
Tabrizi, Sarah Winnicki, Angela Yen, Daniel J Park, Dustin Griesemer, Elinor K
Karlsson, Sunny H Wong, Moran Cabili, Richard A Adegbola, Rameshwar N K
Bamezai, Adrian V S Hill, Fredrik O Vannberg, John L Rinn, Eric S Lander,
Stephen F Schaﬀner, and Pardis C Sabeti. Identifying Recent Adaptations in
Large-Scale Genomic Data. Cell, ƾǂƿ(ǁ):Ǆƽǀ–Ǆƾǀ, February ƿƽƾǀ. doi: ƾƽ.ƾƽƾǃ/
j.cell.ƿƽƾǀ.ƽƾ.ƽǀǂ. URL http://dx.doi.org/10.1016/j.cell.2013.01.035ã
ĉis paper describes a genome-wide scan of selection in human populations
using composite statistics. I played a small role in this analysis, utilizing publicly
available RNA-seq data to infer transcriptional activity of non-coding regions
identiėed by this selection scan.
[ƿǅ] Hsiao-Han Chang, Daniel J Park, Kevin J Galinsky, Stephen F Schaﬀner,
Daouda Ndiaye, Omar Ndir, Soulyemane Mboup, Roger C Wiegand, Sarah K
Volkman, Pardis C Sabeti, Dyann F Wirth, Daniel E Neafsey, and Daniel L Hartl.
Genomic sequencing of Plasmodium falciparum malaria parasites from Senegal
reveals the demographic history of the population. Molecular Biology and Evo-
lution, ƿǆ:ǀǁƿǄ–ǀǁǀǆ, June ƿƽƾƿ. doi: ƾƽ.ƾƽǆǀ/molbev/mssƾǃƾ. URL http:
//mbe.oxfordjournals.org/content/29/11/3427ãĉis paper describes pop-
ulation genetic analyses and selection scans in ƿǂ fully-sequenced Senegal para-
sites. ĉey are a subset of the ǁǂ parasites described in Chapter ǀ. ĉis eﬀort
was led by Harvard OEB graduate student Hsiao-Han Chang. I provided analy-
ses based on the iHS long-haplotype selection test and helped to analyze sequence
data.
ǄǄ
[ǃ] Alfred Amambua-Ngwa, Daniel J Park, Sarah K Volkman, Kayla G Barnes,
AmyBei, AmandaKLukens, Papa Sene,DariaVanTyne,DaoudaNdiaye,DyannF
Wirth, David J Conway, Daniel E Neafsey, and Stephen F Schaﬀner. SNP geno-
typing identiėes new signatures of selection in a deep sample of West African P.
falciparummalaria parasites.Molecular Biology and Evolution, ƿǆ:ǀƿǁǆ–ǀƿǂǀ, June
ƿƽƾƿ. doi: ƾƽ.ƾƽǆǀ/molbev/mssƾǂƾ. URL http://mbe.oxfordjournals.org/
content/29/11/3249ãĉis paper describes population genetic analyses and se-
lection scans in Ǆǂ parasites from Senegal and the Gambia genotyped on a high-
density SNP array. ĉis eﬀort was led by Alfred Ngwa and David Conway (MRC
Gambia) and DanNeafsey and Steve Schaﬀner (Broad Institute). I processed and
ėltered array genotype data for this project and performed long haplotype selec-
tion tests (REHH and iHS).
[ƾǄǂ] Sarah K Volkman, Daouda Ndiaye, Mahamadou Diakite, Ousmane A
Koita, Davis Nwakanma, Rachel F Daniels, Daniel J Park, Daniel E Neafsey, Marc
ATMuskavitch, Donald J Krogstad, Pardis C Sabeti, Daniel LHartl, andDyann F
Wirth. Application of genomics to ėeld investigations of malaria by the interna-
tional centers of excellence for malaria research. Acta Tropica, ƾƿƾ(ǀ):ǀƿǁ–ǀǀƿ,
March ƿƽƾƿ. doi: ƾƽ.ƾƽƾǃ/j.actatropica.ƿƽƾƾ.ƾƿ.ƽƽƿ. URL http://dx.doi.org/
10.1016/j.actatropica.2011.12.002ãĉis paper is a review papermalaria ge-
nomics as well as a description of the new ICEMR project (International Cen-
ters of Excellence forMalaria Research). ĉis was led by Sarah Volkman (Harvard
SPH). I played a minor role, and contributed small sections of text.
[ƾƽƾ] Danny A Milner, Jimmy Vareta, Clarissa Valim, Jacqui Montgomery,
Rachel F Daniels, Sarah K Volkman, Daniel E Neafsey, Daniel J Park, Stephen F
Schaﬀner, Nira C Mahesh, Kayla G Barnes, David M Rosen, Amanda K Lukens,
Daria Van Tyne, Roger C Wiegand, Pardis C Sabeti, Karl B Seydel, Simon J
Glover, Steve Kamiza,Malcolm EMolyneux, Terrie E Taylor, andDyann FWirth.
Human cerebral malaria and Plasmodium falciparum genotypes in Malawi.
Malaria Journal, ƾƾ:ǀǂ, March ƿƽƾƿ. doi: ƾƽ.ƾƾǅǃ/ƾǁǄǂ-ƿǅǄǂ-ƾƾ-ǀǂ. URL
http://www.malariajournal.com/content/11/1/35ãĉis paper describes
the application of a ƿǁ SNP PCR barcode assay to explore the association be-
tween multiplicity of infection and severity of disease outcome in children. It was
Ǆǅ
led by Dan Milner (Harvard SPH). I played a minor role, mostly in the initial
population genetic analyses that led towards the selection of the ƿǁ SNPs.
[ƿƾ] Kate M Broadbent, Daniel J Park, Ashley R Wolf, Daria Van Tyne, Jen-
nifer S Sims, Ulf Ribacke, Sarah Volkman, Manoj Duraisingh, Dyann F Wirth,
Pardis C Sabeti, and John L Rinn. A global transcriptional analysis of Plasmod-
ium falciparum malaria reveals a novel family of telomere-associated lncRNAs.
Genome Biology, ƾƿ(ǃ):Rǂǃ, June ƿƽƾƾ. doi: ƾƽ.ƾƾǅǃ/gb-ƿƽƾƾ-ƾƿ-ǃ-rǂǃ. URL
http://genomebiology.com/2011/12/6/R56ãĉis paper describes a transcrip-
tional scan and characterization of a family of long non-coding RNAs in the para-
site in vitro. ĉiswas ledbyHarvardSystemsBiology graduate studentKateBroad-
bent. I provided some statistical analyses and bridged the project from its initial
rotation student to its ėnal owner.
[ƾƾǂ] Daniel ENeafsey, Mara KNLawniczak, Daniel J Park, SethNRedmond,
M B Coulibaly, S F Traoré, N Sagnon, C Costantini, Charlie Johnson, Roger C
Wiegand, FrankHCollins, Eric S Lander, Dyann FWirth, Fotis C Kafatos, Nora J
Besansky, George K Christophides, and Marc A T Muskavitch. Snp genotyping
deėnes complex gene-Ěow boundaries among african malaria vector mosquitoes.
Science, ǀǀƽ(ǃƽƽǀ):ǂƾǁ–Ǆ, Oct ƿƽƾƽ. doi: ƾƽ.ƾƾƿǃ/science.ƾƾǆǀƽǀǃ. URL http:
//www.sciencemag.org/content/330/6003/514ãĉis paper describes popula-
tion genetic analyses of the vector mosquito,Anopheles gambiae. It was led by Dan
Neafsey (Broad Institute),Mara Lawniczak (Imperial College London), andMarc
Muskavitch (BostonCollege). I designed the genotyping array used for this study,
and provided early-stage analysis of the array data.
[ƾƾǁ] Daniel E Neafsey, Bridget M Barker, ĉomas J Sharpton, Jason E Stajich,
Daniel J Park, Emily Whiston, Chiung-Yu Hung, Cody McMahan, Jared White,
Sean Sykes, DavidHeiman, Sarah Young, Qiandong Zeng, Amr Abouelleil, Lynne
Aěuck, Daniel BesseĨe, Adam Brown, Michael Fitzgerald, Annie Lui, J Pendexter
Macdonald, Margaret Priest, Marc J Orbach, John N Galgiani, ĉeo N Kirkland,
Garry T Cole, Bruce W Birren, MaĨhew R Henn, John W Taylor, and Steven D
Rounsley. Population genomic sequencing of Coccidioides fungi reveals recent
hybridization and transposon control. Genome Research, ƿƽ(Ǆ):ǆǀǅ–ǆǁǃ, July
ƿƽƾƽ. doi: ƾƽ.ƾƾƽƾ/gr.ƾƽǀǆƾƾ.ƾƽǆ. URL http://genome.cshlp.org/content/
Ǆǆ
20/7/938ãĉis paper has nothing to dowithmalaria. It describes the population
genetics and interspeciėc analyses of two related fungi: Coccidioides immitis and
Coccidioides posadasii. ĉis was led by Dan Neafsey (Broad Institute). I played a
minor role, assisting with SNP discovery and gene annotation.
A.ƿ MĵłŊňķŇĽńŉň Ľł ńŇĹńĵŇĵŉĽŃł ŃŇ ŇĹŋĽĹŌ
Additionally, I have a fewmore manuscripts currently in preparation or review:
Ulf Ribacke,Mackenzie BartleĨ, SaurabhDPatel, Niroshini Senaratne, Daniel J
Park,ManojTDuraisingh, PardisC Sabeti, SarahKVolkman, andDyannFWirth.
Adaptive evolution of a ubiquitin ligase is linked to altered drug sensitivity in plas-
modium falciparum. Science Translational Medicine. Manuscript under review.ãI
played aminor role, assisting with the interpretation and reanalysis of results from
the REHH selection test in Van Tyne et al. [ƾǄƽ] and incorporating derived allele
analyses for mutations of interest.
Hsiao-Han Chang, Eli L Moss, Daniel J Park, Daouda Ndiaye, Soulyemane
Mboup, Roger C Wiegand, Sarah K Volkman, Pardis C Sabeti, Dyann F Wirth,
Daniel E Neafsey, and Daniel L Hartl. ĉe malaria life cycle intensiėes both
natural selection and random genetic driě. Proceedings of the National Academy
of Sciences, USA. Manuscript in preparation.ãI played a minor role, providing
helpful conversations and feedback on the population model used in this study
and guiding the protocols for the analysis of raw sequence data. ĉis constitutes
the ėnal chapter of Hsiao-Han’s OEB dissertation, submiĨed to Harvard in May
ƿƽƾǀ.
Awa B Deme, Amy K Bei, Ousmane Sarr, Daniel E Neafsey, Stephen F
Schaﬀner, Daniel J Park, Rachel F Daniels, Aida Sadikh Badiane, Papa El
Hadji Omar Gueye, Ambroise Ahouidi, Daouda Ndiaye, Souleymane Mboup,
Dyann FWirth, and Sarah K Volkman. Analysis of the pĖrpƿ genetic diversity in
senegal and implications for rapid diagnostic test use.Malaria Journal. Manuscript
in preparation.ãI played a minor role, providing some advice on population ge-
netic analyses and providing some summarized sequence data for the gene pĖrpȋ
ǅƽ
from sequenced parasites in Senegal. ĉis eﬀort was led by Senegalese graduate
student Awa Deme, who was a participant in a computational methods workshop
that I taught in Dakar, Senegal in ƿƽƾƽ.
Daria Van Tyne, Daniel J Park, and Dyann F Wirth. Understanding malaria
drug resistance evolution in real-time. Trends in Parasitology. Manuscript in
preparation.ãI provided edits to this review paper in the areas of GWAS and se-
lection studies.
ǅƾ
ĉis is a ėnal term paper assignment for OEBȋȍȋ (Coales-
centĉeory), taught in Fall ȋȉȊȉ by JohnWakeley (Harvard
University). See Section B.ȍ for details on author contribu-
tions.
B
Ascertainment Bias CorreČions to
SeleČion Studies in Plasmodium
falciparum
ĉĽň ķļĵńŉĹŇ ĹŎńŀŃŇĹň ĵłĸ ĹŎńĵłĸň on a previous analysis of di-rectional and balancing selection in the malaria parasite, Plasmod-ium falciparum. ĉis previous analysis was a visualization of P. fal-
ciparum gene diversity vs. divergence inChapter ƿ [ƾǄƽ]. Here, I exploreways that
this analysis may have been aﬀected by ascertainment bias and aĨempt to correct
for it and calculate measures of signiėcance utilizing coalescent approaches.
ǅƿ
B.ƾ IłŉŇŃĸŊķŉĽŃł
Genomic studies of the Plasmodium falciparum parasite have advanced consider-
ably in the past decade. From the initial sequencing and assembly of the genome
to the characterizations of population diversity, and numerous studies since then,
we now have a growing understanding of P. falciparum’s population history, global
population structure, LD structure, and some of the strongest foci of selection
pressure. Despite the rapidly decreasing cost of high throughput sequencing, a
number of recent and continuing studies still rely on SNP genotyping chips to
measure individual parasites for genomic variation [e.g. ƾƽǄ, ƾƾǀ].
However, it has been long known that a number of population genetic analyses
from chip-derived data are sensitive to ascertainment bias [ǀƿ, ƾƾǄ, ƾƾǅ]. ĉis is
due to the fact that the arrays only assay a pre-speciėed set of SNPs obtained in
a smaller sample of individuals. ĉis predisposes us to the detection of mostly
common polymorphisms and biases the allele frequency spectra. In the case of
P. falciparum, most current genotyping array designs are based on discovery data
from less than ƿƽ haploid strains originally described by a trio of ƿƽƽǄ papers [Ǆǁ,
ƾƽǃ, ƾǄǁ]. Most studies in P. falciparum manage to avoid analyses that would be
signiėcantly aﬀected by ascertainment bias, but some simply concede its possible
inĚuence. For example, Neafsey et al. and Van Tyne et al. use the terminology
“SNP π” to emphasize its departure from the usual population genetic parameter,
π, due to ascertainment bias.
Inmalaria genomics research,weultimatelywish to identify areas of the genome
that may be under selection due to host immune pressure, drug pressure, or other
factors. In this chapter, I wish to further explore a small analysis by Dan Neafsey
(Figure ƿ.ƾB in this dissertation). I reproduce it here as FigureB.ƾA.ĉis visualiza-
tion plots the SNP π of a gene (within one subpopulation) against the gene’s FST
as a measure of within-population diversity vs. between-population divergence.
ĉe visualization suggests that data points with high diversity and low divergence
may be candidates for genes under balancing selection. Conversely, genes with
low diversity and high divergence may be candidates for population-speciėc pos-
itive selection. It is similar to Figure ǁ from Ochola et al. [ƾƿǂ], though Ochola
ǅǀ
et al. use a interspeciėc metric of “divergence” (π=K and θ=K from a Hć test)
whereas Van Tyne et al. use a intraspeciėc divergence metric (FST). Ochola et al.
also does not suﬀer fromascertainment bias, as theyPCR resequenced a set of can-
didate genes, whereas Van Tyne et al. utilizes the biased metric called “SNP π.” In
this chapter, I aĨempt to examine and correct for the eﬀects of ascertainment bias
in Figure B.ƾA and calculate measures of signiėcance for the data.
Figure B.1: Left: 650 genes in P. falciparum plotted by diversity within Senegal (SNP π)
vs. divergence between Senegal and Thailand (FST). Genes on the lower right are sugges-
tive of balancing selection and show an enrichment for known antigens, surface proteins,
and highly polymorphic genes (red). Genes on the upper left are suggestive of directional
positive selection and show an enrichment for known enzymes and transporters (blue).
A handful of genes of biological interest are labeled. This ﬁgure was originally shown in
Van Tyne et al. [170, Fig. 1B] (also Figure 2.1B in this dissertation) with a slightly different
rendering. Right: Senegal Tajima’s D vs. FST. Although Tajima’s D should provide a better
indication of balancing vs. positive selection, this graph fails to separate known antigens
and enzymes as clearly as the one based on SNP π.
B.ƿ RĹňŊŀŉň ĵłĸDĽňķŊňňĽŃł
Even aěer correcting the values of SNP π in Figure B.ƾA for ascertainment bias, it
would be helpful to give a measure of signiėcance to genes at the extreme ends of
the plot. ĉe Tajima’s D statistic can be thought of as an aĨempt to normalize the
amount of polymorphism in a gene, Π, against the amount expected based on the
ǅǁ
number of segregating sites, θW. ĉis addresses some other concerns, such as the
idea that a distibution of πmight be aﬀected by variations inmutation rate or gene
age. Tajima’sD should help discern candidates of balancing selection (D > ƽ) and
positive selection (D < ƽ) from neutrality (D = ƽ). Unfortunately, this metric
does aworse jobof visually separating genes that, basedon annotation, are thought
to be candidates for balancing and positive selection (Figure B.ƾB). An alternate
visualization of Tajima’s D plots θ^W against θ^T (Figure B.ƿA), where Tajima’s D
is the normalized deviation from the unity line. Both ėgures also demonstrate an
overall skew in the positive direction, which is characteristic of ascertainment bias.
Corrections for ascertainment bias were made based on Ramírez-Soriano and
Nielsen [ƾǁǁ] to values for θ^T and θ^W andTajima’s D (Section B.ǀ). ĉe corrected
values are shown in Figure B.ƿB.ĉese corrections succeed in centeringTajima’sD
around zero for most values of θ^. Oddly, for low values of θ^W, Tajima’s D is shiěed
quite negative. Although it has been long known that the Plasmodium falciparum
population has experienced multiple boĨlenecks and population expansions [Ǆǅ,
ƾǂǅ] such eﬀects should not be limited to genes with lower polymorphism, so the
eﬀect seen here is puzzling.
Ascertainment corrections to π and Tajima’s D (Figure B.ǀ) do not drastically
change the overall picture from Figure B.ƾ. Corrected π is a slightly beĨer dis-
criminator between balancing and positive selection candidate genes than SNP π,
but the corrected Tajima’s D is still unable to distinguish the two. Ultimately, we
can see that while both Π (Figure B.ƿB) and π (Figure B.ǀA) can visually sep-
arate balancing and positive selection candidates, Tajima’s D (Figure B.ǀB) can-
not, even aěer corrections for ascertainment bias. ĉis may imply that our pre-
viously deėned categories (known highly variable genes/surface proteins vs. en-
zymes/transporters) may not be the best control groupings for this test. Even
among the highly polymorphic genes where one might expect an enrichment for
positive Tajima’s D, many of these genes lie in large gene families (e.g. the vars,
riėns, stevors, etc.), oěen in the subtelomeres, that result frommany gene duplica-
tion events. Speculatively, this may mean that the “demographic history” of these
gene copies varywidely andmight confound aTajima’sD analysis of these families.
Even so, since the resulting distribution of Tajima’s D values shows rough concor-
ǅǂ
Figure B.2: A visualization of Tajima’s D by plotting Watterson’s θ^W against Tajima’s θ^T.
Left: original data. Right: corrected for ascertainment bias. Genes to the right of the unity
line have positive D and genes to the left are negative. Circle size corresponds to the ab-
solute value of Tajima’s D. As before, red genes correspond to candidates for balancing
selection and blue genes correspond to candidates for positive selection. The SNP π plot-
ted in Figure B.1A differs from the SNP Π shown here in that the former equals the latter
divided by gene length.
dance with a normal distribution (Figure B.ǁC), we would not be too astray in
interpreting these corrected values as Z-scores, usingƿ as a signiėcance thresh-
old.
In the end, this chapter succeeds in correcting a number of parameters for ascer-
tainment bias for P. falciparum genes in a population of Senegal-derived parasites.
It uses these to correct and further explore and expand on a previous visualization
of this data: a diversity-divergence plot that was used to identify candidates of bal-
ancing and positive selection. Although the corrected Tajima’s D metric fails to
separate a control set of genes thought to be under diﬀerent types of selection, we
are able to show that it provides ameasure of signiėcance. ĉis chapter also shows
a foundation of a naive coalescent model used to compute signiėcance, which can
be expandedupon in the future to account for confounding factors that are not cur-
rently addressed, such as demographic history. ĉis model could also be used to
simulate structured populations with limited gene Ěow. In addition to providing
maximum likelihood estimates for migration rates between Senegal andĉailand,
ǅǃ
it could also begin to explore the other axis of Figure B.ƾA not addressed in this
chapter and possibly provide measures of signiėcance for extreme FST values.
Figure B.3: Ascertainment corrections applied to the plots in Figure B.1.
B.ǀ MĹŉļŃĸň
Ascertainment bias corrections are derived from Ramírez-Soriano and Nielsen
[ƾǁǁ]. Although their downloadable Java program did not run on my data, all of
the necessary equations for the corrections of θ^W = S=a and θ^T = Π, are given
in their main text (Equations ǀ, ǂ, and Ǆ) and are implemented here.
Ascertainment bias corrections for Tajima’s D was slightly more complicated,
as the arithmetic for the denominator, the variance component of Tajima’s D, was
rather unwieldy [ƾǁǁ, Eqn. ƾǃ]. As this author feared the possible programming
errors in the absence of thorough testing, andbecause the denominator is basedon
assumptions of an underlying beta distribution, I opted instead to calculateV(Π 
S=a) from the results of ƾƽƽƽ coalescent simulations per gene. ĉe numerator for
Tajima’s D is still based on ascertainment corrections from Ramírez-Soriano and
Nielsen [ƾǁǁ], so any remaining errors in my corrected Tajima’s D values would
be in magnitude, but not direction.
Simulationswere performed usingms [ǃǅ] using a simple, unstructuredmodel.
To simulate a distribution of locus lengths that matched a realistic distribution
ǅǄ
of gene lengths, I run ms once for each gene with parameters scaled to the gene
length. I estimated θ^=L, whereL is the length of the gene in bp, as themean S=(aL)
and mean π = Π=L values, which were both approximately ǁ  ƾƽ ǁ. A sample
size of ƾǄ individuals was used, to match the Senegalese sample size of our empir-
ical data. A recombination parameter, ρ^=L = ƽ:ƽƽǂǄ, is taken from Chang [ƿǃ].
However, unlike Chang, I do not aĨempt to model population growth. ĉe ėnal
ms command line looks like this:
ms 17 1000*ngenes -t 0.0004*glen -r 0.0057*glen glen \
| sample_stats > outputfile
where glen is the simulated gene length and ngenes is the number of genes that
have the length glen. ĉe results of this simulation is shown in Figure B.ǁA. ĉe
variance of Π   S=a is calculated as a function of S=a and is shown to vary lin-
early with S=a (Figure B.ǁB). A linear ėt is performed and used to extrapolate all
of V(Π   S=a) as a function of S=a.
Figure B.4: Left: Watterson’s θ^W against Tajima’s θ^T for 650,000 simulated genes with
the same gene length distribution as the empirical data. Center: simulated data shows a
linear relationship between V(Π   S=a) and S=a. A best ﬁt line is shown in blue. This
line is used to compute a simulated denominator of corrected Tajima’s D for all genes.
Right: quantile-quantile plot shows that the corrected Tajima’s D values roughly conform
to a normal distribution.
ĉe square-root of this simulated variance is used as the denominator for the
corrected Tajima’s D, and the Ramírez-Soriano and Nielsen corrected values of
θ^T;C   θ^W;C are used as the numerator. ĉe quantile-quantile plot in Figure B.ǁC
shows the goodness of ėt between the ėnal, corrected Tajima’s D values, and the
ǅǅ
normal distribution (μ = ƽ; σ = ƾ, which we use here as an approximator for
Tajima’s beta distribution) that might be expected under neutral, panmictic, con-
stant population size conditions.
Figures were rendered using the ggplotƿ package in R. Analysis was done in
python, Java, and R (utilizing the plyr package).
B.ǁ AķĿłŃŌŀĹĸĻĹŁĹłŉň
I am grateful to Hsiao-Han Chang (HarvardOEB) andDanNeafsey (Broad Insti-
tute) for helpful conversations, discussions and suggestions for this chapter. HHC
also provided maximum-likelihood estimates of simulation parameters [ƿǃ]. DN
and Steve Schaﬀner (Broad Institute) originally produced Figure B.ƾA which in-
spired this modiėed analysis.
Sample collection was largely the work of collaborators at the Harvard School
of Public Health (Boston, MA) and Chiekh Anta Diop University (Dakar, Sene-
gal). Chip hybridizations were performed by Charlie Johnson (Broad Institute).
I designed the chip in conjunction with Aﬀymetrix, and the results were analyzed
by me.
All data and analyses leading up to Figure B.ƾA are prior work represented in
Chapter ƿ. All analyses beyond Figure B.ƾA are original to this chapter and this
author. ĉis work was undertaken in the context of a coalescent theory class
(OEBƿǂƿ) taught by JohnWakeley (Harvard OEB).
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SupplementalMaterial for Chapter ƿ
C.ƾ AŊŉļŃŇCŃłŉŇĽĶŊŉĽŃłň ŉŃ SŊńńŀĹŁĹłŉĵŀMĵŉĹŇĽĵŀ
Most analyses and ėgures in this supplemental appendix were produced byme. In
the Supplemental Methods, I performed all SNP Discovery, Array Development
and Assessment, and the Genome-wide Association Study (GWAS). Copy Num-
ber Variation (CNV) Analysis of array data was performed by DEN. PCR Geno-
typing was peformed by numerous techs at HSPH.
Figure C.ƾ was produced by SFS and PCS. Figure C.ƿ and Table C.ƿ were pro-
duced by SFS. Figures C.ǁ and C.ƾƾ were produced by DEN. Figures C.ǂ and C.ǃ
andTableC.ǀwere produced byEA. FigureC.ƾƿ andTablesC.ǃ andC.ǁwere pro-
duced by DVT. Figure C.ǀ and Tables C.ƾ, C.ǂ, and C.Ǆ were compiled by SKV.
Both Supplemental Data Files were produced by me. I produced Figures C.Ǆ,
C.ǅ, C.ǆ, C.ƾƽ andC.ƾǀ. I also produced all Figures andTables Supporting Supple-
ǆƽ
mental Methods: Figures C.ƾǁ, C.ƾǂ, C.ƾǃ, C.ƾǄ, C.ƾǅ, C.ƾǆ, and C.ƿƽ and Table
C.ǅ.
C.ƿ SŊńńŀĹŁĹłŉĵŀMĹŉļŃĸň
C.ƿ.ƾ PĵŇĵňĽŉĹň
Parasites (Table C.ƾ) were obtained from the Malaria Research and Reagent
Resource Repository (MRǁ, http://malaria.mr4.org/) or additional sources
noted (Table C.ƾ, Acknowledgements). ĉe following parasite lines were ob-
tained through MRǁ: parasite line ǀDǄ (MĆ-ƾǂƾ, deposited by D. Walliker);
parasite line ǄGǅ (MĆ-ƾǂƿ, deposited byD.Walliker); parasite lineHBǀ (MĆ-
ƾǂǂ, deposited by T.E. Wellems); parasite line Ddƿ (MĆ-ƾǂǃ, deposited by T.E.
Wellems); parasite line Kƾ (MĆ-ƾǂǆ, deposited by D.E. Kyle); parasite line
Vƾ/S (MĆ-ƾǄǃ, deposited by D.E. Kyle); parasite line RO-ǀǀ (MĆ-ƿƽƽ,
deposited by D. Walliker, U. Certa and R. Reber-Liske); parasite line Dƾƽ (MĆ-
ƿƽƾ, deposited by Y. Wu); parasite line TMǆƽCƿA (MĆ-ƿƽƿ, deposited by D.E.
Kyle); parasite line TMǆƽCǃA (MĆ-ƿƽǂ, deposited by D.E. Kyle); parasite line
TMǆƾCƿǀǂ (MĆ-ƿƽǃ, deposited by D.E. Kyle); parasite lineWRǅǄ (MĆ-ƿǅǁ,
deposited by D.E. Kyle); parasite line Dǃ (MĆ-ƿǅǂ, deposited by D.E. Kyle);
parasite lineMalayanCamp (MĆ-ǀǀƽ, deposited by L.H.Miller andD. Baruch);
parasite line Indochina I (MĆ-ǀǁǄ, deposited by W.E. Collins); parasite line
Santa Lucia (MĆ-ǀǃƿ, deposited by W.E. Collins); parasite line FCC-ƿ (MĆ-
Ǆǀǀ, deposited by W. Trager); and parasite line Tƿ-Cǃ (MĆ-ǅƾǅ, deposited
by X. Su). Patient samples were obtained as part of ongoing studies in Senegal
and Malawi described elsewhere in accordance with human subject guidelines.
Additional parasites were the kind giě of: Alejandro Miguel Katzin (ǂƾ, ƾƽ_ǂǁ,
ǀǃ_ǅǆ, and ǆ_ǁƾƾ); Christian Happi (APOǁƾ); Abdoulaye Djimde and Chris
Plowe (PSƾǅǆ); Joseph Smith (Aǁ); Karen Day (Muzǂƾ.ƾ); Dennis Kyle and
Sodsri ĉaithong (TDƿƽǀ, TDƿǂǄ, TMǀƿǄ, TMǀǁǂ, GHƿ, and PRƾǁǂ); Sandra
do Lago Moraes ( JST); and Xin-zhuan Su (MRƿǁ). DNA from P. reichenowi was
kindly provided by John Barnwell.
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C.ƿ.ƿ PCRGĹłŃŉŏńĽłĻ
Genomic regions (ǁǂǅǅǂƽ-ǁǂǆƿƽǁ) surrounding the pfcrt (MALǄPƾ.ƿǄ) lo-
cus was ampliėed using the polymerase chain reaction using oligonucleotide
primer sequences (CCĈGTCGACCĈAACAGATG, CTAĈCCACCTAC-
CAATATAAAAC) and the resulting DNA sample was sequenced using stan-
dard methods. In a similar manner the genomic region (Ǆǂǁǆǅǁ-Ǆǂǂǂǅǁ)
surrounding the dhě locus (PFDƽǅǀƽw) (oligonucleotide primer sequences:
CAAGAĈGATACATAAAGATAATAT, ĈCĈGATAAACAACGGAAC-
CTCCT); and the pfmdrȊ locus (PFEƾƾǂƽw) (oligonucleotide primer se-
quences: TGĈGAAAGATGGGTAAAGAGCAGAAAGAG, TACĈTCT-
TAĈACATATGACACCACAAACA) were utilized [ǁǆ].
C.ƿ.ǀ SNPDĽňķŃŋĹŇŏ
ĉe SNP discovery methodology was similar to those described in Volkman et al.
[ƾǄǁ]. ƾ ABI shotgun sequence was obtained for nine geographically diverse
parasite isolates that were previously sequenced to ƽ:ƿǂ coverage, bringing to-
tal coverage to ƾ:ƿǂ per isolate. ĉese nine isolates include: ǄGǅ, Santa Lucia
(El Salvador), Vƾ/S, Dƾƽ, FCC-ƿ/Hainan, Dǃ, RO-ǀǀ, Senegal Vǀǁ.ƽǁ and Kƾ.
ĉree of the twelve previously sequenced isolates in Volkman et al. were excluded
from additional sequencing, as theywere previously found to be nearly genetically
identical, suggesting possible contamination in culture [ƾǄǁ]. Reads endswith low
quality (PHRED< ƾƽ) bases were trimmed. Reads less than ƾƽƽ bases, contain-
ing greater than ǀ% internal N’s, or containing a mononucleotide repeat covering
greater than ǅƽ% of the readwere discarded. Reads were aligned to the PlasmoDB
version ǂ of the ǀDǄ genome using BLATǀǄ [ǅƾ] requiring ǆǂ% identity, a min-
imum score of ƾƽƽ, less than ƿƽ% gaps, and coverage of at least half of the read.
Only the highest scoring alignment for each read was kept and paired reads which
aligned more than ƾƽkb apart or in the wrong orientation were discarded. ĉe
Neighborhood Quality Standard (NQS) algorithm was used to distinguish real
polymorphisms from sequence errors [ǁ]. We required the SNP to have a mini-
mumquality score of ƿǂ, and the ėve base neighborhood to have aminimum score
ǆƿ
of ƿƽ. We allowedonemismatch andno indels in the neighborhood. Wediscarded
SNPs when another read from the same sample met the NQS criteria at that posi-
tion but did not have a sequence diﬀerence.
C.ƿ.ǁ AŇŇĵŏ DĹŋĹŀŃńŁĹłŉ ĵłĸ AňňĹňňŁĹłŉ
Based on all ƾƾƾ,ǂǀǃ discovered SNPs [Ǆǁ, ƾƽǃ, ƾǄǁ] in P. falciparum, and given
design parameters and unique sequence constraints, we were able to design as-
says for Ǆǁ,ǃǂǃ markers. Each of Ǆǁ,ǃǂǃ SNPs is represented by a probe set of ƾƿ
to ǅǁ probes, for a total of ǁ.ǁ million genotyping probes on the Aﬀymetrix ǁǆ-
format array. ĉese were hybridized to ǃǀ unique samples (totaling ǅƾ arrays with
replicates). Genotype calls were produced using the BRLMM-P algorithm [ƾ], a
variant of the RLMM algorithm [ƾǁǀ], included in Aﬀymetrix Power Tools ver-
sion ƾ.ǅ.ǂ, and clustered over all ǅƾ arrays. BRLMM-P was forced into a haploid
calling mode by seĨing assigning all SNPs to the “Y chromosome” and seĨing all
arrays to “male”.
ĉe array with sample TMǆǀCƾƽǅǅ is eliminated immediately aěer clustering
(arbitrarily, since the chip claiming to be TMǆƽCǃA and the chip claiming to
be TMǆǀCƾƽǅǅ are identical). We also remove samples CFƽǁ.ƽƾƽ and Senegal
ĉƾƽ.ƽǁ, which were suspected to be multi-clonal based upon molecular barcode
analysis [ǀǆ]. A halofuginone-resistant version of Ddƿ, a human-DNA sample,
and the P. reichenowi ancestral samples are also removed at this stage, leaving ǂǄ
unique samples (totaling Ǆǂ arrays with replicates) for analysis. We then calcu-
late a call rate for each SNP and remove Ǆ,ǄǄǅ SNPs that have below an ǅƽ% call
rate, leaving ǃǃ,ǅǄǅ SNPs. Since technical replicates showed ǆǆ.ǆ% repeatability
between chips, we merged replicate data for each of the ǂǄ samples, producing a
no-call when the replicates indicated discordant genotypes.
Concordance against sequencing data was calculated in both major and mi-
nor alleles for ƾǄ sequenced reference strains [ƾƾǀ]. ĉe following ƾǄ samples
were compared against sequencing data for concordance: ǀDǄ, Ddƿ, FCC-ƿ,
Malayan Camp, Dƾƽ, Kƾ, Vƾ/S, ROǀǀ, Dǃ, Senegal Pǀƾ.ƽƾ, Senegal Pǂƾ.ƽƿ, Sene-
gal Vǀǁ.ƽǁ, Senegal Vǀǂ.ƽǁ, ǄGǅ, Aǁ (subclone of ITƽǁ [ƾǁǄ]), Santa Lucia,
ǆǀ
and HBǀ. ĉese are the ƾǅ parasites presented in Fig ƾ of Volkman et al. [ƾǄǁ],
removing the three found to be genetically identical, and adding the two strains
ǀDǄ and Aǁ. A total of ƾǅ,ǀƽǀ SNPs lacked call overlap between array geno-
types and sequencing genotypes in minor alleles and were thus removed, since
concordance in both alleles could not be fully calculated. Another ǀƽ,ǆǆǀ SNPs
were removed due to imperfect concordance, and of these discordant SNPs, most
(ƿǅ,Ǆǅǆ) exhibited monomorphic behavior on the array, suggesting that much of
the discordance may be aĨributed to either a faulty assay or false discovery. ĉe
remaining ƾǄ,ǂǅƿ perfectly concordant SNPs constituted the high conėdence set
of assays used in our analyses.
C.ƿ.ǂ CŃńŏ NŊŁĶĹŇ VĵŇĽĵŉĽŃł (CNV) AłĵŀŏňĽň
We examined the ability to detect copy number variants (CNV) using the array
by ėrst studying a knownCNVusing the hybridization intensity signal of the SNP
genotyping probes on the array. Kidgell et al. [ǅǀ] reported that the pfmdrȊ locus
was present in ǀ-ǁ copies in the Ddƿ strain relative to a collection of other strains.
We compared Z-scores of the normalized hybridization intensity of perfect match
probes for SNPs in the neighborhood of pfmdrȊ for Ddƿ and six parasites esti-
mated by Kidgell et al. to contain only ƾ copy of the locus (ǀDǄ, ǄGǅ, HBǀ, Dƾƽ,
Dǃ, Kƾ). For each SNP assay we utilized the average hybridization intensity of all
perfect-match probes. Hybridization intensity values were background corrected
and normalized to reduce inter-array variation artifacts. SNPswith a hybridization
intensity standard deviation equal to or greater than half the magnitude of the av-
erage hybridization intensity across all arrays were excluded from analysis. Figure
C.ƾƾ illustrates that probes for many of the SNPs assayed within the pfmdrȊ locus
exhibit notably higher hybridization intensity values in Ddƿ relative to the other
parasites, with ƾǀ assays exhibiting average intensities greater than ƿ standard de-
viations higher than observed in the other parasites.
ǆǁ
C.ƿ.ǃ GĹłŃŁĹ-ŌĽĸĹ AňňŃķĽĵŉĽŃł SŉŊĸŏ (GWAS)
We performed GWAS for drug resistance to thirteen antimalarials: amodiaquine
(ADQ), artemether (ARTM), artesunate (ARTN), artemisinin (ARTS), ato-
vaquone (ATV), chloroquine (CQ), dihydroartemisinin (DHA), halofuginone
(HFG), halofantrine (HFN), lumefantrine (LUM), meĚoquine (MFQ), pipera-
quine (PIP) and quinine (QN). ǂƽ out of ǂǆ samples had drug phenotype data.
ICǂƽ data are shown in Table C.ǁ and Figure C.ƾǀ for these ǂƽ parasites against the
ƾǀ drugs.
ĉe following drugs were obtained from Sigma Aldrich: artemisinin, dihydro-
artemisinin, chloroquine, meĚoquine, and quinine. ĉe following were obtained
from AK Scientiėc: artemether, artesunate, halofantrine, lumefantrine, and pi-
peraquine. ĉe followingwere obtained fromUSP: amodiaquine and atovaquone.
Each drug was tested in triplicate for each parasite. Additionally, some parasites
were tested withmultiple biological replicates: ǀDǄ (nine biological replicates per
drug, each in triplicate), Ddƿ (three replicates) and RO-ǀǀ, Dƾƽ, and ƿƽǄ-ǅǆ (two
replicates).
SNPs were ėltered down to a set that contained at least ǂ strains with a mi-
nor allele as well as an ǅƽ% call rate under every phenotype condition. ĉe ėnal
data set includes Ǆ,ǁǀǄ SNPs. ĉis gives us a genome-wide signiėcance threshold
of logƾƽ(P-value) > ǂ:ƾǄ by Bonferroni correction for multiple testing. For bi-
nary phenotype tests (Fisher’s exact test, Fisher’s permuted, CMH, andHLR), we
used ICǂƽ cutoﬀs shown in Table C.ǁ. For tests requiring deėned geographic clus-
ters (CMH,HLR, Fisher’s permuted), the three population clusters are deėned by
PCA, as in the LRH analysis, and the assignments are shown in Table C.ƾ.
Pointwise P-values were computed using PLINK [ƾǁƿ]. Quantile-quantile
plots (qq-plots) were used to examine the resulting P-value distributions for
inĚating eﬀects due to population structure (Figure C.Ǆ). Because most of the
genome is assumed to ėt the null hypothesis (most of the genome should not be
in association with the phenotype), signiėcant, early deviations from this expec-
tation may result in a high false positive rate. ĉe null expectation is ploĨed as the
unity diagonal line in Figure C.Ǆ. Bonferroni signiėcance is ploĨed as the dashed
ǆǂ
line and Benjamini-Hochberg signiėcance is marked with the doĨed line. Since
most Fisher’s results show evidence of inĚation, we do not report these results in
Figure ƿ.ƿ or Table ƿ.ƾ.
Permutations of Fisher’s exact test can be used to compute empirical pointwise
P-values based on a simulated null distribution. We used PLINK to perform this
permutation while respecting the phenotype frequencies present in our three pre-
deėned population clusters. ĉe resulting P-value distributions (Figure C.Ǆ) do
not show inĚation due to population structure, however no signiėcant hits were
found for any drug.
Similarly, the Cochran-Mantel-Haenszel (CMH) test can perform population-
stratiėed analyses for association. We used PLINK to compute P-values (Figure
C.Ǆ), and again, we see appropriate corrections for population structure, but no
hits reach genome-wide (Bonferroni) signiėcance.
ĉeEﬃcientMixed-ModelAssociation (EMMA) testwas speciėcally designed
to handle quantitative trait associations to a data set with complex population
structure using a linear mixed model [Ǆǆ]. It calculates a genotype similarity ma-
trix instead of discrete categories anddoes not require a priori speciėcation of pop-
ulation structure. ĉe resulting P-value distributions demonstrate liĨle remaining
eﬀect frompopulation structure (FigureC.ǅ)while retaining power to ėnd a num-
ber of associations at genome-wide signiėcance (Figure C.ǅ, ƿ.ƿA, Table ƿ.ƾ).
ĉe Haplotype Likelihood Ratio (HLR) test is a multi-marker association test
[ǆƽ]. Unlike a standard, χƿ-basedmulti-marker test which looks for diﬀerences in
haplotype frequencies in cases vs. controls, the HLR test speciėcally models the
likelihood that a single haplotype rose to dominance in caseswhile all other haplo-
types proportionally decreased. It produces a LOD score, which is the maximum
likelihood estimate for the haplotype frequencies observed in cases (Oƾ : : :Ok),
given the distribution in controls (fƾ : : : fk):
LODML = logƾƽ
P
 
Oƾ : : :Okjαej + (ƾ  α)(fƾ : : : fk)

P (Oƾ : : :Okjfƾ : : : fk)
where j is the haplotypeonwhich themutation arose, ƾ α is the recombination
ǆǃ
rate, and ej = ƾ when i = j and ej = ƽ when i 6= j. ĉe test produces maximum
likelihood estimates for j and α.
So while a χƿ-based association ėnds any signiėcant diﬀerences in haplotype
frequencies, theHLR testmodels a speciėc scenario that is common in rapid selec-
tive events. ĉeHLR test does not provide signiėcantly more power than a single
marker test in regions of high LDãin extreme cases, these regions may only have
two haplotypes, and a multi-marker test will have the same power as a bi-allelic
SNP test. But in regions where LD is low in controls and a single, long haplotype
is prevalent in cases, the HLR test is highly sensitive. ĉe HLR test is a one-sided
test and we ran separate tests for both drug resistance (called “risk”) and drug sen-
sitivity (“protect”). Results for drug sensitivity are available in Figure C.ƾƽ, but
are not reported generally as we are more interested in selective events for drug
resistance.
We used PLINK to produce sliding window haplotypes across the genome and
calculate haplotype frequencies for input to the HLR test. We produced input
for all two, four and six-marker windows. ĉe resulting LOD scores did not map
well to known distributions, such as the χƿ ƾ-degree of freedom distribution. We
instead converted the pointwise LOD scores to empirical pointwise P-values by
performing approximately ǀǄƽ,ƽƽƽ permutations of the null model for each test
condition. ĉis allows us to calculate empirical P-values up to a signiėcance of
about logƾƽ(P-value) = ǂ:ǃ. Similar to the permuted Fisher’s test, we preserved
population-speciėc phenotype frequencies by only allowing permutations within
each of our three deėned populations. Resulting P-value distributions ėt expecta-
tions well for the vast majority of test conditions (Figures C.ǆ, C.ƾƽ) and the test
demonstrates power to detect a number of loci at genome-wide signiėcance (Fig-
ure ƿ.ƿA, Table ƿ.ƾ).
ǆǄ
C.ǀ SŊńńŀĹŁĹłŉĵŀDĵŉĵ FĽŀĹň
ƾ. Drug data, PFȊȉ_ȉȌȎȎ copy number data, and top GWAS and LRH hits.
Permanent URL (XLS, ǃƽkB):
doi://10.1371/journal.pgen.1001383.s001
ƿ. Genotype data. Tab separated text ėle containing genotype data for ǂǄ iso-
lates across ƾǄ,ǂǅƿ SNPs. Additional information such as translation conse-
quences (based on PlasmoDB vǂ.ƽ annotations) are also provided. Perma-
nent URL (TXT, ǀ.ǀMB):
doi://10.1371/journal.pgen.1001383.s002
ǆǅ
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Figure C.1: Principal components analysis of population structure within (A) Africa, (B)
the Americas, and (C) Asia. Plots of the ﬁrst two principal components using Eigenstrat
[130] using the Affymetrix array. Each solid circle represents an individual, and the color is
assigned according to the reported origin.
ǆǆ
	  
Figure C.2: Linkage disequilibrium (LD), measured by rƿ, for each of the three population
samples (Senegal, Thailand, Brazil). Plotted are rƿ for linked markers (red lines) and for
unlinked markers (blue lines), as well as the level of background LD expected because of
small sample size (green lines).
ƾƽƽ
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Figure C.3: Genes were classiﬁed by gene ontology (GO) functional categories and strati-
ﬁed by level of nucleotide diversity (π) as estimated byZ-scores. Select categories (highest
ﬁve and lowest ﬁve categories along with categories in between that differ by incremental
Z-scores) are shown. The majority of genes in GO categories for molecules found at the
cell membrane have high levels of nucleotide diversity, while most of the genes classiﬁed
into GO categories for conserved molecules lack nucleotide diversity.
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Figure C.4: SNP diversity and divergence by translation consequence. Diversity at as-
sayed SNPs (SNP π) and Divergence between different populations as assayed by FST,
for different classes of SNPs: intergenic (4,263 SNPs), intronic (584 SNPs), synonymous
(3,957 SNPs), and nonsynonymous (8,778 SNPs). Intronic SNPs have the widest error bars
due to their relative sparseness on the array. Non-synonymous SNPs are generally among
the least diverse and most differentiated class of SNPs.
ƾƽƿ
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Figure C.5: Relative extended haplotype homozygosity (REHH) scores. Relative extended
haplotype homozygosity (REHH) scores prior to any normalization, plotted for each core
allele, (A) indexed by chromosome and position, and colored by chromosome, and (B) as
a function of core allele frequency.
Figure C.6: Long-range haplotype (LRH) analysis yields genome-wide signiﬁcant candi-
dates for recent positive selection. For each core allele, we calculated relative extended
haplotype homozygosity (REHH), and from the set of all REHH scores we calculated a cor-
responding distribution of Q-values. We plotted   logƾƽ(Q), for all Q-values < ƾ, for
each core allele, indexed by chromosome and position, and colored by chromosome. The
red dotted line corresponds to the typicalQ-value signiﬁcance threshold of 0.05. Gene an-
notations from http://plasmodb.org for some signiﬁcant scores are labeled. For com-
parison, the well-known sweeps around drug resistance loci pfcrt and dhfr are labeled. This
data is also shown in tabular form in Table C.3.
ƾƽǀ
Figure C.7: GWAS P-value distributions for Fisher’s exact test, permuted Fisher’s exact
test, and Cochran-Mantel-Haenszel (CMH) tests. Quantile-quantile plots (qq-plots) show
log P-values for every SNP on the y axis against the null expectation on the x axis. Fisher’s
exact test results generally show P-value inﬂation due to confounding effects from popu-
lation structure for many drugs (“Fish”). As such, no results from this test are reported. To
account for population structure, permutations of the null distribution were performed while
preserving phenotypic associations to three predeﬁned population clusters (“Fishp”). CMH
also performs a stratiﬁed association test given predeﬁned population clusters (“CMH”).
The permuted Fisher’s test and CMH test results show appropriate correction for popula-
tion structure, but show no hits at genome-wide signiﬁcance to report.
ƾƽǁ
Figure C.8: GWAS results for the Efﬁcient Mixed-Model Association (EMMA) test. QQ-plots
show little to no confounding effect from population structure, with the possible exception
of artesunate (ARTN). The signiﬁcant ARTN result is not reported in Table 2.1 or Figure 2.2 for
this reason. Manhattan plots depict the genomic location of signiﬁcant hits, also reported
in Table 2.1 and Figure 2.2.
ƾƽǂ
Figure C.9: GWAS P-value distributions for the Haplotype Likelihood Ratio (HLR) tests for
association to drug resistance. Population-sensitive permutations of the null model were
used to calculate P-values from LOD scores. Final distributions of P-values show little to
no confounding effect from population structure for most tests. Exceptions include the 6-
SNP artemether (HLR_risk_6_ARTM) test and the 4-SNP amodiaquine (HLR_risk_4_ADQ)
test—these results are not reported in Table 2.1 or Figure 2.2. Manhattan plots for other
tests that reached genome-wide signiﬁcance are in Figure 2.2A.
ƾƽǃ
Figure C.10: GWAS P-value distributions for Haplotype Likelihood Ratio (HLR) tests for
association to drug sensitivity. Population-sensitive permutations of the null model were
used to calculate P-values from LOD scores. Final distributions of P-values show little to
no confounding effect from population structure. Genome-wide signiﬁcant hits include pi-
peraquine (HLR_protect_4_PIP) on a haplotype that spans PF07_0126, PF07_0127 and
MAL7P1_167 and amodiaquine (HLR_protect_4_ADQ) on a haplotype in PFL1800w. A
chloroquine hit on pfcrt just misses genome-wide signiﬁcance. These results are not re-
ported in Table 2.1.
ƾƽǄ
!Figure C.11: Intensity Z-score for the Affymetrix array across chromosome 5. The results
illustrate that probes for many of the SNPs assayed within the pfmdr1 (888-988k) locus
exhibit notably higher hybridization intensity values in Dd2 relative to the other parasites,
with 13 assays exhibiting average intensities greater than 2 standard deviations higher than
observed in other strains. This is consistent with the copy number variation reported in
the pfmdr1 locus, with 3-4 copies present in the Dd2 strain relative to a collection of other
strains.
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Figure C.12: PF10_0355 copy number variation measured by Southern blotting. Select
parasite isolates were digested with AﬂIII, EcoRV and XbaI and fragments were detected
using probes to portions of the PF10_0355 and dhps genes. Primers used for making
probes were: dhps F: 5’-GTGATTGTG TGGATCAGAAGA TGAATA ATC-3’; R: 5’-GGA TTA
GGTATAACAAAAGGACCAGAGG-3’; PF10_0355 F: 5’-GGGGAAAGCATA TAA TAA TAC
TAT AGA TGC-3’; R: 5’-CTT GGA GGA ACA AGA ACC CCC TTA TTA TCA-3’; Radioactivity
was measured using a phosphorimager plate and quantiﬁed using Quantity One software
(version 4.6.5). Halofantrine (HFN) response is listed as sensitive (S) or resistant (R) for each
strain.
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Figure C.13: Drug resistance phenotype classiﬁcation for sweep and GWAS analyses.
ICǂƽ data were collected for thirteen antimalarial drugs against all genotyped parasite lines.
Quantitative ICǂƽs were converted into binary “sensitive” and “resistant” phenotypes at the
cutoffs shown (see also Table C.4). These binary phenotypes were only used for the Hap-
lotype Likelihood Ratio (HLR) test. Drug abbreviations: amodiaquine (ADQ), artemether
(ARTM), artesunate (ARTN), artemisinin (ARTS), atovaquone (ATV), chloroquine (CQ), di-
hydroartemisinin (DHA), halofugi- none (HFG), halofantrine (HFN), lumefantrine (LUM), mef-
loquine (MFQ), piperaquine (PIP) and quinine (QN).
ƾƾƽ
C.ǂ SŊńńŀĹŁĹłŉĵŀ TĵĶŀĹň
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Table C.1: 63 parasites used in the studywith the name (parasite), geographic origin (region,
country), source, and molecular barcode [39], as well as which samples were included in
SNP discovery (SEQ), population characterization (POP), long-range haplotype (LRH), and
GWAS analyses. For GWAS, * indicates that the sample was used, but not included in any
population cluster for stratiﬁed or permuted analyses. The human control sample and the
ancestral P. reichenowi sample were not used in any analyses reported here.
Sample Information Used in Analysis 
Parasite Region Country Source Barcode SEQ POP  LRH GWAS 
51 America Brazil Alejandro Miguel Katzin CATTGCAGACTXCACCTTAGATTG  x   x 
608 America Brazil Alejandro Miguel Katzin TACCCGGGATTACAAACTAGACTT  x   x 
10_54 America Brazil Alejandro Miguel Katzin CACTGCAGACTXTACACTAACCTG  x   x 
36_89 America Brazil Alejandro Miguel Katzin TACTGCAGATCGCCCCTACGCCTG  x   x 
365_89 America Brazil Alejandro Miguel Katzin TGCTCCGGATTACAAACAAGACTT  x     
3D7 Europe Netherlands MRA-151 TACTCCGGTCCGCACCCACGATGG  x x * 
7G8 America Brazil MRA-152 TACCCCAGACTXTCAATTAACCTG x x   x 
9_411 America Brazil Alejandro Miguel Katzin CACTCCAGACTGCAACTACGACTG  x   x 
A4 America Brazil J. Smith TATTCCGGTTCATACCCXAGATTG  x x   
APO41 Africa Nigeria Christian Happi CATTGGGGTCTACACCCAAGACTG  x x   
CF04.008_12G Africa Malawi Dan Milner TACCCGGGACCGCCCACAAGATTG  x   x 
CF04.008_1F Africa Malawi Dan Milner TATTCGGAACCGCACCCTAAATTG  x x x 
CF04.009 Africa Malawi Dan Milner TATTCCGAACCGTACCCTCGATTG  x x x 
D10 Asia PNG MRA-201 CACTCCAGATTGCAACTTAGCTTG x x x x 
D6 Africa Sierra Leone MRA-285 TACTGGAAACTGCAACCAAACTTG x x x x 
Dd2 Asia Indochina/Laos MRA-156 CATCGCAATTCGCCCCTTAGACTG  x x x 
FCC2 Asia China MRA-733 TACCCCAAATCGCACATTAACCTG x x x x 
GH2 Asia Thailand S. Thaitong/D. Kyle CACTGCGGTTTATCAATTAGCCTG  x x x 
HB3 America Honduras MRA-155 TACTCCAGACTACACACTCACTTG  x   * 
IGHCR14 Asia India Aditya Dash/Chetan Chitnis TACCCCAGACCXCACACTAGACGG  x   * 
Indochina_I Asia Indochina/Laos MRA-347 TACTCGAGTCTACAACCACGATTG  x x x 
JST America Brazil Sandra do Lago Moraes CACCGCGGTTTATAAACAAGATTG  x   x 
K1 Asia Thailand MRA-159 TATTCGGATTTGTCCCTACGCCTG x x x x 
M24 Africa Kenya X. Su CATTGCGGTTTACCCATAAGCCTG  x x x 
Malayan Camp Asia Malaysia MRA-330 TATTCCGGATTGTCACTTAGACTG  x x * 
Muz51.1 Asia PNG Karen Day TACTCCAGATTATCACCTAGCCTG  x x x 
PR145 Asia Thailand S. Thaitong/D. Kyle CACTCCAGATCACAACCAAAACTG  x x x 
PS189 Africa Mali C. Plowe/Djimde CACTCCGGATTACAAACAAGCTTT  x x   
RAJ116 Asia India Aditya Dash/Chetan Chitnis CACTCCGAACTGCAACCACAACGG  x   * 
RO33 Africa Ghana MRA-200 CACCCGGGATCGCAAACTAAACTT x x x x 
Santa Lucia America El Salvador MRA-362 CACCCGGGATTACAAACAAACCTT x x   * 
SenP05.02 Africa Senegal S. Mboup CACCCGGGATTACAAACAAGCTTT  x x x 
SenP08.04 Africa Senegal S. Mboup TACCCCGGATCGCAAACAAACTTT  x x x 
SenP09.04 Africa Senegal S. Mboup CACTCGGGTTTATACATXCAACGT  x x x 
SenP11.02 Africa Senegal S. Mboup CGCTCGAGATTACAAACTAGACTT  x x x 
SenP19.04 Africa Senegal S. Mboup TGTTCCGGTCTACAAATTAACCGT  x x x 
SenP26.04 Africa Senegal S. Mboup TATCCGAATTTATCAATACAACGT  x x x 
SenP27.02 Africa Senegal S. Mboup TACTCCGGTTTATACACTCAACGT  x x x 
SenP31.01 Africa Senegal S. Mboup TACTGCGGTCCGCAAACAAGATTG  x x x 
SenP51.02 Africa Senegal S. Mboup TATCCGGGACTGCAACTTCGACGG  x x x 
SenP60.02 Africa Senegal S. Mboup TACTCGAAACCGCAAACTAACCTT  x x x 
SenT15.04 Africa Senegal S. Mboup TGCTCCAAATCGTACCCAAGCTGT  x x x 
SenT26.04 Africa Senegal S. Mboup CGCTCGGATTTATCCCTACGCCGT  x x x 
SenT28.04 Africa Senegal S. Mboup CACCCCAGTTTATCAACAAACTGT  x x x 
SenV34.04 Africa Senegal S. Mboup TXCTCCAGATTATACCTAAACCTG x x x x 
SenV35.04 Africa Senegal S. Mboup CGCTCGAGTCCGTCCACACACTGT  x x x 
SenV42.05 Africa Senegal S. Mboup TGTTCCGATCTATCCACAAGACXT  x x x 
T2_C6 Asia Thailand MRA-818 TACTCCGGATTATACACTAAACGT  x x   
TD203 Asia Thailand S. Thaithong/D. Kyle CGCCCCAGATCATAAATTAAACGT  x x x 
TD257 Asia Thailand S. Thaithong/D. Kyle TACTCGGGATCGTAACCACACTGT  x x x 
TM327 Asia Thailand S. Thaithong/D. Kyle TGTCCGAATCTATAAACACAACGT  x x x 
TM345 Asia Thailand S. Thaithong/D. Kyle CACCCCAGTCTATCACTACACCGT  x x   
TM90C2A Asia Thailand MRA-202 TATTCCGATTTATCAACTCACCGT  x x x 
TM90C6A Asia Thailand MRA-205 CACCCCAGTCTATCACTACACCGT  x x   
TM91C235 Asia Thailand MRA-206 CGCTCCGGACTGCACCCAAGATTG  x x x 
V1/S Asia Vietnam MRA-176 TGCCCCAGATCACAACTAAGATTT x x x X 
WR87 Asia Vietnam MRA-284 TACTGGAAATCACAACTAAGACTT  x x X 
CF04.010 Africa Malawi Dan Milner mixed     
Dd2_HFG_280 Asia Indochina/Laos       
Human Control           
Preichenowi     John Barnwell      
SenT10.04 Africa Senegal S. Mboup NACTNGGGACTATAACCAAACCTG     
TM93C1088 Asia Thailand MRA-207 CACCCCAGTCTATCACTACACCGT     
ƾƾƿ
Table C.2: Analysis of the ability of SNPs on the array to act as a proxy for another. This
ability is measured using the standard correlation metric rƿ. In our data set, 28% of SNPs
in the Brazilian sample (which has the most LD) had a nearby SNP on the array in strong
LD (rƿ > ƽ:ǂ) with it, while in the Senegal sample the proportion was only 16%. Most of
the time, therefore, we will only be able to detect association with markers that have been
directly typed. The exception is strong selective sweeps, which affect many markers within
a region.
Fraction of SNPs rƿ > ƽ:ǀ rƿ > ƽ:ǂ rƿ > ƽ:ǅ
Senegal ƿǃ% ƾǃ% ƾƽ%
ĉailand ǀǁ% ƿǁ% ƾǅ%
Brazil ǀǀ% ƿǅ% ƿǁ%
ƾƾǀ
Table C.3: Long Range Haplotype (LRH) hits. All REHH hits with Q-value< ƽ:ƿǂ.
chr pos core hap len qvalue gene description chr pos core hap len qvalue gene description
2 608790 G 14428 0.2071 PFB0675w hypothetical 7 476305 C 47128 0.0443 PF07_0037 Cg2 protein
2 617743 T 16930 0.2133 PFB0685c acyl-CoA synthetase, PfACS9 7 476305 C 26619 0.0443 PF07_0037 Cg2 protein
2 623146 C 22333 0.0323 PFB0687c RING zinc finger protein 7 482133 T 10978 0.0133 PF07_0038 Cg7 protein
3 466483 A 35321 0.0568 PFC0460w hypothetical 7 482133 T 20791 0.0085 PF07_0038 Cg7 protein
3 466610 A 35448 0.0133 PFC0460w hypothetical 7 485744 G 14589 0.0133 MAL7P1_28 ribonucleases p/mrp protein subunit
4 755220 T 15162 0.1236 PFD0830w dhfr 7 485744 G 17180 0.0085 MAL7P1_28 ribonucleases p/mrp protein subunit
4 755243 C 15139 0.2133 PFD0830w dhfr 7 488164 A 15424 0.0777 MAL7P1_28 ribonucleases p/mrp protein subunit
4 764100 G 50270 0.1528 PFD0840w hypothetical 7 488164 A 14760 0.0535 MAL7P1_28 ribonucleases p/mrp protein subunit
5 1042120 A 18768 0.0075 PFE1250w acetyl-CoA synthetase, PfACS10 7 490748 C 18008 0.0323 PF07_0040 lysophospholipase-like protein
5 1042527 A 18361 0.0085 PFE1250w acetyl-CoA synthetase, PfACS10 7 490748 C 14664 0.0244 PF07_0040 lysophospholipase-like protein
5 1056621 T 14545 0.0591 7 490877 T 18137 0.0323 PF07_0040 lysophospholipase-like protein
5 1159412 C 12844 0.0085 PFE1400c beta adaptin protein 7 490877 T 14535 0.0133 PF07_0040 lysophospholipase-like protein
5 1159501 T 12755 0.0085 PFE1400c beta adaptin protein 7 494285 A 21431 0.0551 MAL7P1_29 hypothetical
5 1333609 G 5132 0.2341 PFE1640w PfEMP1, truncated 7 505396 G 17088 0.2133 MAL7P1_30 hypothetical
5 1333639 G 5102 0.2341 PFE1640w PfEMP1, truncated 7 505412 G 17104 0.2133 MAL7P1_30 hypothetical
5 1333690 T 5051 0.0664 PFE1640w PfEMP1, truncated 7 936167 A 15183 0.043 MAL7P1_105 hypothetical
5 1333703 A 5038 0.2341 PFE1640w PfEMP1, truncated 7 940007 G 11940 0.2133 PF07_0085 ferrodoxin reductase-like protein
5 1333716 G 5025 0.2341 PFE1640w PfEMP1, truncated 7 940111 T 12044 0.2133 PF07_0085 ferrodoxin reductase-like protein
5 1333729 T 5012 0.2341 PFE1640w PfEMP1, truncated 7 940147 A 12080 0.2133 PF07_0085 ferrodoxin reductase-like protein
5 1333741 G 5000 0.2341 PFE1640w PfEMP1, truncated 8 336524 T 6205 0.193 MAL8P1_135 hypothetical membrane protein
5 1333790 A 4951 0.2341 PFE1640w PfEMP1, truncated 8 452794 A 778 0.1492 PF08_0105 rifin
6 741192 A 55183 0.2335 8 862485 A 33846 0.1239 PF08_0054 heat shock 70 kDa protein
6 741293 C 55082 0.2133 PFF0855c rifin 8 866334 C 29997 0.0443 MAL8P1_64 hypothetical
6 741366 A 55009 0.2133 PFF0855c rifin 8 1104023 T 8994 0.0591
6 1025852 A 17872 0.2133 PFF1220w hypothetical 8 1114567 A 8029 0.0873 MAL8P1_23 ubiquitin-protein ligase 1
6 1065237 G 33215 0.1492 PFF1280w hypothetical 8 1117372 G 10834 0.0905 MAL8P1_23 ubiquitin-protein ligase 1
6 1098314 C 26112 0.0905 PFF1325c c3h4-type ring finger protein 8 1118090 T 11552 0.0622 MAL8P1_23 ubiquitin-protein ligase 1
6 1114565 C 25158 0.0905 PFF1350c acetyl-coenzyme a synthetase 8 1118190 T 11652 0.0091 MAL8P1_23 ubiquitin-protein ligase 1
6 1114929 G 23554 0.0323 PFF1350c acetyl-coenzyme a synthetase 9 272201 C 12632 0.1259 PFI0265c RhopH3
6 1115373 A 23998 0.0323 PFF1350c acetyl-coenzyme a synthetase 9 282410 G 11553 0.0932 PFI0275w hypothetical
6 1115454 C 23938 0.043 PFF1350c acetyl-coenzyme a synthetase 9 284833 T 12260 0.1492 PFI0280c autophagocytosis associated protein
6 1116047 G 24531 0.0244 PFF1350c acetyl-coenzyme a synthetase 9 284842 T 12269 0.1492 PFI0280c autophagocytosis associated protein
6 1116171 G 24655 0.043 PFF1350c acetyl-coenzyme a synthetase 9 284910 G 12337 0.1492 PFI0280c autophagocytosis associated protein
6 1116315 C 24799 0.043 PFF1350c acetyl-coenzyme a synthetase 10 324964 G 45666 0.2335 PF10_0078 histone deacetylase, putative
6 1117520 G 26004 0.043 PFF1350c acetyl-coenzyme a synthetase 12 50106 T 288 0.0873 PFL0030c PfEMP1
6 1124426 C 32910 0.0535 PFF1365c HECT-domain (ubiquitin-transferase) 12 947550 A 63271 0.2335 PFL1130c hypothetical
6 1283916 G 13004 0.1978 12 954384 C 56437 0.225 PFL1130c hypothetical
7 428373 C 39799 0.1269 PF07_0027 DNA-directed RNA polymerase 2 12 990296 T 43303 0.0103 PFL1170w polyadenylate-binding protein
7 449953 C 31672 0.0443 12 1002740 T 55747 0.0568
7 459787 T 21838 0.0276 MAL7P1_27 pfcrt 12 1002741 A 55748 0.0568
7 460216 G 21409 0.0443 MAL7P1_27 pfcrt 14 279667 T 34730 0.0959 PF14_0074 hypothetical
7 461218 T 20407 0.0443 MAL7P1_27 pfcrt 14 960714 G 49486 0.0631 PF14_0228 hypothetical
7 465826 G 39654 0.0953 PF07_0035 cg1 protein 14 1225984 A 8890 0.0443 PF14_0291 hypothetical
7 465826 G 16307 0.158 PF07_0035 cg1 protein 14 1226019 T 8925 0.0443 PF14_0291 hypothetical
7 467846 G 41674 0.013 PF07_0036 Cg6 protein 14 1226103 C 9009 0.1528 PF14_0291 hypothetical
7 467846 G 14287 0.019 PF07_0036 Cg6 protein 14 1226130 C 9036 0.0443 PF14_0291 hypothetical
7 475935 T 46758 0.0664 PF07_0037 Cg2 protein 14 1226242 A 9148 0.0314 PF14_0291 hypothetical
7 475935 T 26989 0.1009 PF07_0037 Cg2 protein 14 1226303 T 9209 0.0248 PF14_0291 hypothetical
7 475948 A 46771 0.0664 PF07_0037 Cg2 protein 14 1608531 A 54272 0.2133 PF14_0374 hypothetical
7 475948 A 26976 0.1009 PF07_0037 Cg2 protein 14 2812662 C 35145 0.1722 PF14_0653 hypothetical
7 476288 G 47111 0.0591 PF07_0037 Cg2 protein 14 2812679 T 35128 0.1722 PF14_0653 hypothetical
7 476305 C 47128 0.0443 PF07_0037 Cg2 protein 14 2838163 G 46456 0.2215 PF14_0660 hypothetical
7 476305 C 26619 0.0443 PF07_0037 Cg2 protein
ƾƾǁ
Table C.4: ICǂƽ drug resistance phenotype data (nM). ND: No data
sample ADQ ARTM ARTN ARTS ATV CQ DHA HFG HFN LUM MFQ PIP QN 
Resistance 
Threshold 20 5 5 10 3 50 2 1.5 5 50 20 30 100 
10_54 16.48 1.551 3.079 2.002 3.335 63.57 0.7305 1.032 1.832 29.22 5.844 30.61 60.14 
36_89 16.63 4.431 4.418 8.947 3.327 79.45 5.916 1.139 1.491 21.22 3.865 30.95 ND 
3D7 6.8168 2.8094 3.6543 8.4817 2.6474 8.8972 2.5971 0.9846 6.6259 86.2639 20.8618 19.0066 24.5422 
51 29.53 3.661 3.688 9.564 4.192 108.2 3.005 ND 2.509 20.59 7.559 41.53 125.9 
608 15.16 3.089 3.07 4.351 6.978 93.25 2.784 1.155 1.198 10.09 5.83 10.47 104.9 
7G8 18.37 1.464 3.1 2.988 4.161 56.18 2.789 0.7968 1.071 31.1 6.053 40.11 38.87 
9_411 ND 1.158 1.66 5.99 ND ND 0.8257 ND 1.525 5.687 0.6979 54.52 ND 
CF04.008_1F ND 3.718 3.035 6.777 0.8209 6.02 2.522 1.094 3.481 36.68 4.939 18.71 82.44 
CF04.009 ND 4.1495 3.771 8.845 ND ND 1.7316 ND 9.792 72.48 10.356 29.865 ND 
D10 15.2461 3.5656 7.2633 8.7383 2.3062 11.6735 4.4617 1.5121 10.5989 92.63 25.4271 38.127 18.1534 
D6 14.92 2.076 3.138 6.612 0.6697 3.611 1.333 0.4141 6.201 29.56 6.216 3.999 4.898 
Dd2 10.0602 3.4412 3.5525 9.2125 1.2793 73.4253 2.3138 0.8717 4.7277 74.7528 14.9576 26.21 78.8966 
FCC2 9.687 3.165 3.202 8.728 1.213 9.47 4.096 1.48 7.74 156.3 35.99 24.36 27.95 
GA3 15.11 3.591 3.203 6.281 2.391 102.1 3.674 1.495 6.49 ND 27.22 43.25 31.96 
GH2 23.3 6.718 5.983 16.78 2.366 98.03 5.694 1.707 16.03 346.7 17.82 48.54 149.1 
HB3 8.703 1.169 3.019 3.117 1.181 9.78 0.9405 1.413 2.764 71.51 11.18 31.22 20.28 
IGHCR14 4.879 0.6559 1.416 1.202 0.4847 4.967 0.382 1.451 1.725 53.57 11.51 9.564 4.99 
Indochina_I 12 20.57 19.6 ND ND 243.1 ND 0.8852 4.0E-04 6.178 3.902 28.99 153 
JST 30.02 2.35 5.658 3.838 2.193 129.1 1.698 1.203 1.296 22.07 6.811 41.34 24.52 
K1 16.07 1.902 3.124 3.176 2.442 86.42 3.509 1.52 1.907 30.84 13.57 35.78 77.81 
M24 7.63 4.6 4.43 5.546 1.524 13.09 2.49 1.158 1.919 59.81 13.48 14.23 55.33 
Malayan_Camp 7.944 2.887 1.811 1.775 1.171 7.279 2.319 1.126 1.283 ND 6.983 31.26 8.196 
Muz51.1 19.64 3.29 3.18 7.449 1.939 60.44 2.271 1.13 1.696 19.5 8.501 28.23 39.73 
PR145 11.11 15.79 13.66 29.7 6.59 51.24 12.02 1.106 16 140.8 53.43 31.58 149.1 
RAJ116 19.23 1.075 1.805 1.367 1.315 68.59 1.035 1.546 0.0049 6.418 4.105 34.31 4.36 
RO33 11.3737 2.6614 6.0825 6.9751 1.8615 11.0702 2.8762 1.6415 3.1416 69.66 8.094 34.0955 13.4901 
Santa_Lucia 20.44 3.629 4.61 8.644 0.3903 11.76 3.567 1.171 0.7153 30.34 5.822 38.02 260.1 
SenP05.02 16.24 5.695 3.178 11.25 2.493 ND 3.518 1.52 0.9853 30.43 6.798 29 ND 
SenP08.04 17.33 4.873 4.15 11.12 1.19 14.85 3.015 0.4386 11.72 62.21 26.03 7.81 44.76 
SenP09.04 4.517 5.332 4.177 15.7 0.7054 8.312 5.092 1.404 9.234 174 25.44 14.78 54.86 
SenP11.02 92.05 12.75 11.15 19.99 1.881 25.83 8.258 0.7377 17.35 88.75 44.76 14.44 94.63 
SenP19.04 7.157 11.66 10.98 24.04 ND 11.4 9.225 1.858 14.71 95.17 50.83 30.21 ND 
SenP26.04 44.23 12.71 3.23 14.82 1.143 40.38 8.889 0.4341 20.6 57.79 84.86 5.288 ND 
SenP27.02 9.269 3.232 3.635 8.222 ND 9.813 2.664 1.258 1.83 31.2 5.972 21.2 ND 
SenP31.01 6.961 1.991 1.999 6.131 0.4997 8.854 2.966 1.214 3.177 78.89 17.03 22.56 ND 
SenP51.02 29.62 5.041 4.748 8.875 0.3225 62.05 3.398 1.627 3.319 48.55 8.601 34.89 50.08 
SenP60.02 15.8 4.084 4.978 9.62 0.9355 99.93 3.854 1.255 1.616 21.99 11.93 21.19 47.78 
SenT15.04 ND 3.595 3.016 6.9315 ND ND 3.3665 ND 5.262 51.32 3.948 49.53 ND 
SenT26.04 16.05 3.149 3.116 4.827 1.19 79.98 2.991 1.43 2.905 30.92 7.877 24.72 121.1 
SenT28.04 11.9 3.744 3.139 7.846 1.1 51.01 2.343 1.461 7.5 62.69 32.64 15.63 139.6 
SenV34.04 21.39 5.1 4.645 6.781 0.5187 ND 3.024 1.627 2.37 30.34 4.018 28.48 ND 
SenV35.04 5.567 3.078 3.68 4.706 0.8165 9.364 5.374 1.359 2.761 45.52 20.6 26.28 ND 
SenV42.05 6.456 1.06 1.565 1.717 0.7363 9.594 1.731 1.016 4.476 13.6 10.04 4.485 ND 
TD203 15.63 8.15 4.736 20.56 8.49 52.86 8.507 1.071 7.938 156.2 30.32 39.2 67.53 
TD257 11.68 11.88 8.532 24.53 2.215 55.41 11.63 1.539 15.96 227.6 50.42 35.53 253.5 
TM327 9.891 6.032 1.7 8.862 1.146 41.12 3.851 2.022 15.49 249.3 41.25 50.89 70.72 
TM90C2A 18.85 16.17 10.31 28.32 3.704 58.94 5.376 1.086 12.51 264.5 28.04 30.04 209.1 
TM91C235 ND 12.43 12.46 17.66 ND ND 7.409 ND 70.65 154.5 57.96 12.69 ND 
V1/S 17.98 1.625 3.459 6.172 4.02 155.5 1.035 1.538 1.739 26.4 12.84 38.58 224.3 
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Table C.5: Parasites used in the GWAS. Parasites used, indicating their nucleotide and
amino acid sequence for various positions (indicated by number) in the dhfr, pfcrt, and
pfmdr1 gene loci.
dhfr pfcrt pfmdr1
Nucleotide 
Sequence at AA 
Position
Amino Acid 
Sequence
Nucleotide Sequence at AA 
Position Amino Acid Sequence
Nucleotide Sequence 
at AA Position
Amino Acid 
Sequence
Parasite
16 51 59 10
8
16
4
50
6
16 51 59 10
8
16
4
50
6
72
-7
6
32
6
35
6
37
1
72 74 75 76 32
6
35
6
37
1
86 18
4
10
34
10
42
12
46 86 18
4
10
34
10
42
12
46
51 C T T A A T A I C N I Y TCTGTAATGAATACA aac Tta aGa S M N T N L R A T Tgt Gat Tat N F C D Y
10_54 C T T A A T A I C N I Y TCTGTAATGAATACA aac Tta aGa S M N T N L R A T Tgt Gat Tat N F C D Y
36_89 C T T A A T A I C N I Y TCTGTAATGAATACA aac Tta aGa S M N T N L R A T Tgt Gat Tat N F C D Y
3D7 C A T G A T A N C S I Y TGTGTAATGAATAAA aac ata aga C M N K N I R A A agt aat gat N Y S N D
7G8 C T T A A T A I C N I Y AGTGTAATGAATACA aac Tta aGa S M N T N L R A T Tgt Gat Tat N F C D Y
9_411 C T T G A T A I C N I Y TCTGTAATGAATACA aac Tta aGa S M N T N L R A T Tgt Gat Tat N F C D Y
A4 C T C A A T A I C T I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T A Agt Aat Gat Y Y S N D
APO41 C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
CF04.008_12G C T T A A T A N R N I Y TGTGTAATTGAAACA aac Ata aTa C M N A N I I T A Agt Aat Gat Y Y S N D
CF04.008_1F C T C A A T A I R N I Y TGTGTAATGAATAAA aac Ata aGa C M N A N I R T A Agt Aat Gat Y Y S N D
CF04.009 C T C A A T A I R N I Y TGTGTAATGAATAAA aac Ata aGa C M N A N I R A T Agt Aat Gat N F S N D
D10 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
D6 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
Dd2 C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N T I T A Agt Aat Gat Y Y S N D
FCC2 C A T A A T A N C N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
GH2 C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A A Agt Aat Gat N Y S N D
HB3 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Gat Gat N F S D D
Indochina_I C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Tgt Gat Tat N F C D Y
JST C T T A A T A N C N I Y TCTGTAATGAATACA aac Tta aGa S M N T N L R A A Tgt Gat Tat N Y C D Y
K1 C A C A A T A N R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T A Agt Aat Gat Y Y S N D
M24 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
Malayan Camp C A T A A T A N C N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N Y S N D
Muz51.1 C A T G A T A N C S I Y AGTGTAATGAATACA aac Tta aGa S M N T N L R T A Agt Aat Gat Y Y S N D
PR145 C T C A T T A I R N I Y GGTGTAATTGAAACA aac Ata aTa G I E T N I I A T Agt Aat Gat N F S N D
PS189 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
RO33 C A C A A T A N R N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R T T Agt Aat Gat Y F S N D
Santa Lucia G A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N T N I R A T Tgt Gat Gat N F C D D
SenP05.02 C T C A A T A N C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T T Agt Aat Gat Y F S N D
SenP08.04 C T C A A T A I R N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
SenP09.04 C T C A A T A I R N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
SenP11.02 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
SenP19.04 C T C A A T A N R N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
SenP26.04 C T C A A T A N R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T T Agt Aat Gat Y F S N D
SenP27.02 C T C A A T A I R N I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R T T Agt Aat Gat Y F S N D
SenP31.01 C A T G A C A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
SenP51.02 C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T T Agt Aat Gat Y F S N D
SenP60.02 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
SenT15.04 C T C A A T A I R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
SenT26.04 C T C A A T A T R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T T Agt Aat Gat Y F S N D
SenT28.04 C T C A A T A R N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
SenV34.04 C A T G A T A N C S I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T T Agt Aat Gat Y F S N D
SenV35.04 C A T G A T A N C S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A T Agt Aat Gat N F S N D
SenV42.05 C T C A A T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A A Agt Aat Gat N Y S N D
T2_C6 C A T G A T A N R S I Y TGTGTAATGAATAAA aac Ata aGa C M N K N I R A A Agt Aat Gat N Y S N D
TD203 C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
TD257 C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
TM327 C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
TM345 C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
TM90C2A C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
TM90C6A C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A A Agt Aat Gat N Y S N D
TM91C235 C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I A T Agt Aat Gat N F S N D
V1/S C T C A T T A I C N I Y TGTGTAATTGAAACA aac Ata aTa C I E T N I I T A Agt Aat Gat Y Y S N D
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Table C.6: PF10_0355 copy number summary for 38 parasites tested by qPCR using the
Delta Delta Ct method. Copy number (CN) was compared to the reference locus PF07_0076
and 3D7 was used as a reference strain. A cut-off of 1.4 was used to deﬁne PF10_0355
copy number greater than 1; parasites with greater than 1 copy of PF10_0355 are shaded.
Parasites are ranked by Halofantrine (HFN) ICǂƽ: HFN-sensitive parasites are indicated by
an S and HFN-resistant parasites are indicated by an R.
Parasite CN HFN 
Indochina_I 0.92 S 
RAJ116 0.92 S 
Santa_Lucia 1.03 S 
SenP05.02 0.98 S 
7G8 0.74 S 
Malayan_Camp 0.94 S 
JST 1.06 S 
36_89 1.07 S 
SenP60.02 1.19 S 
Muz51.1 0.64 S 
IGHCR14 1.63 S 
V1/S 0.89 S 
10_54 0.99 S 
K1 0.87 S 
M24 0.76 S 
SenV34.04 4.92 S 
51 0.77 S 
SenV35.04 0.86 S 
HB3 0.88 S 
RO33 1.26 S 
SenP31.01 0.77 S 
SenP51.02 1.09 S 
CF04.008_1F 0.95 S 
SenV42.05 1.26 S 
Dd2 1.07 S 
SenT15.04 1.71 R 
3D7 1 R 
SenT28.04 0.73 R 
FCC2 0.76 R 
TD203 0.9 R 
D10 1.06 R 
SenP08.04 0.95 R 
TM90C2A 1.43 R 
SenP19.04 1.06 R 
PR145 0.94 R 
GH2 1.71 R 
SenP11.02 7.14 R 
SenP26.04 1.68 R 
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Table C.7: Annotation and GeneID Information for identiﬁed genes in Figure 2.1B.
GeneID  FST Annotation Category Tag 
MAL8P1_23 1.54E-04 0.646 ubiquitin-protein ligase 1, putative enzymes, ACS and 
transporters 
UBQ Ligase 
PF13_0201 6.39E-03 0.216 thrombospondin-related anonymous 
protein, TRAP 
other TRAP 
PFA0650w 4.37E-03 0.323 surface-associated interspersed gene 
pseudogene, (SURFIN) pseudogene 
antigens, var, rifin, 
stevor, surfin 
SURFIN 
PF08_0105 6.10E-03 0.204 rifin antigens, var, rifin, 
stevor, surfin 
Rifin 
PFB0960c 4.31E-03 0.036 P. falciparum Maurer’s Cleft 2 
transmembrane domain protein 2.1, 
PfMC-2TM_2.1 
other Mauer’s Cleft 
MAL7P1_27 6.36E-04 0.387 chloroquine resistance transporter enzymes, ACS and 
transporters 
PFCRT 
PF10_0345 6.52E-03 0.240 merozoite surface protein 3 antigens, var, rifin, 
stevor, surfin 
MSP3 
PFI1475w 1.95E-03 0.221 merozoite surface protein 1, precursor antigens, var, rifin, 
stevor, surfin 
MSP1 
PFB0972w 9.90E-03 0.077 hypothetical protein other * 
PFL0030c 7.95E-03 0.050 erythrocyte membrane protein 1 (PfEMP1) antigens, var, rifin, 
stevor, surfin 
Var2CSA 
PFD0830w 5.96E-04 0.459 bifunctional dihydrofolate reductase-
thymidylate synthase 
enzymes, ACS and 
transporters 
DHFR 
PF11_0344 6.46E-03 0.074 apical membrane antigen 1, AMA1 antigens, var, rifin, 
stevor, surfin 
AMA1 
PF10_0051 5.32E-03 0.215 ADP/ATP carrier protein, putative enzymes, ACS and 
transporters 
ADP/ATP Carrier 
PFB0685c 5.75E-04 0.497 acyl-CoA synthetase, PfACS9 enzymes, ACS and 
transporters 
ACS9 
PFF1350c 2.00E-03 0.584 acetyl-coenzyme a synthetase enzymes, ACS and 
transporters 
ACS 
PFE1250w 1.66E-03 0.602 acyl-CoA synthetase, PfACS10 enzymes, ACS and 
transporters 
ACS10 
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Figure C.14: SNPs located in genes (28,576) were more likely to pass concordance ﬁltering
than intergenic SNPs (19,999).
	   !
Figure C.15: SNPs that were discovered from only one sequenced strain (35,727 SNPs)
show a higher rate of monomorphism on the array than those with higher minor allele counts
(12,848 SNPs). Any amount of this discordance may be explained by false discovery from
sequencing data.
ƾƾǆ
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Figure C.16: To show the effect of GC composition, we took 16bp of ﬂanking sequence on
each side of the SNP to construct a 3D7-based 33mer and calculated the percent GC. The
window boundaries for the graph below are chosen as the octiles of the GC distribution.
SNP performance appears to worsen at GC levels below 20%, which accounts for roughly
half of the SNPs.
	   !
Figure C.17: The effect of unique sequences in ﬂanking regions. Although the initial design
of the array excluded probes that had exact matches elsewhere in the genome, many of
the remaining SNPs are in neighborhoods that contain 1 or 2 base mismatch similarity to
other parts of the genome. We took 16bp of ﬂanking sequence on each side of the SNP
to construct a 3D7-based 33mer and aligned it to 3D7 using SSAHA (word length 10, step
length 1, max gap 2, max insert 1, min hits 24) [119]. 28,352 SNPs aligned uniquely to
their location of origin. The 20,223 SNPs that aligned in multiple locations showed a much
higher rate of discordance.
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Figure C.18: A histogram of marker spacing. Most markers are spaced closely with a few
large gaps in coverage. The mean spacing of concordant markers is 1316bp with a median
spacing of 444bp.
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Table C.8: Statistics onmarker spacing (gaps) by chromosome. The table gives the number
of gaps, as well as the median, mean gaps, 90% percentile (90% gap), and maximum gap
length (max gap) by chromosome (1 – 14).
number median mean ǆƽ% max sum
of gaps gap gap gap gap of gaps
all ƾǄǂǃǅ ǁǁǁ ƾǀƾǃ ǀǃǀǆ ǀǆǂǀǂ ƿǀƾƾǅƾƽƽ
chr ƾ ǃǁǁ ƾǂƽ ǆǂǄ ƿǆǃǅ ƾǅǄǆǅ ǃƾǃƾƽǁ
chr ƿ ǅǂǂ ǀǁǃ ƾƾƽǀ ǀƽǆƽ ƾǃƿǀǃ ǆǁƿǄǂǁ
chr ǀ ǅƿǂ ǁǅǂ ƾƿǅƿ ǀǀƽƽ ƿǁƽǄǃ ƾƽǂǄǃǁƿ
chr ǁ ƾǁǃƿ ƾǅƿ ǅƾǄ ƿƽǁƿ ǀǆǂǀǂ ƾƾǆǂƾƽǆ
chr ǂ ǆǄǄ ǁǁǄ ƾǀǁǁ ǀǅǃǂ ƾǄǂǅǀ ƾǀƾƿǃǀƽ
chr ǃ ƾƽǅǅ ǁƿƿ ƾƿǆǅ ǀǅƽƾ ƿǁǅǂǃ ƾǁƾƿǃƽǁ
chr Ǆ ƾǂǆǆ ƿƿǂ ǆǀǂ ƿǁǁǃ ƾǆǀǁƾ ƾǁǆǂǀǁǆ
chr ǅ ƾƾƽƽ ǁǂǁ ƾƿǅǁ ǀǀƾǆ ƿǁǀƿƽ ƾǁƾƿƽƽǁ
chr ǆ ƾƽǅǄ ǂǂǄ ƾǁƾǂ ǀǅƿƽ ƿǄǃǃƾ ƾǂǀǅƿƾǃ
chr ƾƽ ƾƾƾǀ ǂǀǀ ƾǂƿƽ ǁƾƿƾ ǀǁƽǆǄ ƾǃǆƾƿǆƽ
chr ƾƾ ƾǀǂǄ ǃǀǃ ƾǁǆǄ ǁƾƾǂ ƿƾǆƿƾ ƿƽǀƾǁǃƽ
chr ƾƿ ƾǃǄǅ ǁǃǀ ƾǀǂƾ ǀǄǀǄ ƾǄƽƾƽ ƿƿǃǃǂǆƽ
chr ƾǀ ƾǅǀƾ ǃǃǆ ƾǂǃƿ ǁǀǀǀ ƾǆǆǃǃ ƿǅǃƽǁǀǃ
chr ƾǁ ƾǆǂƿ Ǆǃǅ ƾǃǅǀ ǁǂƾǃ ƿǀǆǁƿ ǀƿǅǂǆƾƿ
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Figure C.19: Final concordant marker density across all fourteen chromosomes.
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Figure C.20: Distribution of markers per gene: 59% of all P. falciparum genes contain at
least one concordant marker. Below is a plot of the number of markers per gene. Most
genes that have markers have only one or two (median marker count per gene is two).
Mean marker count per gene is 4.1.
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ftp://ftp.broadinstitute.org/pub/malaria/pnas-park-2012-suppfile-1.
zip
ƿ. Consensus sequence calls for each of ǁǂ strains and ƿǀ million bases. VCF
ėle is bgzip compressed and indexed by tabix and vcěools. PermanentURL
(VCF.GZ, ƿGB):
ftp://ftp.broadinstitute.org/pub/malaria/pnas-park-2012-suppfile-2.
vcf.gz
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We identiėed ǀƿ regions under selection using theXP-EHH test and identiėed top
candidate mutations within each region associated with drug resistance using the
EMMA test (Dataset ƾ). Of the ƾǃǀmutations, ǁǅ (ƿǆ%) were intergenic; ǃ (ǁ%)
were intronic; ǀǀ (ƿƽ%) conferred synonymous changes; and Ǆǃ (ǁǄ%) conferred
non-synonymous changes. We evaluated the annotations for the ǂǆ genes on this
list using gene and protein prediction algorithms through PlasmoDB.org [ƾǁ] and
associated links, including predicted GO function, pathway, inter-pro domains or
user comments, combined with any published literature for each gene. ĉe great
majorityof theǂǆgenes (ǃǂ%)canbecollectively classiėed into the followingcate-
gories: surfacemolecules or transporters (ƾƾ/ǂǆ or ƾǆ%, of which ǃ/ǂǆ or ƾƽ% are
transporters) including pfcrt; molecules involved in genomemaintenance or tran-
scriptional regulation (ǆ/ǂǆor ƾǂ%);metabolic enzymes (ƾƿ/ǂǆor ƿƽ%, ofwhich
ǀ/ǂǆ or ǂ% mediate lipid metabolism) including dhě; and molecules involved in
ubiquitination (ǃ/ǂǆ or ƾƽ%). Remaining genes were determined as mediators of
various other cellular functions including protein binding, invasion, and gamete
fertilization (ƾƿ/ǂǆ or ƿƽ%) or unclassiėed (ǆ/ǂǆ or ƾǂ%).
ƾƿǂ
We also analyzed all ǀǂ genes within the chromosome ǃ region (between
position ƾ,ƾƾǄ,ƿǃǆ and ƾ,ǀǆƽ,ǃǃƿ) found to be under selection in pyrimethamine-
resistant parasites. ĉis region contained a large stretch of intergenic mutations
and it was diﬃcult to localize the signal to any one gene. It contains a large
number of metabolic genes (ƾƿ/ǀǂ or ǀǁ%, of which ǀ/ǀǂ or ǆ% participate
in lipid metabolism; ƿ/ǀǂ or ǃ% mediate folate metabolism); chaperones and
genes involved in ubiquitination (ǂ/ǀǂ or ƾǁ%); with additional genes classi-
ėed as genome maintenance or transcription regulation (ǅ/ǀǂ or ƿǀ%); surface
molecules or transporters (ǀ/ǀǂ or ǆ%); other biological functions including
structural proteins (ƿ/ǀǂ or ǃ%); and the remainder (ǂ/ǀǂ or ƾǁ%) as unclassi-
ėed.
Molecules implicated in the ubiquitination cascade were mainly associated
with resistance to pyrimethamine and include a putative Eƿ conjugating enzyme
(PFLƿƾƽƽw), which likely acts as a ubiquitin Eƿ variant (UEV) due to the lack
of a catalytic cysteine and a HECT Eǀ ubiquitin ligase (MALǅPƾ.ƿǀ). Within
the chromosome ǃ region there were several other molecules proposed to mod-
ulate ubiquitination including a HECT Eǀ (PFFƾǀǃǂc) and a Cullin-like Eǀ
(PFFƾǁǁǂc). Two other molecules contain domains suggestive of a possible role
in ubiquitination, including PFƽǅ_ƽƽǅƽ that contains a PUB domain found in
proteins linked to the ubiquitin proteasome system [ǀ], and PFFƾǁǅǂw, which
contains an ubiquitin interacting motif. Also in this region are two putative chap-
erones, including a protein containing a Dna J domain (PFFƾǁƾǂc) associated
with heat shock molecules [ǀǅ] and a TRP (PFFƾǂƽǂw) involved in RNA degra-
dation [ǁƾ] with a proposed chaperone function. Finally, there is a putative RING
Eǀ (PFDƽǄǃǂw) in a region of selection associated with primaquine sensitivity.
Several genes putatively involved in lipid metabolism were identiėed in our
regions of drug associated-selection, including an acyl-CoA synthetase, PfACSǅ
(PFBƽǃǆǂc) [ƾǅ] and a putative phosphopantothenoylcysteine synthetase
HECT—homologous to the E6-AP carboxyl terminus
PUB—peptide:N-glycanase/UBA or UBX
TRP—tetratricopeptide repeat protein
ƾƿǃ
(PFDƽǃƾƽw, under selection in quinine-resistant parasites) proposed to be
involved in CoA biosynthesis. Other lipid-metabolism associated molecules
in the chromosome ǃ region include an acetyl-CoA synthetase (PFFƾǀǂƽc)
[ƾǀǅ]; an ethanolaminephosphotransferase (PFFƾǀǄǂc-a/b) [ǅǅ, ƾǄƿ]; and a
phosphatidylcholine-sterol acyltransferase precursor (PFFƾǁƿƽw). Finally, the
PFDƽǀǂƽw gene, predicted to play a role in isoprenoid biosynthesis [ǄǄ], is in a
region under selection in artemisinin-sensitive parasites.
Folate pathway molecules in regions of selection speciėc to pyrimethamine-
resistantparasites include thedhě locus (PFDƽǅǀƽw); PFƾǁ_ƽǁǅǄ(aminomethyl-
transferase); as well as PFFƾǀǃƽw (ǃ-pyruvolytetrahydropterin synthetase; and
PFFƾǁǆƽw (methenyltetrahydrofolate activity) found within the chromosome
ǃ region. Folate metabolism has been shown to be a target of pyrimethamine
resistance mechanisms, and speciėcally SNP changes in dhě and dhps, as well as
copy number variants in gchȊ [ǅǀ] are associated with anti-folate resistance [ƾƾƽ].
ĉere are three ABC transporters among the gene lists including PFƾƽ_ƽƽǁǆ,
MALǅPƾ.ǆǄ, and PFƽǅ_ƽƽǄǅ, which are intriguing since these molecules have
been shown to modulate drug responses in malaria (e.g. pfmdrȊ) and other or-
ganisms [ǅǆ]. Finally, we believe that there are a large number of molecules from
among thegenomemaintenanceor transcriptional regulation classiėcationmaybe
candidates for drug modulation through changes in gene expression [ƾƽǀ], chro-
matin or histone structure [ǀǀ, ǀǄ], or RNA binding [ǆǆ].
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Drug assays were performed as described [ƾǀƿ] with slight modiėcations for ǀǅǁ-
well format. Synchronized ring-stage parasites were cultured in the presence of
serial dilutions of test compounds in ǁƽμL of RPMI supplemented with Albu-
MAX II (Life Technologies ƾƽƿƾ-ƽǁǂ) at ƾ.ƽ% hematocrit and an initial para-
sitemia of ƾ.ƽ% in black clear-boĨom plates (Greiner Bio-one Ǆǅƾƽǆƽ). Follow-
ing a Ǆƿ hour incubation under standard culture conditions, SYBR Green I dye
ƾƿǄ
(Invitrogen SǄǂǃǀ) was added to a dilution of ƾ:ǂƽƽƽ and plates were stored at
room temperature until the Ěourescence signal was read on a SpectramaxMǂplate
reader (Molecular Devices, ex ǁǅƽnm, em ǂǀƽnm). Raw Ěourescence data were
analyzed using the Prism vǂ.ƽ soěware package (GraphPad Soěware, Inc.). Aěer
background subraction and normalization, ICǂƽ values were determined based on
application of a nonlinear regression log(inhibitor)-response curve ėt.
D.ǁ.ƿ XP-EHH
Selection-association tests were run using the cross population extended haplo-
type homozygosity test (XP-EHH) [ƾǂƾ]. Replicate ICǂƽ data was geometrically
averaged (equivalently, logƾƽ(ICǂƽ) data was arithmetically averaged) and then
converted to binary phenotypes (“sensitive” vs. “resistant”) according to cutoﬀs
shown in Figure D.ƾ and Dataset ƾ. For drugs with a bimodal distribution, binary
cutoﬀs were chosen at positions that clearly separated the sensitive and resistant
populations. For drugs with a more unimodal distribution, cutoﬀs were manually
placed at a distribution minimum near the median ICǂƽ, since the XP-EHH test,
likemany other tests, loses powerwhen either of the two populations becomes too
small (when the cutoﬀ is too far from the median). Although these may not rep-
resent samples that are especially sensitive or resistant in the traditional sense, it is
common in studies of quantitative phenotypes to simply compare the upper part
of a distribution against the lower part for binary tests [ƾǂ].
ĉe recombination map was constructed with LDhat vƿ.ƾ [ǆǄ] using a block
penalty of ǂ.ƽ, ƾƽ million rjMCMC iterations, a missing data cutoﬀ of ƿƽ%, min-
imum minor allele frequency of ǅ%, and otherwise default parameters. Since the
XP-EHHtest does not toleratemissing data, SNPswith data in at least ǅƽ%of indi-
vidualswere imputedwithPHASEƿ.ƾ.ƾ [ƾǂǃ]. AsPHASE requires “diploid” data,
we dropped the sample with the lowest call rate (SenPǃƽ.ƽƿ) to create an even
number of haploid individuals, randomly paired together. ǅǀ,ǂǁƽ fully-imputed
SNPs were polymorphic among the remaining ǁǁ individuals. We then ėltered
out singleton SNPs and used only ƿǆ,ǃƽǂ SNPs that had at least two samples with
a minor allele (minor allele frequency of ǁ%).
ƾƿǅ
ĉeXP-EHHtest calculates haplotypedecay separately for the resistant popula-
tion and sensitive population using the extendedhaplotype homozygosity statistic
(EHH). It then integrates these values with respect to genetic distance and com-
putes a log ratio of these areas for the resistant population over the sensitive popu-
lation. ĉese log ratios, aěer normalization, are calledXP-EHHscores orZ-scores,
as they are found to correspond to a normal distribution, with the exception of the
tails that diverge from the null expectation (Fig. D.ǁB). Other than its application
to a phenotypically-divided population (instead of a geographically-divided pop-
ulation), the original algorithmswere used as published [ƾǂƾ] without anymodiė-
cations. Signiėcantly positiveZ-scores are indicative of positive selection amongst
resistant parasites. Negative scores are indicative of selection in sensitive parasites.
We used a two-sided conversion ofZ-scores to P-values, but generally focused our
aĨention on positive Z-scores. It would be equally valid to do a one-sided, leě- or
right-tailed conversion for studies that are interested in speciėc selection scenar-
ios.
We aĨempt to localize the signal in these regions by searching for the strongest
EMMA signal in that window for that phenotype. We use this SNP to suggest a
causal gene for the region (Dataset ƾ). We do not require signiėcance from the
EMMA test, as the region has already been identiėed as genome-wide signiėcant
by theXP-EHH test. We do not combine the results from these or any other statis-
tics.
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Figure D.1: Drug response distributions for the twelve drugs used in this study: histograms
of logƾƽ(ICǂƽ) across 45 strains. Dark gray lines indicate binary cutoff values used for the
XP-EHH test.
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Figure D.2: Drug response correlation heat map for the twelve drugs used in this study.
Pearson correlations are rendered for each pair of drugs, based on logƾƽ(ICǂƽ) values for
each strain.
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Figure D.3: EMMA GWAS plots (sequence data, 45 samples): (A) EMMA Manhattan plots
of  logƾƽ(P) against genomic position. (B) EMMAP-P plots against the expected uniform
distribution. Dashed line indicates Bonferroni-corrected signiﬁcance of 5%. The shaded
area indicates a 95% conﬁdence interval around the null.
ƾǀƿ
Figure D.4: XP-EHHGWAS plots (sequence data, 45 samples): (A) XP-EHHManhattan-like
plots of Z-scores against genomic position. (B) XP-EHH Q-Q plots of XP-EHH Z-scores
against the expected normal distribution. Dashed lines indicate a 95% conﬁdence interval
around the null.
ƾǀǀ
Figure D.5: EMMA GWAS plots (array data, 24 samples): (A) EMMA Manhattan plots of
  logƾƽ(P) against genomic position. (B) EMMA P-P plot against the expected uniform
distribution. Dashed line indicates Bonferroni-corrected signiﬁcance of 5%. The shaded
area indicates a 95% conﬁdence interval around the null.
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I performed all analyses shown in this appendix and created all ėgures. Ex vivo
drug data for GWAS was generated by DVT.
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Figure E.1: Derived allele frequency (DAF) spectra over all samples and by year.
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Figure E.2: DAF over time for major drug loci. This shows the estimated derived allele
frequency at each year (black line) for seven known drug loci. The ﬁrst three loci on chro-
mosome 4 at left are dhfr mutations N51I, C59R, and S108N. The last locus at left on chro-
mosome 5 is pfmdr1 N86Y. The three loci at right on chromosome 7 are pfcrt mutations
N75K, K76T, and R371I. 95% conﬁdence intervals are drawn in gray for each estimate of
the DAF based on binomial sampling error. None of these loci show signiﬁcant movements
over this time period.
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Figure E.3: HMMstatistics are biased at extreme derived allele frequencies. This shows null
simulations of the LRT statistic against the expected χƿ distribution. The data is plotted
separately for each of ten bins corresponding to deciles of the derived allele frequency
distribution shown in Figure E.1. The ﬁrst three deciles (corresponding toDAF < ƽ:ƽǀǃǂ)
show signiﬁcant departures from χƿ. Most of the intermediate frequencies ﬁt well, but the
ﬁnal decile (DAF > ƽ:ǆƿǄ) shows departures again. This suggests that the model has
difﬁculty with extreme allele frequencies.
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Figure E.4: HMM statistics at different drift strengths and time spans. This shows null
simulations of the LRT statistic against the expected χƿ distribution. Data is plotted sepa-
rately for two values ofNe (100 on top, 1000 on bottom) and three thresholds for minimum
number of samples per year, resulting in 4, 5, or 6 years of data. The four year data set
comprises the years 2008-2011. The ﬁve year data set adds 2004. The six year data set
adds 2002.
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Figure E.5: Volcano plot. This visualization of statistical signiﬁcance (  logƾƽ P) vs. effect
size (s) is often used in RNA expression studies and allows one to visually prioritize selection
strength, given a threshold for signiﬁcance.
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Figure E.6: Double-zero variants lead to inﬂated statistics. Many of the variants exhibiting
strong negative selection are due to loci that have time series data similar to the example
shown in (A). Small observations are seen in the ﬁrst year, followed by complete absence
in the ﬁnal two years. This is interpreted by the HMM as evidence for very strong negative
selection, but may simply be due to inaccurate estimates by the HMM at the edges of allele
frequency space. The distribution of s including all variants (B) is reduced to a signiﬁcantly
smaller range when removing these “double zero” variants (C). A volcano plot colored by
double zero status (D) illustrates that nearly all of the most extreme negative values are due
to this artifact.
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Figure E.7: Long-haplotype selection tests in three West African populations. The top
three panels depict signals from the iHS long haplotype selection test [173] in Burkina Faso,
Mali (both from Manske et al. [95]) and Senegal (described here). Positive values denote
selection for the ancestral allele, negative values denote selection for the derived allele.
The bottom three panels depict signals from the XP-EHH long haplotype differentiation test
[151] between the three populations. Positive values denote selection in the ﬁrst named
sample, negative values denote selection in the second named sample.
ƾǁƿ
E.ǂ EŎ ŋĽŋŃGWAS ŉĹňŉň
Figure E.8: EMMA results for GWAS on 125 Senegalese samples for resistance to chloro-
quine, pyrimethamine, meﬂoquine, artemisinin, artesunate, and dihydroartemisinin. Tests
show strong signals at previously known loci at pfcrt (chloroquine), dhfr (pyrimethamine),
and pfmdr1 (meﬂoquine), with no signiﬁcant signals from any of the artemisnin-related
drugs.
ƾǁǀ
Figure E.9: XP-EHHGWAS results for drug resistance-associated positive selection. Drugs
tested include chloroquine, pyrimethamine, meﬂoquine, artemisinin, artesunate, and di-
hydroartemisinin. Positive signals indicate positive selection in drug resistant parasites.
Negative signals indicate positive selection in drug sensitive parasites.
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